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Abstract 
This thesis describes studies on the analysis of arsenic (As) in human biological 
samples, mainly urine but also hair and fingernails using inductively coupled plasma 
mass spectrometry (ICP-MS) and graphite furnace atomic absorption spectrometry 
(GF-AAS). The relationship between ethnicity and arsenic metabolism was investigated 
for the first time for a population in the United Kingdom. This investigation has been 
carried out through comparative analysis of arsenic in human urine, hair and fingernails 
in volunteers from three different ethnic groups (Whites, Asians and Somali Black-
Africans) who are only exposed to background levels of arsenic. Results obtained with 
63 volunteers showed ethnic differences in urinary arsenic excretion as well as 
differences in arsenic levels in fingernail samples.  The averages of total arsenic levels 
for the Somali Black-Africans (urine 7.2 µg/g creatinine; fingernails 723 µg/kg) are 
significantly (P< 0.05) different from both the Asians (urine 20.6 µg/g creatinine; 
fingernails 153.9 µg/kg) and Whites (urine 24.5 µg/g creatinine; fingernails 177.0 
µg/kg). The Somali group also shows a higher percentage (50%) of dimethylarsinate 
(DMA) and a lower percentage (48%) of arsenobetaine (AB), compared to Asians 
(16% DMA and 83% AB) and Whites (22% DMA and 77% AB).  
The effect of fasting on urinary arsenic species distribution was also 
investigated by monitoring urine samples from 29 Ramadan fasting volunteers, with 
each volunteer providing a sample at the beginning (RF1) and at the end (RF2) of an 
approximately 12 hours fast.  The results obtained showed the frequency of MA 
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 detection for RF2 was 12 and 2-fold higher than for the non-fasting and RF1 
groups, respectively.  This suggests fasting may alter the pattern of arsenic metabolism 
and excretion.  However, there was no significant difference (P> 0.05) in the average of 
total level of arsenic for RF1 (18.3 µg/g creatinine) and RF2 (17.7 µg/g creatinine).   
A relationship between excretion of arsenic and selenium in individuals exposed 
to background levels of arsenic and selenium was investigated through analysis of urine 
samples from 93 volunteers from Leicester, UK.  A positive correlation between 
arsenic and selenium was found and the As:Se ratio was 0.7 ± 0.4. The intra-individual 
variation of As:Se ratio does not alter significantly over time, as determined by 
monitoring urine samples from a volunteer over a period of one year. Furthermore, 
within a single day, with urine samples collected at the beginning and after a 12-hour 
fast, the As:Se ratio was found to be similar (0.7 ± 0.5).   These findings suggest a close 
relationship between these two metalloids, the biological significance of which needs to 
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Millions of people worldwide suffer from chronic exposure to inorganic arsenic 
(As) through their drinking water (Samanta et al., 1999). In Bangladesh and India alone 
over 100 million people are affected (Tokunaga et al., 2002). Arsenic in the 
environment can exist as organic and inorganic compounds.  Exposure to inorganic 
arsenic is associated with various health effects such as cancer of skin, lung, kidney, 
liver and bladder; skin manifestations such as melanosis and keratosis have also been 
reported (Samanta et al., 2000).  Urinary excretion is the major pathway for the 
elimination of arsenic compounds from the human body (Le at al., 1994).  Therefore, 
urinary arsenic can be used as a biomarker of exposure to arsenic in humans, although 
arsenic in hair and nail also can also be used. Arsenic in urine reflects only recent 
exposure while arsenic in hair and nail represent chronic exposure (Mandal et al., 
2004).  This thesis focuses mainly on the analysis of arsenic in human urine. 
1.1 Arsenic Chemistry 
 
Arsenic (As) has the atomic number and atomic mass of 33 and 74.92 
respectively, as shown in Table 1.1 (Lenntech, 2007). Arsenic is a metalloid widely 
distributed in the environment. Arsenic occurs with a valence state of +3 and +5, with 
rare occurrences of -3 and 0. For this reason, + 3 (arsenite (As (III)) and +5 (arsenate 
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 (As (V)) are the main species that dominate studies of arsenic in chemistry (Kirk-
Othmer, 1992). 
 
Table 1.1 Chemical properties of arsenic (compiled from Lenntech, 2007). 
Atomic number 33 
Atomic mass 74.9216 g.mol -1   
Electronic shell  [ Ar ] 3d10 4s2 4p3 
Melting point 814 °C (36 atm.)   
Boiling point 615 °C (sublimation) 
Density 5.7 g.cm-3 at 14°C 
Standard potential - 0.3 V (As3+/ As ) 
Electronegativity  2.0 
Ionic radius 0.222 nm (-2) 0,047 nm (+5) 
0,058 (+3) 
Energy of first ionisation 947 kJ.mol -1 
Energy of second ionisation 1798 kJ.mol -1 
Energy of first ionisation 947 kJ.mol -1 
 
Inorganic compounds of arsenic can occur as halides, hydride (arsine), oxides, 
acids, and sulphides (Kirk-Othmer, 1992). Different conditions can affect arsenic’s 
valence state as well as its chemical forms such as pH, oxidation-reduction potential, 
microbial activity, and the presence of different ions, e.g. sulphur, iron, and calcium 
(Vance, 2007).  In natural waters, arsenic occurs predominantly as As (III) and As (V) 
(Smedley and Kinniburgh, 2002). In oxidising environments the pentavalent forms 
H3AsO4, H2AsO4-(aq), HAsO42-(aq) and AsO43-(aq) are predominant, whilst trivalent 
forms such as  H3AsO3, H2AsO3-(aq), HAsO32-(aq) and AsO33-(aq), are typically 
predominant species in reduced conditions (Smedley and Kinniburgh, 2002; 
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 Bhattacharya et al., 2003). In these reduced conditions organic arsenic such as 
methylarsonate (MA) and dimethylarsinate (DMA) were also reported in  groundwaters 
(Gault et al., 2003; Shraim et al., 2002). The degree of protonation of As (III) and As 
(V) is pH dependent.  At low pKa H3AsO3 occurs as neutrally charged species, whereas 
H3AsO4  occurs as the oxyanion species (Gault et al., 2005a).  Redox potential (Eh) and 
pH are important factors for arsenic species (Smedley and Kinniburgh, 2002). An Eh-
pH diagram for arsenic at 250C is shown in Fig. 1.1 (Ferguson and Gavis, 1972). The 
diagram results were obtained at one atmosphere with a total arsenic level of  10-5 mol/l 
and sulphur level of 10-3 mol/l (Ferguson and Gavis, 1972). At pH > 10 both As (III) 
and As (V) are present as anionic species, because the pKa1 values for both species 
(Table 1.3 ) are less than pH 10 (Yalcin and Le, 1998). As shown in Fig. 1.1, reduced 
and acidic conditions favour precipitation of As2S3 and AsS (Smedley and Kinniburgh, 
2002; Cullen and Reimer 1989). Therefore, high levels of arsenic in water is not to be 
expected where there is a high concentration of free sulphide (Moore, 1988). 
  




Figure 1.1 The Eh-pH diagram for arsenic (adapted from Ferguson and Gavis,1972)  
 
Fig.1.2 shows the position of arsenic and selenium (Se) in the periodic table.  
These two elements appear close to each other in the table and it has been suggested 
that they interact with each other in humans (Levander, 1977). Section 1.4.1.6 discusses 
the effect of selenium on arsenic metabolism in humans.  
 
  




Figure 1.2 The Periodic Table with As and Se highlighted in red and green boxes, 
respectively 
 
1.2 Arsenic occurrence 
 
Arsenic can originate from both natural and anthropogenic sources; these are 
discussed separately below. Natural sources include wind-blown dust, volcanoes and 
seafood (Lima et al., 2002; Yamaushi et al., 1992 ), while examples of anthropogenic 
sources include insecticides (lead arsenate), herbicides (cacodylic acid), cotton 
desiccants (arsenic acid), wood preservatives (copper/chromium arsenate) and growth 
promoters for swine and poultry (substituted phenylarsonic acid) (Vahter, 1994).  
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 1.2.1 Natural occurrence of arsenic  
Arsenic occurs naturally in earth’s crust, animals, soil, water, air, rocks and 
plants. Weathering of rocks results in arsenic release in the environment as a dust or in 
groundwater (Mandal and Suzuki, 2002; Smedley and Kinniburgh, 2002).  
1.2.1.1 Arsenic in the earth’s crust 
 
The concentration of arsenic in the earth’s crust is between 2 to 5 mg/kg, and it 
ranks 20th of all elements. The natural arsenic mineral consists of  60% arsenates, 20% 
sulphides and sulfosalts and 20% arsenides, arsenites, oxides and elemental arsenic 
(Smedley and Kinniburgh, 2002;  Meerdink, 2001). The main mineral containing 
arsenic is sulphide, and the most abundant arsenic sulphide ores are arsenopyrite 
(FeAsS), realgar (As4S4) and orpiment (As2S3) (Smedley and Kinniburgh, 2002). 
1.2.1.2 Arsenic in soil 
 
 Arsenic bound to organic materials in the soil mainly occurs as inorganic 
arsenic. As(V) is a predominant species under oxidizing conditions, while As(III) is the 
main species under reduced conditions (Bhumbla and Keefer, 1994). The concentration 
of arsenic in uncontaminated soils is from 0.1 to 40 mg/kg (Mandal and Suzuki, 2002; 
Pendias and Pendias, 1992). In contaminated soils, the range was found to be between 
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 1.2.1.3 Arsenic in water 
 
Generally, the average arsenic concentration in seawater, river water and 
groundwater is 1.5, 0.1-0.8, and <10 µg/l (the background of arsenic concentration in 
most countries), respectively. However, a large range of arsenic concentration (< 0.5 – 
5000 µg/l) has been reported in groundwater, which occurs under various natural 
conditions (Smedley and Kinniburgh, 2002). 
Groundwater arsenic contamination has already been reported in 20 countries 
around the world (Fig. 1.3). The most affected countries, in order of severity, are 
Bangladesh, West Bengal (India), Inner Mongolia (China) and Taiwan (Chakraborti et 
al., 2002). Millions of people in arsenic-contaminated groundwater areas drink water 
with arsenic concentration of  50 µg/l, while the recommended guideline by the World 
Health Organization is 10 µg/l (Chakraborti et al., 2002; Smedley and Kinniburgh, 
2002). 
 The mechanism blamed for releasing arsenic in groundwater is arsenic mobility, 
caused by weathering reaction and biological activity (Smedley and Kinniburgh, 2002). 
Breakdown of sulphide rocks containing arsenic convert arsenic to As (III), which 
enters the groundwater (Mandal et al., 2002). It is considered that a reductive 
dissolution of arsenic-bearing ferric hydroxides is driven by microbial degradation. 
Recently, Islam et al. (2004) showed that arsenic release took place after Fe(III) 
reduction, and that anaerobic metal-reducing bacteria can play a key role in the 
mobilisation of arsenic in sediments from a contaminated aquifer in West Bengal. In a 
study of a shallow aquifer in West Bengal, the microbial community at 24 and 45m 
depths was identified as the Acinetobacter species; in fact, this species comprises most 
of the 24m sedimentary bacterial population (Gault et al., 2005b).  
  






Figure 1. 3 Documented groundwater arsenic-contamination around the world, 










1.2.1.4 Arsenic in food 
 
Most foods contain a low concentration of arsenic. Usually arsenic in food 
occurs in organic and inorganic forms, with organic forms dominating in fish and 
seafood (WHO, 1981). Arsenic in food is generally concentrated at < 1mg/kg wet 
weight, with the exception of some seafood. Marine fish contains arsenic on average < 
5mg/kg. Seaweed from Japan has been reported to contain an average concentration of 
arsenic in the range of 19 -172 mg/kg dry weight. The use of arsenic containing feed 
additives for poultry and swine lead to accumulation of arsenic in these animals (WHO, 
1981). Recently, organic arsenic was reported in rice and chicken (Williams et al., 
2005; Polatajko et al., 2004). It has been reported in a review by Mandal et al. (2002) 
that fish, fruits and vegetables contain <10% inorganic arsenic, the remainder being 
mainly organic arsenic, while arsenic in some foods such as milk, beef, pork, poultry, 
dairy products and cereals is mainly inorganic, at an average of 65-75%.  
1.2.1.5 Arsenic in Plants 
 
In general, the concentration of arsenic in plants varies between <0.01 to 5 mg/g 
(dry weight basis) (Mandal and Suzuki, 2002). Different plant species can take up 
arsenic and then translocate it within various parts of the plant. The highest arsenic 
concentrations are always found to be in roots and old leaves (Pendias and Pendias, 
1992). The concentration of arsenic varies from 0.009 to 1.5 mg/kg in plants grown in 
uncontaminated soils, the highest arsenic concentrations being recorded in leafy 
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 vegetable and the lowest in fruits (Pendias and Pendias, 1992). The arsenic 
concentration in different vegetables from the UK and EU - purchased in Leicester City 
market - was reported to be in the range < 5 – 87 µg/kg (Al-Rmalli, 2004). 
1.2.1.6 Arsenic in the human body 
 
In general, 98.5% of the human body is made up of six elements. These are, in 
increasing order of abundance within the body, oxygen, carbon, hydrogen, nitrogen, 
calcium and phosphorus. Other elements such as potassium, sulphur, sodium and 
magnesium represent 0.8% while copper, zinc, selenium, molybdenum, fluorine, 
chlorine, iodine, manganese, cobalt and iron represent 0.7%. Arsenic and a range of 
other elements (lithium, strontium, aluminium, silicon, lead, vanadium, and bromine) 
only occur in trace amounts in the human body (Harper et al., 1977).   
In humans, arsenic can accumulate particularly in ectodermic tissues such as 
hair and nails. The human body contains between 3 to 4 mg arsenic (Table 1.2), a 
figure which tends to increase with age (WHO, 2001). Most tissues in human body 
contain less than 0.3-47 µg/g (dry weight), with the exception of teeth, hair and nails 
(WHO, 2001). Anionic and soluble arsenic species are more highly absorbed by the 
human body than are insoluble species (Mandal  and Suzuki, 2002). 
Unexposed individuals in Europe have approximately 10-20 µg/l of arsenic in 
their urine (Ritsma et al., 1998; Stoeppler et al., 1994; Cornelis et al., 1995). The 
normal levels of arsenic in different biological samples (urine, hair and nail) have been 
reported as five to 40 µg per 1.5 l per day in urine (Farmer and Johnson, 1990), 80 to 
250 µg/kg in hair (Arnold et al., 1990) and 430 to 1080 µg/kg in nail (Ioanid et al., 
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 1961). In the human blood, an arsenic concentration of 5.1 ± 6.9 g/l was reported 
as an average level in normal individuals (Foa et al., 1984). 
Table 1.2 Background levels of total arsenic in human body, biological samples 
and the natural environment 
Material Arsenic concentration  Reference 
Whole human body 3 - 4 mg  WHO, 2001 
Whole human body  0.3-147µg/g(dry weight), with 
the exception of teeth, hair and 
nails 
WHO, 2001 
Human urine 10-20 µg/l Ritsema et al., 1998 
Human urine  5 to 40 µg per 1.5 l (per day)  Farmer and Johnson, 1990 
Human hair 80 to 250 µg/kg  Arnold et al., 1990 
Human nail 430 to 1080 µg /kg Ioanid et al., 1961 
Human blood 5.1 ± 6.9 g/l Foa et al., 1984 
Soils 0.009 to 1.5 mg/kg Pendias and Pendias, 1992 
Plants 0.1-40 mg/kg  Mandal and Suzuki, 2002 
Terrestial food < 1mg/kg  WHO, 1981 
Seafood < 5mg/kg WHO, 1981 
Groundwater < 10 µg/l Smedley and Kinniburgh, 2002 
River water 0.1-0.8µg/l, Smedley and Kinniburgh, 2002 
Seawater 1.5 µg/l Smedley and Kinniburgh, 2002 
 
1.2.2 Anthropogenic occurrence of arsenic  
 
Anthropogenic sources of arsenic exceed natural sources by 3:1 (Mandal et al., 
2002and reference therein). These consist of insecticides (lead arsenate), herbicides 
(sodium arsenite, used as weedkiller) desiccants and wood preservatives (chromated 
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 copper arsenate) and feed additives (substituted phenylarsonic acids). 
Approximately 90% of the world’s arsenic  production is attributed to China, the 
USSR, France, Mexico, Germany, Peru, Namibia, Sweden and the USA (U.S. 
Department of the Interior, 1973; Nelson, 1977). Arsenic can be released into the air, 
soil and water as a result of human activities such as fossil burning, fertiliser 
application, the use of arsenical pesticides and the disposal of industrial waste (Mandal 
et al., 2002). McLeod and co-workers (Bellis et al., 2003) reported arsenic deposited 
from the atmosphere for the first time on tree bark pockets, a deposition associated with 
human activities, especially copper industries. 
1.3 Arsenic toxicity 
 
 The toxicity of arsenic varies due to its chemical forms and oxidation states, in 
addition to other factors such as physical state (gas, solution or powder). The toxicity of 
inorganic arsenic compounds decreases in the order AsH3 > As (III) > arsenoxides > As 
(V) > arsonium compounds (Mandad et al., 2002; and references cited therein), while 
that of organic arsenic compounds decreases in the order MA > DMA> MA (Le and 
Ma, 1997). The toxicity of both arsenic compound forms was reported in increasing 
order, accompanied by a Lethal Dose of 50 per cent (LD50) as follows: arsenobetaine 
(AB) < DMA < MA < As (V) < As(III), with corresponding LD50 values (mg/kg) in 
rats of >10000, 700 - 2600, 700 - 1800, 20 and 14 (Le and Ma, 1997). Table 1.3 gives 
the structures and abbreviations of different arsenic species.  Arsenic species such as As 
(III), As (V), MA and DMA, which are present in natural waters (Le et al., 1994), are 
more toxic than others which are found in seafood [AB, arsenocholine (AC), 
tetramethylarsonium ion (TETRA) and arsenosugars]  (Samanta et al., 2000; Larsen et 
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 al., 1993). Inorganic arsenic species (As (III) and As (V)) undergo methylation in 
the human body after ingestion; the major route for elimination of arsenic is urinary 
excretion (Le et al., 1994). Since the chemical form of arsenic determines its toxicity, it 
is usually not sufficient just to determine the total level of arsenic in urine; speciation 
analysis is also necessary. 
 Ingested inorganic arsenic is metabolised in humans into MA and DMA 
compounds. Methylarsonite (MA (III)) and dimethylarsinite (DMA (III)) are produced 
as intermediates during the biotransformation process, with the first of these being 26 
time more toxic than As (III) in human hepatocytes (Petrick et al., 2003). MA (III) and 
DMA (III) were shown to damage DNA in human peripheral lymphocytes, which 
shows that these species as genotoxic (Mass et al., 2001). Another aspect of arsenic 
toxicity is inactivation of enzyme systems, which occurs by interaction of As (III) with 
enzymes through binding to -SH and -OH groups. This interaction mainly favours 
enzymes with two adjacent SH-groups. The enzymes that generate cellular energy in 
the citric acid cycle are adversely affected. The inhibitory action involves inactivation 
of pyruvate dehydrogenase by complexation with As (III), which leads to prevention of 
adenosine-5-triphosphate (ATP) production. This results in reduction of energy 
production, and finally slow damage of cells (Mandad et al., 2002). Chronic exposure 
to arsenic in drinking water results in arsenocosis, the symptoms of which are skin 
pigmentation, hyperkeratosis of hands and feet (Fig. 1.4), skin cancer, liver damage, 
peripheral vascular disease, blackfoot disease and diabetes (Shraim et al., 2003; Tseng 
et al., 1996; Tseng et al., 2004). Acute exposure to arsenic results in vomiting, nausea 
and garlic odour on the breath (ATSDR, 2000). 
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 Table 1.3 Relevant structures, formulae and molecular weights for commonly 
occurring arsenic containing compounds found in food and the environment and also 
detected in human urine. 
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Figure 1.4 Long-term effect of arsenic in drinking water on feet and hands, 
modified from Harvard (2007). 
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 1.4 Arsenic metabolism in humans 
 
Humans are exposed to arsenic through drinking water, food or general 
environmental contamination (Mandal et al., 2002). After exposure, inorganic arsenic 
in particular will be metabolised into methylated arsenic species.  Methylation of 
arsenic in humans is generally thought to involve alternating reduction and oxidative 
methylation steps (Cullen and Reimer, 1989). Different methylated arsenic compounds 
are formed as shown in Fig.1.5 (Challenger, 1945), which describes arsenic’ s 
methylation process. Buchet and Lauwerys (1985, 1987) report that Glutathione (GSH) 
is essential in reduction, and that S-adenosyl methionine (SAM) donates a methyl group 
to arsenic in its trivalent form (in oxidative methylation step) which is sequentially 
methylated to form MA and DMA. However, Hayakawa et al. (2005) recently reported 
that the metabolic transformation of As (III) to MA and DMA can take place through a 
new metabolic pathway involving arsenic methyltransferase (Cyt19) via arsenic 
triglutathione (ATG) and monomethylarsonic diglutathione (MADG), instead of  
oxidative methylation of As (III) and MA(III) via the Challenger pathway. The authors 
suggested that ATG can be generated non-enzymatically from As (III) in the presence 
of GSH., The methylation of arsenic is subsequently catalysed by Cyt19, a process 
which involves the transfer of a methyl group from S- SAM to arsenic in the presence 
of ATG and the formation by MADG of a substrate of Cyt19 for further methylation to 
dimethylarsinic glutathione (DMAG). These compounds (MADG and DMAG) are 
oxidised to MA and DMA respectively, which are found as major arsenic  metabolites 
in human urine, as shown in Fig. 1.6 (Hayakawa et al., 2005).  
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Figure 1.6 A new pathway for the methylation of arsenic (Hayakawa et al., 2005). 
 
 
The methylation process is generally considered to be a detoxification process, 
because the MA and DMA produced from the methylation process are less toxic than 
inorganic arsenic (Vahter and Marafante, 1983a; Fischer et al., 1985). However, other 
intermediates in the pathway - namely MA (III) and DMA (III) - are now known to be 
more toxic than inorganic arsenic (Styblo et al., 2000). Therefore, Petrick et al., (2000), 
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 major metabolite after the ingestion of arsenosugars, which are present in seaweed. 
This has led to the conclusion that consumption of the arsenosugars could pose a risk to 
human health (Francesconi et al., 2002; Hulle et al., 2004).  Many studies of arsenic 
speciation have focused on the separation/quantification of As (III), As (V), MA, DMA 
and AB.  The separation of these arsenic species is pH dependent with the pKa1 values 
9.3, 2.3, 2.6, 6.2 and 2.2 respectively (Wrobel et al., 2002) (Table1.3).  A simplified 
schematic diagram indicating the course of arsenic in humans, from intake to excretion 
(in urine), is shown in Fig.1.7. This figure lists the most commonly found arsenic 
species in human urine and shows the main biotransformation steps involved in human 
arsenic metabolism.  
 
1.4.1 Arsenic metabolism in relation to various parameters 
 
Arsenic metabolism is modulated by various biological factors such as exposure to 
inorganic arsenic through drinking water, dietary arsenic, genetics and ethnicity.  
Furthermore, levels of certain metabolites and metal ions are also known to modulate 












Figure 1.7 A simplified flow chart describing the fate of arsenic in humans. The 
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1.4.1.1 Definition of exposed and unexposed volunteers 
 
Due to its ubiquitous presence in the environment, it is virtually impossible to 
avoid exposure from arsenic. Hence, all humans are exposed to background levels of 
arsenic through their diet, drinking water… etc., and as mentioned previously (see Table 
1.2) the average concentration of arsenic in the whole human body is 3-4 mg  and 0.3-
147µg/g (dry weight), with the exception of teeth, hair and nails (WHO, 2001).   
However, there are situations where humans are exposed to high levels of arsenic.  This 
includes exposure through environmental or occupational sources.   These people are 
often described in the scientific literature as exposed populations.  People who are only 
exposed to background levels of arsenic are often described as unexposed individuals 
(Ritsema et al., 1998), in order to distinguish them from exposed populations.  The term 
exposed is used either alone or in combination with the words environmental or 
occupational (Chakraborty et al., 2006; Morton and Mason, 2006; Christian et al., 
2006). In this thesis, all the volunteers were only exposed to background levels of 
arsenic and are therefore termed as unexposed.  The term unexposed is used in order to 
distinguish them from people who are exposed to high levels of arsenic through 
drinking water, diet or occupational exposure. 
 
1.4.1.2 Arsenic metabolism as a function of exposure   
 
Exposure to arsenic in drinking water is a major area of research. Many studies 
have been carried out with exposed populations in different countries with high levels 
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 of arsenic in their drinking water, especially Bangladesh, India, Argentina, Taiwan 
and Chile (Tokunaga et al., 2002; Chowdhury et al., 2003; Vahter et al., 1995; Chung et 
al., 2002; Lin and Chiang, 1985). The mechanism underlying the presence of arsenic in 
groundwater in West Bengal and Bangladesh is unclear, although recent studies suggest  
metal-reducing bacteria may play a role (Islam et al., 2004; Gault et al., 2005b). 
Different arsenic species were reported in the urine of populations exposed to arsenic in 
drinking water (mainly inorganic arsenic), with percentages of commonly found 
species being 60-80% DMA, 10-20% MA and 10-20% inorganic arsenic (Vahter, 1994; 
Feldman et al., 1999). Some studies investigating exposed populations have not 
adequately controlled the diet of the volunteers, which raises doubts regarding the 
distribution of arsenic species detected in urine (Chowdhury et al., 2003).  Inhalation 
was also considered as a route of exposure to arsenic: in a single case in a laboratory a 
human inhaled trimethylarsine (TMA) during a synthesis process. The inhaled TMA 
was believed to be metabolised to AB in the human body (Goessler et al., 1997), 
because a higher level of AB than the background level was detected in urine after 
exposure to TMA. This however has been questioned by others (Edmonds, 1998). 
Based on animal experiments, the administered TMA was metabolised to TMAO 
(Yamauchi et al., 1990), and administered TMAO was excreted unchanged (Yamauchi 
et al., 1990); there was no evidence of TMAO conversion to AB. Therefore, Edmonds 
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 1.4.1.3 Understanding arsenic metabolism through ingestion 
studies 
 
 In order to understand arsenic metabolism in humans, ingestion studies have 
been carried out using food rich in arsenic such as seafood and seaweed. In addition to 
AB, which is the predominant arsenic species in seafood (Ritsema et al., 1998), a 
substantial increase in DMA was observed in urine, resulting from the metabolism of 
arsenosugars in seaweed and mussels. The presence of inorganic arsenic and DMA can 
arise from food sources: Williams et al. (2005) reported significant quantities of these 
species in rice. Moreover, experimental ingestion studies reveal individual 
intervariability in arsenic  metabolism (Lai et al., 2004). One of the main problems with 
such experimental ingestion studies is a concern regarding consumption of arsenic-rich 
food by volunteers. Therefore, these studies are often carried out with a small number 
of volunteers (5-10), making it difficult to attain reliable conclusions. Generally, 
experimental ingestion studies with toxic arsenic compounds are carried out with 
animals. However, Buchet and Lauwerys (1994) reported an ingestion experiment 
involving 34 volunteers where 500 µg As as inorganic arsenic, MA and DMA were 
administered as a single oral dose. Their results confirmed that no arsenic species other 
than inorganic arsenic, MA and DMA were present in urine. This was alongside a 
partial methylation of inorganic arsenic to MA and DMA, and methylation of MA to 
DMA, while DMA was excreted unchanged. In another DMA ingestion study in 
humans, the ingested DMA was equivalent to 0.1 mg As/kg body weight. However, 
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 1.4.1.4 Arsenic metabolism as a function of ethnicity/genetics 
 
 The role of genetics in arsenic metabolism is still at its infancy, and very few 
studies have been carried out in this field. However, several genes related to arsenic 
metabolism have been identified, such as the glutathione S-transferase (GST) genes (for 
example GSTM1 and GSTP1 null genotypes, which are related to the higher percentage 
of excretion of MA and DMA respectively) (Ricardo et al., 2006; Chiou et al., 1997). In 
addition, Aposhian and Aposhian (2006) reported that a number of polymorphisms in 
human GST omega (), CYT 19 and purine nucleoside phosphorylase (PNP) are also 
linked to changes in urinary arsenic species.  Some studies indicate that there is a 
relationship between arsenic metabolism and ethnicity (Loffreddo et al., 2003; Lai et 
al., 2004; Wrobel et al., 2002).  However, this has not been unequivocally proven as 
most of these studies have been performed among exposed populations using primarily 
epidemiological data. Some of these studies compare population residing in different 
countries, which introduces the problem of a lack of control for variables such as diet 
(Lai et al., 2004). 
1.4.1.5 Homocysteine and folate  
 
Biological compounds such as homocysteine and folic acid are reported to be 
associated with arsenic metabolism (Chung et al., 2002; Gamble et al., 2005).  These  
molecules are important in the context of this study, since Chapter 5 presents data 
investigating the effect of fasting on arsenic metabolism.   It has been reported that 
levels of these two biological compounds undergo significant changes during fasting. 
Subjects undergoing fasting demonstrated an increase in levels of folic acid level 
(Cahill et al., 1998) and a contrasting decrease in levels of homocysteine level 
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 (Aksungar et al., 2005).   De Kimpe et al. (1999) reported that homocysteine 
inhibits  arsenic methylation.  
1.4.1.6 Selenium 
 
Selenium (Se) is a metalloid element with atomic weight 79, located in group 16 
– close to arsenic (group 15) – in the periodic Table (Fig. 1.2). The valence state of 
selenium can change from -2, through 0, +2, +4 and +6, which are associated with its 
geologic distribution, redistribution and use (Harr, 1978). The abundance of selenium is 
estimated to be the 69th common element in the earth's crust with an average content of 
0.05 - 0.09 mg/kg (Glover, et al., 1979). Fishbein (1983) reviewed both natural and 
anthropogenic occurrences of selenium. Selenium is an essential trace element 
important for human health and is known to be a component of some enzymes such as 
glutathione peroxidase and iodothyronine 5`-de-ioninase, in addition to selenoproteins 
(Arthur et al, 1994; Rayman, 1997; Rayman, 2000).  
The dietary sources of selenium include a range of different foods such as 
Brazil nuts, grain, wheat, cucumber, mushroom and shellfish (Ogra et al., 2004). The 
ingested selenium species (organic and inorganic selenium) are metabolised to selenide, 
which is then utilised for the synthesis of selenoproteins, or methylated stepwise to 
methylated selenium metabolites (Suzuki, 2005). The major urinary selenium 
metabolite is selenosugar (1{beta}-methylseleno-N-acetyl-D-galactosamine).  In 
response to excessive selenium doses, trimethylselenonium (TMSe) is excreted as a 
urinary metabolite. The normal level of selenium in urine was reported in the range of 
10 – 100 µg/l (Wang et al, 2001).  
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 Selenium was reported to have a role in reducing arsenic toxicity, because 
the two elements act as metabolic antipodes (Hsueh et al., 2003). Animal experiments 
have revealed antagonistic interaction between selenium and arsenic (review by Gailer 
(2007)). A new arsenic-selenium compound (Seleno-bis(S-glutathionyl) arsinium ion 
[(GS)2AsSe]-) in the bile of rabbits was identified when  injected with aqueous selenite 
(Se (IV)) and As (III) solutions (Gailer et al., 2000). 
An association between urinary selenium and arsenic was also reported by 
Christian et al.(2006). Urinary selenium was related to a higher percentage of DMA 
and a lower percentage of inorganic arsenic in human urine.  Selenium treatment for 
arsenocosis patients was reported by Wuyi et al. (2001). The results obtained confirmed 
decreased level of arsenic in the blood, hair and urine of the treated patients. 
1.5 Biomonitoring of exposure to arsenic in humans 
 
 Biomonitoring is defined as the measurement of trace compounds in humans 
(Becker et al., 2003). Biomonitoring is carried out by collecting samples such as blood, 
urine, hair, nails and breast milk in order to detect the occurrence of biomarkers of 
exposure. The biomarker is defined as an alteration of biochemical processes in cells 
that can be measured in biological samples or systems. Therefore, biomarkers can be 
categorised as those of exposure (detection of analyte and its metabolites) and of effect 
(detection of biological response) (Becker et al., 2003). In this study the biomarker 
under investigation is arsenic and as previously discussed this can be monitored in 
human blood, urine, hair and nails (Yoshida, 2004). 
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 1.5.1 Arsenic determination in humans’ biological samples 
 
Studies on arsenic levels in humans have been performed on blood plasma, 
serum, faeces, urine and ectodermic tissues such as hair, nails and skin-scale 
(Heyndrickx and Parisis, 1984; Shraim et al., 2003; Mandal et al., 2004; Eisler et al., 
1994). Table 1.2 summarises the normal levels of arsenic in different biological 
samples. However, urine samples are most commonly used for biomonitoring of 
arsenic exposure in humans. 
Blood samples:  Blood samples have been used as biofluids to assess arsenic exposure 
(Wu et al., 2001; Hasegawa et al., 2007), as they reflect an individual’ s arsenic intake. 
About 90% of arsenic in blood is rapidly cleared (Vahter, 1983b). Nevertheless, arsenic 
in blood is a useful indicator of continuous arsenic exposure (Morton and Dunnette, 
1994). The method of blood sample collection is through venipuncture, which makes it 
difficult to study populations. However, blood samples are relatively free from 
exogenous contamination (Yoshida et al., 2004).   
Hair Samples:  Hair samples have been used as ectodermic tissue for arsenic exposure 
(Mandal et al., 2003). Arsenic species such as inorganic arsenic and dimethylarsonate 
are deposited at the root of hair and migrate into hair shafts. Therefore, the amount of 
arsenic in longitudinal segments of hair shafts reflects the arsenic exposure at the time 
point when hair is formed (Yoshida et al., 2004). It follows that the total amount of 
arsenic in hair samples is an indicator of the average arsenic exposure over a significant 
period of time. Hair samples are prone to exogenous contamination through dust 
fixation, sweating or washing the hair with contaminated water. The removal of the 
external contamination selectively is thus not easy without losing some internal arsenic 
(Yoshida et al., 2004). 
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 Nail samples:  Nail samples, either finger- or toenails, have been used as 
ectodermic tissues for arsenic exposure (Mandal et al., 2003; Karagas et al., 2001; 
Wilhelm et al., 2005). The nails samples reflect the arsenic burden for three and six 
months for finger and toenails respectively, since arsenic binds to sulfhydryl groups of 
keratin, which then shifts to the tips of the nails during the growing period (Yoshida et 
al., 2004). The nail samples are also prone to possible external contamination (Yohida 
et al., 2004). 
Urine samples: Urine samples are the most commonly used biological samples for 
monitoring recent arsenic exposure (Calderon et al., 1999; Wilhelm et al., 2005). The 
collection procedures of urine samples are 24-h and spot urine samples. The latter is 
preferred by most researchers because the other method is more troublesome to use and 
the differences between them are minor (Calderon et al., 1999). The spot urine sample 
adjusted with creatinine is always used as an index of arsenic exposure, in preference to 
the more difficult 24-h urine sample collection (Yoshida et al., 2004). 
1.5.2 Urinary arsenic analysis 
  
As already mentioned above urine is widely recognised as an important biofluid 
for identification of biomarkers that can be used both to understand biochemical 
processes and to develop diagnostic tests.  The vast majority of studies investigating 
arsenic in humans have focused on determining total arsenic and arsenic species in 
urine rather than other commonly used biological samples such as blood, hair or nails. 
This is because the clearance of arsenic from the blood is very rapid (Chung et al., 
2002), and arsenic content of hair and nails is prone to external contamination (Johnson 
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 and Farmer, 1991). In addition, hair and nails represent long-term exposure values 
during a period of two to five months for nails and 12 to 18 months for hair (Yoshinaha 
et al., 1990; Nowak and Kozlowski, 1998).  Furthermore, analysis of urine samples has 
the added advantage that it is abundant and easy to collect. Up to 80% of ingested 
arsenic is excreted in urine after three days (Hulle et al., 2004), making inorganic 
arsenic in urine samples an important biomarker for determining recent exposure.  
1.5.2.1 Collection and storage of urine 
 
Human urine samples are usually collected in polyethylene bottles and stored at 
4 and -20 oC prior to analysis. Previous studies have suggested that storage conditions 
have an effect on the stability of arsenic species present in human urine. Very few 
stability studies (Palacios et al., 1997; Feldman et al., 1999; Yoshinaga et al.,2000; 
Chen et al., 2002) were carried out on the five arsenic species (As (III), As (V), MA, 
DMA and AB) most commonly found in human urine. Palacios et al. (1997) found that 
spiked arsenic species (MA, DMA and AB) in urine sample were stable for 67 days at 
ambient temperature and 4 oC.   Feldmann et al. (1999) concluded that low temperature 
(4 and -20 oC) conditions are suitable for storage of urine samples for up to 2 months, 
without the use of any additives. AB was reported (Feldman et al., 1999) to be very 
stable for up to 8 months at three temperatures conditions 25, 4 and -20 oC. In addition, 
MA and DMA were also reported to be stable for up to 8 months at 4 and -20 oC 
storage conditions, while As (III) and As (V) were less stable under these conditions.  
Furthermore, the four arsenic species (As (III), As (V), MA and DMA) were less stable 
at 25 oC for up to 2 months. Chen et al. (2002) investigated the stability of As (III), As 
(V), MA and DMA  species in human urine at -20 oC and found their levels constant for 
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 up to 6 months. Yoshinaga et al. (2000) carried out a study to investigate the 
stability of DMA and AB in freeze-dried urine (CRM NIES No.18) for one and two 
years, respectively by analysing freshly reconstituted samples. The freeze-dried CRM 
of these species were found to remain stable during storage at 40C (Yoshinaga et al., 
2000).  
1.5.2.2 Arsenic  speciation versus total arsenic analysis in urine 
 
Toxicity of arsenic varies with chemical species and chemical speciation 
analysis is therefore essential in risk assessment (Le and Ma, 1997). Since 
biomonitoring requires an accurate analytical method, certified reference materials 
(CRMs) are of crucial importance for evaluating method performance. The methods 
used for the certification of arsenic in human urine have previously been discussed 
(Yoshinaga et al., 2000).  Total urinary arsenic cannot be used as an indicator of 
exposure to toxic arsenic species because it overestimates exposure for those who have 
consumed food containing non-toxic arsenic (e.g. seafood rich in AB) (Kales et al., 
2006). However, determination of toxicologically relevant arsenic compounds (As (III), 
As (V), MA, DMA) in urine can be used as an indicator of exposure to toxic arsenic. 
When an individual is exposed to As (V), this species will be reduced to As (III), then 
methylated to MA and DMA sequentially (Zheng et al., 1999). It is also increasingly 
being realised that DMA (III) and MA (III) are more toxic than As(III) and As(V) 
(Gong et al., 2001). Table 1.3 shows structures, formulae, molecular weights and pKa 
values for commonly occurring arsenic containing compounds found in food and the 
environment and also detected in human urine. In addition, Table 1.4 shows different 
arsenic species that have been detected in human urine. 
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 1.5.2.3 Spectroscopic techniques for arsenic determination in 
human urine 
In order to determine what species of arsenic occur in urine, different 
techniques have been employed.  Talmi and Bostick (1975) have reviewed methods for 
arsenic determinations including spectrophotometric, X-ray, electrochemical, neutron 
activation and atomic spectrometric techniques. The techniques that have mainly been 
used for the determination of arsenic and arsenic containing compounds involve 
chromatographic separation prior to elemental detection.  High performance liquid 
chromatography (HPLC) hyphenated with inductively coupled plasma-mass 
spectrometry (ICP-MS) utilises the powerful separation of chromatography and the 
lower limit of detection of ICP-MS. Hydride generation - atomic absorption 
spectrometry / fluorescence spectrometry (HG-AAS/AFS) has been used for the 
determination of toxic forms of arsenic (As (III), As (V), MA and DMA) in urine, 
because only inorganic arsenic, methylated arsenic and recently arsenosugars 
(Schmeisser et al., 2004) can form arsine gas  without a decomposition (mineralisation / 
oxidation) step. Graphite furnace atomic absorption spectrometry (GF-AAS) is 
commonly used for urinary total arsenic determination; the advantage of this method is 
the ease of sample preparation. The determination of arsenic by GF-AAS requires the 
use of a matrix modifier, which increases ashing temperature and enhances the 
stabilisation of the analyte. Liquid chromatography mass spectrometry (LC-MS) has 
been used for the determination of organoarsenic species in urine and arsenosugars in 
oyster (Shimisu et al., 1999; Sánchez-Rodas et al., 2002). Table 1.4 summarises 
different arsenic species that have been detected in human urine by using the various 
spectroscopic techniques.  
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Table 1.4 Arsenic species that have been detected in human urine by using various 
spectroscopic techniques. The table is not intended as a comprehensive summary of all 
the studies reported in the literature, but gives examples of selected applications.  
 
Detection Species identified Ref. 
ICP-MS Total arsenic (Nixon and Moyer, 1996) 
ICP-MS As (V), As (III), DMA, MA (Todorv et al., 2005) 
ICP-MS As (V), As (III), DMA, MA, AB (Wrobel  et al., 2002) 
ICP-MS AB, AC, TMAO,Me4 As+ (Larsen  et al., 1993) 
ICP-MS As (V), As (III), DMA, MA, AB, AC (Moldova et al., 1998) 
ICP-MS As (V), As (III), DMA, MA, AB, AC, Me4 As+ (Le and Ma, 1998) 
ICP-MS DMA, TMAO, oxo-DMAE, thio-DMAE oxo-
DMAA,  
thio-DMAA, thio-arsenosugar 
(Raml  et al., 2005) 
ICP-MS DMA, TMAO, DMAE,(9 unknown) arsenosugar 
metabolites 
(Hulle et al., 2004) 
ICP-MS Diphenylarsinic acid (Shibata et al., 2005) 
ICP-MS DMA, Oxo-dimethylarsenopropanoic acid (Oxo-
DMAP), 
Thio-dimethylarsenopropanoic acid (Thio-DMAP), 
Oxo-dimethylarsenobutanoic acid (Oxo-DMAB), 
Thio-dimethylarsenobutanoic acid (Thio-DMAB). 
 
(Schmeisser et al., 2006) 
   
HG-AAS Total arsenic (Vahter et al., 1995) 
HG-AAS As (V), As (III), DMA, MA (Heilier  et al., 2005) 
HG-AAS As (V), As (III), DMA, MA, AB, AC (Moldova et al., 1998) 
HG-AAS As (V), As (III), DMA, MA, AB, AC,Me4 As+ (Le and Ma, 1997) 
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HG-AFS Total arsenic (Le and Ma, 1997) 
HG-AFS As (V), As (III), DMA, MA (Heilier et al., 2005) 
HG-AFS As (V), As (III), DMA, MA, AB, AC,Me4 As+ (Le and Ma, 1997) 
   
GF-AAS Total arsenic (Torra et al., 2004) 
   
LC-MS AB, DMA (Shimisu et al., 1999) 
 
1.5.3 Arsenic determination in human hair and fingernail 
 This thesis mainly covers the determination of total arsenic and speciation 
analysis of arsenic in human urine. In addition, a few samples of human hair and 
fingernails were analysed for total arsenic, in order to attain a better understanding of 
the relationship between arsenic metabolism and ethnicity (Chapter 3).  The details of 
the methodology used for hair and nail analysis are provided in Chapter 2. 
While urine is considered as a reliable sample for recent arsenic exposure (Wei et al., 
2000), hair and nails are considered appropriate for long-term (several months) 
exposure (Koons and Peters 1994; Takagi et al.1988). Besides the excretion of ingested 
arsenic through urine, it is also known to be stored in sulfydryl-rich tissue such as hair 
and nail, being accumulated by binding to sulfydryl groups of keratin in these tissues 
(Hinwood et al., 2003). External contamination is considered to be a drawback for hair 
and nail samples, as this could lead to overestimation of internal arsenic or loss of the 
endogenous arsenic by the washing process (Yoshida et al., 2004). This was confirmed 
by an absorption experiment reported by Raab and Feldman (2005), which showed that 
different arsenic species were absorbed by hair. Their study showed that inorganic 
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 arsenic forms As (V) and As (III) are better absorbed by hair than MA and DMA. 
In speciation analysis of hair and nails of the populations chronically exposed to 
arsenic, major species are inorganic arsenic accompanied by different amounts of DMA 
and MA (Mandal et al., 2003).  
1.6 Aims of the thesis 
 
This thesis describes the application of different spectroscopic techniques (GF-
AAS, ICP-MS and HPLC-ICP-MS) for analysis of arsenic in mainly human urine 
samples, although some hair and nail samples were also analysed.  The aims of the 
study were to establish a background level for urinary arsenic in unexposed UK 
population and to explore whether ethnicity and fasting alters the pattern of urinary 
arsenic excretion.  Evaluation of the relationship between arsenic and selenium in 
human urine were additional aims of the research. 
The role of ethnicity in arsenic metabolism in unexposed populations was 
investigated among volunteers through analysis of biological samples. Urine, hair and 
fingernails samples of unexposed individuals, from three different ethnic communities 
residing in the same city (Leicester, UK), were analysed.  A possible influence of 
fasting and the pattern of urinary arsenic were explored by investigating urine samples 
from Ramadan fasting volunteers. This is important since millions of people in arsenic 
affected regions of Bangladesh and India perform Ramadan fasting for one month each 
year.  The relationship between arsenic and selenium, which are periodic table 
neighbours was also investigated by analysis of urine samples from unexposed 
volunteers.  Baseline level of urinary As:Se ratio was determined for these volunteers. 
This study also involved monitoring urine samples from an individual volunteer over a 
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 period of one year, in order to see whether this ratio alters significantly as a 
function of diet. 
 
1.7 Summary  
 
Arsenic is ubiquitous in the environment in food and water in organic and 
inorganic forms, the former being less toxic than the latter. Arsenic is metabolised in 
humans through a methylation process, in which inorganic arsenic is methylated to MA 
and DMA.  Organic arsenic such as AB is excreted unchanged in human urine. Arsenic 
exposure in humans can be monitored through analysis of urine, hair and nail samples.  
Different spectroscopic techniques including GF-AAS, HG-AAS/AFS and ICP-MS 
have been used for biomonitoring arsenic in such samples.  Understanding of arsenic 
metabolism in humans is still incomplete. Most studies investigating arsenic 
metabolism have focused on analysis of arsenic in human urine.  Such studies fall into 
the following categories: (i) exposure to environmental and occupational exposure to 
arsenic  (background level, considered as dietary exposure, also being covered); (ii) 
experimental ingestion studies (the effect of ingesting specific food types - e.g. seafood 
and seaweed - on urinary arsenic); and (iii) genetics / ethnicity (the role of genetic 
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2.1 Theoretical background to 
Instrumentation, Sample Pre-treatment 
and Chromatography 
 
Different spectroscopic methods were used in this thesis, in order to carry out 
total arsenic and arsenic species measurement in human urine. Inductively coupled 
plasma mass spectrometry (ICP-MS) was used throughout this project for total arsenic 
analysis. High performace liquid chromatography- Inductively coupled plasma mass 
spectrometry (HPLC-ICP-MS) was used for arsenic speciation measurement in human 
urine samples.  However, hair and nail analysis were carried out using graphite furnace 
atomic absorption spectrometry (GF-AAS).  
2.1.1 Graphite furnace  atomic absorption spectrometry (GF-AAS) 
 
The measurement of reduced intensity of electromagnetic radiation from a light 
source after its passage through a tube containing a gaseous ground state population of 
atoms is known as atomic absorption. The terms atomic absorption spectroscopy and 
atoms absorption spectrometry are often used interchangeably, although the former 
refers to the study of fundamental principles of atomic absorption while the latter refers 
to use of the atomic absorption for the quantitative determination of elements in 
samples (Butcher and Sneddon, 1998).  
  
   
53 
 In atomic absorption spectrometry (AAS) the light absorbed by atoms of 
the analyte is proportional to the number of ground-state atoms present in the 
atomisation cell (flame or graphite furnace). This has been referred to as Lambert’ s 
Law, which can be expressed in the following equation  (Moffett, 2000):  
A = abc 
Where: A = absorbance 
 a =  absorption coefficient. 
 b = length of the absorbance path. 
 c = concentration of absorbing atoms. 
From the above equation it can be seen that, if a and b are kept constant, then A is 
directly proportional to c, which is an ideal case of the Lambert’ s Law.   
In GF-AAS analysis, the sample is heated in a graphite furnace until the element 
atomises. To analyse arsenic in urine samples, the sample should be diluted and mixed 
with a matrix modifier, after which the mixture is dried, ashed and finally atomised at 
an appropriate temperature.  The best performance of GF-AAS for arsenic analysis is 
achieved using a wavelength of 193.7 nm with Zeeman background correction. The 
splitting and polarisation of atomic spectral lines in the presence of a magnetic field is 
called the Zeeman effect. The magnetic field does not affect molecules and particulates 
in the matrix, which cause background absorption. With the magnetic field off, the total 
absorbance is measured; and with it on only the background is measured (Varian, 
2003). A liquid sample (5-100µl) is introduced directly into the tube using an 
autosampler.  The graphite tube is held in place between two electrodes and aligned 
within the optical path in an AAS instrument, as shown in Fig. 2.1. (Ebdon et al, 1998). 
Fig. 2.2 shows a picture of GF-AAS (SpectraAA-220Z, Varian, Australia) with 
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 graphite tube atomiser (GTA). The GTA is a device, which is heated to the 
temperature required for analyte atomisation by passing a current through it. This setup 
was used for total arsenic determination in biological samples (more details are 
provided in section 2.2.2). 
The graphite tube has disadvantages such as porosity and a tendency for carbide 
formation. These could be overcome by coating the tube with pyrolytic graphite and by 
heating the tube in a methane atmosphere. The tube could also be coated with 
lanthanum to help reduce carbide formation (Ebdon et al., 1998).  By programming the 
power supply controlling the temperature of the furnace, the three steps of drying, 
ashing and atomisation can be carried out automatically on the sample, each at its 
particular temperature (Ebdon et al., 1998).   
 




Automated sample         
introduction 
Graphite furnace 
Optical path Optical path 








Figure 2.2 Graphite furnace instrument, SpectraAA-220Z with a graphite tube 
atomiser (GTA), for total arsenic determination in biological samples.  
 
Chemical interference is also one of the disadvantages of the GF-AAS technique 
and can lead to analyte loss, which occurs when halides are present because of their 
volatility. It is therefore essential to add a chemical modifier in order to stabilise the 
analyte during the atomisation temperature by forming intermetallic compounds such as 
As–Ni. The addition of nitric acid to the urine sample will help form hydrogen chloride 
(urine contains varying amounts of sodium chloride) (Norymberski and Stubbs, 1956), 
which will vaporise during atomisation. Background correction is even more essential 
with furnace atomisation because of the matrix effect, which could be reduced during 
the ashing step. An inert gas such as nitrogen or argon is used to purge the furnace.  
Argon is preferred to nitrogen as a purge gas because it has a low diffusion rate, which 
results in a larger signal, while nitrogen forms nitrides with certain elements such as Ti, 
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 V and Ba. For improved precession and shorter analysis time, the atomiser is 
cooled with water (Ebdon et al., 1998).   
 
2.1.2 Inductively coupled plasma mass spectrometry (ICP-MS) 
 
ICP-MS is considered the most efficient technique for elemental analysis of 
liquid samples. A combination of high performance liquid chromatography (HPLC) 
with ICP-MS is often the technique of choice in arsenic speciation in human urine. This 
is because of the ease with which the instrument can be coupled to HPLC and its 
resolving power, in addition to the sensitivity, lower detection limit and large dynamic 
range of ICP-MS (Moldovan et al., 1998; Inoue et al., 1994; Samanta et al., 2000). 
ICP-MS offers better detection limits for many elements than some other spectroscopic 
techniques, making it a powerful tool for elemental analysis (Montaser, 1998). The 
polyatomic interference produced from the chloride ion present in urine is a major 
drawback of this technique. However, there are new instruments containing reaction 
cells, which are designed to remove polyatomic interferences (Tanner et al., 2002). 
Chloride ions react with the argon plasma gas to form argon chloride that has the same 
mass to charge ratio as arsenic. Five approaches have been used to minimise or 
eliminate the 40Ar35Cl’ s interference with arsenic. One is the use of hydride generation 
or chromatography to separate the chloride from the arsenic. A second is the addition of 
a molecular gas, such as nitrogen, to the plasma to reduce the formation of 40Ar35Cl. 
The third is isotopic correction using either an empirically derived relationship of a 
measured isotope such as 35Cl16O with 40Ar35Cl or the classical 40Ar37Cl / 82Se / 83Kr 
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 correction based on known isotope abundances (Larsen et al, 1993). The 
mathematical correction for 40Ar35Cl is as follows ( Gault et al., 2005): 
I(75As) = I(75As) - R(35Cl/37Cl) × {I(77) - R(77Se/82Se) × [I(82) - R(82Kr/83Kr)]} 
where I is the intensity and R is the ratio of natural abundances of specified isotopes. 
The fourth approach involves using a high resolution mass spectrometer (sector 
field double focusing) instead of a quadrupole analyser. The fifth approach offers two 
possibilities for chemical resolution of interferences: (1) by collision/reaction of the 
interfering polyatomic ions with gases such as H2, He or Xe, which destroys a 
polyatomic ion and consequently removes it from the m/z range of interest; and (2) by 
reaction of the ion of interest with oxygen, which results in the formation of a new 
product ion that can be detected at a new non-interfered m/z value (Szpunar, 2005). 
These five approaches to overcome the polyatomic interferences – chromatography, 
reaction/collision cell technology, high resolution mass analyser and mathematical 
correction – have been reported in recent reviews (Szpunar, 2005; Montes-Bayon et al., 
2003; Francesconi  and   Kuehnelt, 2004). 
A schematic representation of an ICP-MS is shown in Fig 2.3.  In ICP-MS the 
sample is converted into an aerosol by a nebuliser.  Large droplets that may be 
produced by the nebuliser must be removed in the spray chamber in order to increase 
precision and to decrease interferences. The aerosol is subsequently transported into the 
plasma, which usually operates at temperatures of 5000–10000 K at atmospheric 
pressure. Therefore the ICP is a high energy and hard ionisation source, where the 
following processes occur sequentially and nearly simultaneously: desolvation-
vaporisation-atomisation-excitation-ionisation of the analyte (B'Hymer and Caruso, 
2004; Montaser, 1998). 
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 Fig. 2.4 shows a photograph of the ICP-MS  (ELAN DRCII, Canada) 
instrument at Hull University. This setup was used for the determination of total arsenic 
in human urine (more details are provided in section 2.2.4). Fig. 2.5 shows a 
photograph of the LC-ICP-MS (PQII, UK) instrument at Manchester University. This 
setup was used for arsenic speciation analysis in human urine (more details are 
provided in section 2.2.5). 
 





















Spray chamber  
MS interface  
  




Figure 2.4 The experimental setup for total arsenic analysis showing the ICP-MS 
instrument (ELAN DRCII). This instrument was used at the University of Hull for total 
arsenic determination in human urine. 
 
Figure 2.5 The experimental setup showing HPLC pump and column linked to the 
ICP-MS instrument (PQ II).This instrument was used at The University of Manchester 
for arsenic speciation in human urine. 
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 In the ICP-MS the end tip of the plasma is extracted into a low-pressure 
interface containing both a sampler and skimmer cone. The plasma formation takes 
place in a stream of argon gas flowing through an assembly of three concentric quartz 
tubes known as a plasma torch (Fig. 2.6). The torch is surrounded at the top by an 
induction coil connected to a radiofrequency (RF) generator. The induction coil is made 
of copper and cooled by argon gas or water. A current in the argon gas is induced by a 
magnetic field generated by the RF through the coil, after the argon gas is seeded with 
energetic electrons. These electrons are produced either by a high voltage, or a solid 
state piezoelectric transducer.  An efficient introduction of a sample aerosol into a 
central channel of the plasma results in the efficient desolvation, vaporisation, 
atomisation, excitation, and ionisation of the sample.  A simultaneous multi-element 
determination can be carried out by  argon ICP, since ICP is capable of exciting-
ionising a wide range of elements, especially metals. The argon plasma gas isolates and 
confines an analyte’ s passageway, which results in sequesteration of the analyte’ s 
atomic and ionic species that provides optimum conditions for its sampling from the 
ICP. The sampling cone orifice of the ICP-MS interface can be easily positioned along 
the axial channel in a region that leads to maximum analyte signal and minimum 
background intensity for mass spectrometric measurements. A number of voltages must 
be set with respect to the ion optics of the mass spectrometer, which in turns depends 
on the type of ion optics used. Therefore the optimal lens voltage is applied as a 
function of mass. A quadruple-based mass analyser is used in an ICP-MS instrument 
because of its relative simplicity, low cost and good performance (Montaser, 1998).  
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 Generally, pneumatic glass concentric nebulisers (PNs) are most 
commonly used in ICP-MS. PNs are of two basic configurations: concentric or 
crossflow. In the former, a high speed gas stream surrounds a capillary, through which 
the sample solution passes. While in the latter the tube carrying a high speed gas stream 
is set at right angles to the capillary carrying the sample solution. The liquid breaks up 
because of the mobilisation of a high speed gas, leading to the formation of an aerosol. 
The analyte transportation efficiency one of the most concerns of the PNs performance 
is in the range of 1–5%. The PN tends to consume relatively large amounts of sample 
solution (1–2 ml/min), a problem which low sample consumption nebulisers were 
developed to overcome (Montaser, 1998). However, the quartz concentric nebuliser 
provides the lowest possible background signal, an ability ascribed to a minimum 
background contamination (PerkinElmer, 2004). 
There are two main basic types of spray chamber used in ICP-MS. The cyclonic 
spray chamber is operating by centrifugal force, in which droplets are separated 
according to size by means of a vortex produced by the peripheral flow of the sample 
aerosol and argon gas inside the chamber; consequently, smaller droplets are 
transported with the gas stream into ICP-MS and larger droplets exit through the drain. 
The other main type, the double pass spray chamber, is commonly used in ICP-MS 
instrumentation. It is generally of Scott design, in which the selection of the small 
droplets takes place by directing the aerosol into a central tube, the larger droplets 
exiting the spray chamber via a drain tube.  Pressure in the drain tube forces small 
drops back between the outer wall side and the central tube, and then they exit the spray 
chamber into the sample injector of the plasma torch (Thomas, 2001).  
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 The conventional torch that used in ICP-MS has an internal diameter of 
18mm and consumes 15 l/min of argon at 1.5kW. The torch consists of three concentric 
quartz tubes (Fig.2.6): (i) an outer gas flow (12–14 l/min. argon), which sustains the 
discharge and cools the plasma confinement tube to prevent it from melting;  (ii) an 
intermediate gas flow (0.5 –1 l/min. argon), which is necessary for plasma formation 
and stabilisation; and (iii) an injector gas flow rate (0.4 – 1 l/min. argon), which carries 
the sample aerosol into central tube of the torch and plasma. Larger torches are more 
powerful than smaller torches, because the former operate at higher power levels and 
gas flow rates, typically providing ICP discharges more robust than the plasma formed 
in smaller torches.  RF is a device used to supply power to ICP discharges, and can be 
divided into two types: power oscillators (free-running oscillators) and power 
amplifier/oscillator combinations (crystal-controlled generators). The purpose of the RF 
is to generate an alternating current at a preferred frequency, using this to ignite and 
maintain the plasma. As soon as an electrical current passes through the induction coil, 
the voltage generated across the coil is directly proportional to frequency. The RF 
generator operates at a frequency range of 2–50MHz, in the majority of ICP 
instruments typically operating at 27 or 40 MHz with an output power of 1–2kW 




   
  





Figure 2.6 Schematic drawing of the plasma torch for ICP-MS (Montaser, 1998). 
 
  There are three main fundamental characteristics of the plasma discharges: (i) 
gas temperature (Tg). (ii) electron temperature  (Te).  (iii) electron number density (ne). 
Argon ICP has Tg   in the range of   4500 – 8000 K ,  Te  in the range of   8000 – 10,000 
K and ne  1 -3 x 10 15 cm-3.  These conditions combined with relatively long plasma 
sample interaction time (2 – 3 ms) result in almost complete vaporisation- atomisation 
of the sample aerosol as well as decreasing of chemical and physical interferences in 
the plasma.  This robustness offers a low-noise condition for detecting a wide range of 
elements in diverse materials at different concentration (major, minor, trace, and ultra 
trace) levels (Montaser, 1998).     
In order to prevent carbon deposition on the sampler and skimmer cones, it is 
important to introduce oxygen into the nebuliser gas with an amount in the range of 25-
Outer gas flow  
(plasma gas flow) Intermediate gas flow  
(auxiliary gas flow) 
Injector gas flow  
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 115 ml/min.  A sample with high total dissolved solids can lead to the clogging of 
the  sampler and skimmer cones. Use of a small skimmer cone orifice (~ 0.5 mm) and a 
relatively large torch injector gas orifice (2.5 mm) combined with a relatively low 
solution uptake rate (0.4 ml/min.) are capable of reducing the possibility of clogging 
(Montaser, 1998).      
Dynamic reaction cell (DRC) is located between ion optics and the quadrupole 
(Fig. 2.3). It is function is to remove polyatomic interferences that originate from a 
combination of plasma gas and sample matrix components before they enter the mass 
analyser quadrupole. It is unlike the collision cell, which allows all the reaction 
products to enter into the quadrupole. The DRC uses different reaction gases such as 
oxygen, methane and ammonia. These reaction gases remove interferences by different 
processes such as oxidation, electron transfer and proton transfer, collision and 
dissociation were also considered among these processes (PerkinElmer, 2004). 
There are three main types of mass spectrometer used in ICP-MS: magnetic 
sector, time-of-flight and quadrupole. The commonly used is the quadrupole, which 
consists of a set of four rods with space in the middle for ions to enter. These rods are 
connected to each other electrically in opposing pairs. An alternating voltage and RF 
current are applied to each pair of electrodes. The quadrupole separates ions based on 
their m/z ratio, allowing only one mass at a given time to pass to the detector 




   
65 
 2.1.3 Sample pre-treatment and chromatographic separation  for   
arsenic in human urine 
Matrix effects – particularly in urine samples, which contain a number of 
different compounds – cause interferences with analyte measurement.  Filtration and 
sample dilution is necessary to reduce matrix effect on the chromatographic separation 
(Zheng et al., 1999).  
Regarding hair and nail samples, the washing procedure is necessary for 
removing exogenous contamination. The digestion process is an essential antecedent 
step to the determination of total arsenic in hair and nail samples. The purpose of the 
digestion process is to destroy most or all the organic matrix of the sample while 
retaining the analyte element in solution form (Schelkoph and Milne, 1988; Edwards, 
1990). These issues are discussed in more details below. 
2.1.3.1  Sample filtration  
 
Filtration is normally used in the determination of arsenic in human urine to 
alleviate the matrix effect. Commonly a 0.45 µm filter is used for filtering the urine 
prior to total or speciation analysis of arsenic in human urine (Lintschinger et al., 1998; 
Chen et al., 2002).  In addition, urine sample  dilution is also essential to overcome this 
problem (Zheng et al., 1999). 
2.1.3. 2   Sample digestion 
 
 In general, biological samples such as hair and nails are used as biomarkers for 
arsenic exposure. These biological samples are always subjected to several pre-
treatment steps (sample wash and digestion) prior to analysis. The washing process 
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 involves several steps using 0.1% Triton-X, deionised water and acetone, or 
ultrasonic, mechanical agitation and deionised water (Schrauzer et al., 1992; Saad et al., 
2001; Samanta et al., 2004; IAEA, 1978), in order to remove dirt and any exogenous 
contamination. The digestion process involves using HNO3 and H2O2 followed by 
boiling at high temperature or microwave digestion (Mandal et al., 2004; Samanta et 
al., 2004). Fig. 2.7 shows a microwave (PROLABO A301, France) used for hair and 
fingernail digestion (more details are provided in section 2.2.2.7). 
 
Figure 2.7 Microwave used for digestion of biological samples (hair and nail).  
 
2.1.3.3  Chromatographic separation for arsenic in human urine 
 
For the determination of arsenic species in human urine, different chromatographic 
separation methods have been employed.  These methods have been used to separate 
arsenic and arsenic containing compounds prior to elemental detection. High 
performance  liquid chromatography (HPLC) hyphenated with inductively coupled 
plasma-mass spectrometry (ICP-MS), hydride generation atomic absorption 
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 spectrometry (HG-AAS) and hydride generation atomic fluorescence spectrometry 
(HG-AFS), are the three  most commonly used methods for the determination of 
arsenic and its metabolites in human urine (Lingberg et al., 2007).  
Different chromatographic techniques have been used for arsenic separation in 
human urine such as reversed-phase (RP), reversed-phase ion paring (IP), and ion-
exchnage (IEC), which include anion- and cation-exchange chromatography (Shibata 
and Morita, 1989; Tokunaga et al., 2002; Zheng et al., 1999; Le et al., 2000).  
Typically, anion-exchange is the most commonly used method for arsenic 
speciation (Francesconi and Kuehnelt, 2004) and this approach was used in this study. 
It is based on the interaction of negatively charged analytes with positively charged 
functional groups of the stationary phase. The packed materials in the anion-exchange 
column are beads of crosslinked styrene and divenyl benzene. The ionic functional 
groups bonded to the packing material are typically quarternary amines or primary 
amine groups. The mobile phase used in this column is often an aqueous salt buffer 
mixed with an organic modifier such as methanol (Montes-Bayon et al., 2003). 
Ammonium carbonate is one of the preferred buffers to be used especially for ICP-MS, 
because it has shown little signal drift and no excessive residue on the sampler or 
skimmer cones after prolonged use (B’ Hymer and Caruso, 2002; B’ Hymer and Caruso, 
2004).  A photograph showing a typical anion exchange column used during the 
method development stage of the study is shown in Figure 2.8 
  




Figure 2.8 The setup of the fraction collector for arsenic species separation using an 





2.2 Experimental  Procedures and Method 
Development  
This section describes the developed and/or adapted analytical methods used in 
this study for urinary arsenic analysis.  The techniques used were GF-AAS, HPLC-ICP-
MS and ICP-MS. Experimental procedures and methods development studies are also 
presented. It also takes into account the experimental progression employed to optimise 
the analytical methods by using these techniques. A sub-section on statistical methods 
applied throughout the thesis is also described. 
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 2.2.1 Methodology 
 
All the steps involved in sample collection, storage, pre-treatment and 
measurement are discussed in detail in the following sections. There were four 
techniques used for analysis. GF-AAS was initially used to measure total arsenic in 
urine. It was also used for off-line speciation analysis. However, this was time-
consuming, and no satisfactory resolution for arsenic species was achieved. ICP-MS 
and HPLC-ICP-MS showed powerful ability to detect both total arsenic and arsenic 
species, respectively, especially at low levels of arsenic in urine.  
2.2.1.1 Methodological steps for arsenic determination in biological 
samples 
 
As discussed in section 2.1.3, before the urine sample is analysed using 
spectroscopic techniques it must be subjected to a number of pre-treatment steps. The 
first step is often filtration, usually through 0.45 µm membrane filter. Subsequently the 
urine is diluted to alleviate the matrix effect. Thereafter, in the case of speciation 
analysis HPLC is used to separate the different arsenic species. The sample is then 
subjected to spectroscopic analysis that identifies and quantifies the different species. 
The steps involved in urine, hair and nail analysis starting with the collection step and 
ending with its analysis using different spectroscopic techniques used in this project are 








 Figure 2.9  Schematic diagram showing the steps used for urine, hair and nail analysis 
using different spectroscopic techniques.  
 
2.2.1.2 Ethical approval, urine sample collection and preparation 
 
A questionnaire was designed for urine sample collection and was accompanied 
by a letter to explain to the volunteer what the project was about and how to deal with 
the sample in terms of collection and storage (Appendix 2.1). The Faculty of Health 
and Life Sciences, Human Research Ethics Committee, at De Montfort University, 
Leicester, approved the study design and aims.  In the questionnaire, each individual 
was asked to refrain from eating fish and seafood for 3 days prior to sample collection 
and to complete a self-administered questionnaire asking for demographic information 
such as ethnicity, age, gender etc.   First morning urine samples (mid-stream) were to 
be  collected directly into polyethylene bottles (Fisher, UK). The pH of each urine 
 Hair and nails collection 











Urine collection and storage 
 
GF-AAS 
 Washing and digestion  
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 sample was measured using the Combur9Test® (Roche, Germany) urine test strip 
(Fig. 2.10); nitrite and blood were also measured in each sample. Because dietary 
nitrate is converted to nitrite by E .coli and most urinary tract infections and pathogens, 
the detection of nitrite is an indication of the presence of nitrite-forming organisms in 
urine (Roche, 2001). The samples were kept in a freezer at -20 0C until the analyses 
were carried out. Prior to analysis, the samples were filtered through a 0.45 µm syringe 
filter (Millipore, Bedford, USA) and diluted 5-fold with 2 %v/v HNO3 for total arsenic 
determination, and  5-fold with the mobile phase for speciation analysis, by using ICP-
MS and HPLC-ICP-MS respectively.  
  
Figure 2.10  Urine test strip to test urine samples for pH, nitrite and blood. The strip is 
shown before and after the urine test. 
 
2.2.1.3 Determination of creatinine 
 
Creatinine adjustment is routinely used to correct for factors that are not related 
to arsenic level in urine, such as urine concentration and urine volume (Hinwood et al., 
2002). The urine volume can be influenced by fluid intake and respiration rate. 
Creatinine excretion varies with different factors such as gender, age, body mass and 
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 intake of cooked meat (Hinwood et al., 2002; Carrieri et al., 2001). In population 
studies investigating environmental arsenic exposure, it is usual to perform a creatinine 
adjustment (Hinwood et al., 2002). 
Creatinine was determined photometrically using a Metra Creatinine Assay Kit 
(Quidel Corporation, USA), linked to a plate reader measuring absorbance at 540 nm 
(Multiskan MCC/340, Finland). The principle of the Metra Creatinine assay is based on 
the Jaffe method, in which a coloured solution results from the reaction between 
alkaline picrate and creatinine (Quidel, 2004). This assay is quantitative and involves 
the use of urine samples. The following steps were adopted for the determination of 
urinary creatinine. Urine samples were diluted with deionised water (1:40), then  150 µl 
of the working solution was added to the 50 µl of diluted sample after which the 
mixture was incubated for 30 minutes at room temperature. Finally, the sample was 
measured by using a plate reader at 540 nm. The calibration graph produced by using a 
standard solution of creatinine in the range of 0 - 40 mmol/l, is displayed in Fig. 2.11. 
The measurement of creatinine was validated by measuring a high and a low creatinine 
standard as shown in Table 2.1. 
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Figure 2.11  Calibration curve for creatinine measurement. 
 
 
Table 2.1 Concentrations of creatinine standards and their corresponding 
absorbance at 540 nm. 





   
Creatinine (mmol/l) Expected average Found Mean ± SD (n =3) 
Control (L) 7.3 7.9 ± 0.0 
Control (H) 25.6 24.8 ± 0.1 
   
 Expected range Found range 
Control (L) 6.2 - 8.5 7.9 -7.9 
Control (H) 21.5 - 29.6 24.7 - 24.8 
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 2.2.2 Method development for total arsenic using GF-AAS 
 
This section discusses analytical issues associated with the determination of 
total arsenic analysis. These issues are related to the selection of the chemical modifier, 
the recovery test, the determination of the limit of detection, and the method of 
validation. This discussion also includes total arsenic determination in hair and 
fingernail samples. 
2.2.2.1 Chemical modifier selection 
 
 The main purpose of using a chemical modifier is to stabilise the analyte and/or 
to increase the volatility of the matrix. Therefore, most of the matrix can be removed 
during the ashing (pyrolysis) stage before atomisation, by volatilisation or 
decomposition (Lima et al., 1998). Nitric acid (UPA, Romil, UK) was used for 
standards and sample dilution (1% v/v HNO3) throughout the experiment. Three 
modifiers were tested:  
(1) A palladium modifier (500mg/l) was prepared from Pd (II) acetate (Aldrich, UK) in 
0.25% ascorbic acid and 1% v/v HNO3 (Pohl et al., 1993).  
(2) A nickel modifier (1000mg/l) was prepared from Ni(NO3)2.6H2O (BDH, UK) in 5% 
v/v HNO3 (Nham, 1989).  
(3) A PdS2O8  modifier was prepared as a 1:1 mixture of 0.6g Pd(II) acetate (Aldrich, 
UK)  in 15% v/v HNO3 and an aqueous solution of 2% w/v K2S2O8 (Fisher Scientific), 
(Nixon et al., 1991).   
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 Deionised water (18M/cm, Milli-Q) was used for the preparation of 1% 
v/v HNO3, throughout the experiment for sample dilution and standards preparation. 
Standard solutions of arsenic solution were prepared from a 1000±3 g/ml As (V) 
solution (CPI, International) gravimetry. 
A SpectrAA-220 GF-AAS system (Varian, UK) with Zeeman background 
correction was used for the analysis of arsenic in human urine. The instrument 
comprises a pump system for sample introduction, an autosampler, Zeeman background 
correction and graphite tube atomiser (GTA) as shown in Fig. 2.1.  Table 2.2 gives the 
temperature programme (recommended by the manufacturer) for graphite furnace 
measurement of arsenic. The operating conditions of the GF-AAS are shown in Table 
2.3. 









1 85 5.0 1.0 No No 
2 95 40.0 1.0 No No 
3 120 10.0 1.0 No No 
4 1400 5.0 1.0 No No 
5 1400 1.0 1.0 No No 
6 1400 2.0 1.0 No Yes 
7 2600 0.6 0.0 Yes Yes 
8 2600 2.0 0.0 Yes Yes 
9 2600 2.0 1.0 No No 
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 Table 2.3 The operating conditions for GF-AAS 
GF-AAS (Zeeman background correction)  
Instrument SpectraAA-220Z (Varian,UK) 
Wavelength 193.7 nm 
Lamp current 10 mA 
Slit width 0.2 nm 
Injection volume 20µl 
Modifier volume 2 µl 
 
2.2.2.2 Dilution factor selection 
 
A urine sample from an unexposed  volunteer was collected directly into an acid 
washed polyethylene bottle. The sample was spiked with a known concentration of 
arsenic (205.8µg/l As (V)) and then diluted to 100, 151 and 201 folds with 1% v/v 
HNO3, and then measured by GF-AAS to compare the recovery from different 
modifiers.  The aim was to determine which conditions are suitable for the sample to be 
accurately analysed.  The main variables to be considered were the dilution factor and 
different the matrix modifiers. 
2.2.2.3 Recovery test for the modifiers and dilution factors 
 
%Recovery = 100*(SSR-SR)/SA  
where, SSR = spiked sample result 
  SR = sample result (i.e. unspiked) 
             SA = spike concentration added 
Four calibration standards were prepared for each modifier by using the 
autosampler automix facility from the As (V) standard (10.34µg/l).  The standards 0.00, 
1.72, 2.87 and 3.44 µg/l, were used for calibration curves of the modifiers Pd, Ni and 
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 PdS2O8. Diluted samples were gravimetrically prepared from spiked sample 
(205.8µg/l) [(1:100), (1:151) and 1:201)], for recovery test purpose.  Recoveries for the 
three modifiers are shown in Table 2.4. 
Table 2.4 Total arsenic concentration (µg/l) in unspiked urine (SR) and spiked 








100 <LOD 52.0 25.3 
151 <LOD 79.5 38.6 Pd 
201 <LOD 132.0 64.1 
     
100 110.0 300.0 92.3 
151 148.5 253.5 51.0 Ni 
201 168.0 360.0 93.3 
     
100 <LOD 231.0 112.2 
151 <LOD 273.0 132.7 PdS2O8 
201 128.0 324.0 95.2 
 
2.2.2.4 The modifier of choice 
 
A 200-fold factor was chosen to eliminate the matrix effect.  From Table 2.4 it 
can be concluded that the greater the dilution, the higher the recovery. The accuracy of 
this method was established by the quantitative recovery of arsenic added to the urine 
sample.  The test for recovery of arsenic was done by adding arsenic to the urine 
sample, which was then tested with three modifiers, the best recovery being obtained 
with the Ni and PdS2O8 modifiers at 200-fold.  The Ni was preferable to the PdS2O8 
modifier, and was used as the modifier of choice for economic reasons. 
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 2.2.2.5 Limit of detection and limit of quantification 
 
The limit of detection (LOD) and the limit of quantification (LOQ) were 
calculated using the equations LOD = 3 x SD; LOQ = 10 x SD (Thomsen et al., 2003), 
where SD is the standard deviation of ten measurements of the blank (1% v/v HNO3). 
Table  2.5 shows the raw data for LOD and LOQ calculations. 
Table 2.5 Determination of LOD and LOQ for total arsenic using GF-AAS. 
Tube Sample 
ID 
Conc µg/l %RSD Mean 
Abs 
BG Abs Readings 
1:1 Blk 0.64 22.6 0.0129 0.0190 0.0150 0.0109 
1:2 Blk 0.47 21.0 0.0096 0.0157 0.0081 0.0110 
1:3 Blk 0.48 25.2 0.0097 0.0126 0.0114 0.0080 
1:4 Blk 0.58 8.9 0.0118 0.0165 0.0110 0.0125 
1:5 Blk 0.55 12.9 0.0112 0.0188 0.0102 0.0122 
1:6 Blk 0.57 17.3 0.0117 0.0201 0.0131 0.0102 
1:7 Blk 0.57 21.6 0.0117 0.0232 0.0135 0.0099 
1:8 Blk 0.67 23.7 0.0135 0.0132 0.0113 0.0158 
1:9 Blk 0.74 21.6 0.0150 0.0159 0.0173 0.0127 
 1:10 Blk 0.64 0.6 0.0131 0.0140 0.0130 0.0131 
   
Mean 0.591  
SD 0.084  
LOD = 3 x  SD  0.25  
LOQ = 10 x SD 0.84  
 
 
2.2.2.6 Method validation 
 
An arsenic  standard  (30 µg/l) was prepared from As (V) stock solution and 
used to explore the reproducibility of GF-AAS. This standard was measured ten times, 
the average was 31.2 ± 1.4 µg/l and the reproducibility was 4.4 %RSD. The typical raw 
data is presented in the Appendix (2.2). A certified human urine sample (CRM NIES 
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 No.18 ) was also measured for total arsenic, after a dilution of 200-fold with a 
blank (1%v/vHNO3) the result was 147.3 ± 21.2 µg/l (n = 6), compared to the certified 
result of 137 ± 11 µg/l.  Typical raw data for blank, standards, control and CRM are 
presented in the Appendix (2.2). This study demonstrates that using Ni as a modifier 
can achieve an accurate measurement of total arsenic in human urine. This method 
showed that the analysis of arsenic in urine samples can be successfully accomplished 
by suppressing the matrix interference using high dilution levels.  The dilution 
procedure is simple and efficient.  The advantages of this method are a short analysis 
time, prolonged graphite tube life (at high dilution there are no more residues to 
degrade the tube) and no pre-treatment of the sample. However, the disadvantage of 
this method is that it cannot be applied to urine samples with low arsenic 
concentrations, due to the high dilution factor and the somewhat high LOD of the 
instrument.  
2.2.2.7 Hair and fingernail collection, pre-treatment and total 
arsenic determination 
Hair samples from the head, at different positions, and fingernails, from all the 
fingers, were collected from unexposed volunteers residing in Leicester, UK. All 
samples were kept in sealed plastic bags and stored at room temperature. The hair and 
fingernails samples were washed using the procedure reported by Schrauzer et al. 
(1992). All samples were washed four times with 1% Triton X-100, then rinsed once 
with acetone, three times with deionised water, and twice more with acetone. Each 
sample was washed for approximately 30 minutes and subsequently all the samples 
were dried in an oven at 700C for 20 minutes. An aliquot of 0.06g of fingernails and 
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 0.1g of hair samples were taken for digestion. The digestion procedure was carried 
out by using 5 ml of concentrated HNO3 for 20 minutes and 2 ml of 30% H2O2 for 10 
minutes. Both steps involved application of microwave digestion at 25% power (200W) 
(PROLABO A301, France) Fig. 2.7. The digested samples  were made up to 10 ml in a 
volumetric flask with deionised water, after which  the total arsenic content was 
determined using GF-AAS instrument. 
Certified Reference Material (GBW09101) was used for validation analysis of 
human hair, which was certified to contain a total arsenic level of 590 ± 70 µg/kg. The 
mean measured value using GF-AAS was 613 ± 18.4 µg/kg (n =3). 
 
2.2.3 Establishing a method for arsenic speciation in human urine 
using HPLC-GF-AAS (off-line) 
 
 To establish a method for speciation of AB, DMA, MA, As (III) and As (V), the 
following conditions were used to perform the speciation analysis. HPLC with a 
fraction collector was setup to perform the arsenic species separation. The 
chromatographic conditions  used are shown in Table 2.6. The separation data of the 
five standards arsenic species are shown in Table 2.7, and their chromatograms are 
presented in Fig. 2.12.  The aim of this method was to establish arsenic speciation, and 
to determine the retention time of each species. However, there was a disadvantage of 
overlap phenomena by using this method. The overlap was observed with the retention 
times of DMA /As (III) and MA/As (V). This was probably due to the spread of 
standards over the fractions collection. A complete cycle of one sample separation and 
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 quantification took more than 100 minutes, which was considered as a 
disadvantage of this method. 
A guard column SAX (4 x 3 mm i.d) ( Phenomenex, UK) and an anion 
exchange column PRP-X100 (250 x 4.6 mm i.d ) (Hamilton, USA), were used for 
arsenic species separation. The fraction collector RediFrac (Pharmacia Biotech, 
Sweden) (Fig. 2.8) was used to collect the fractions.  The GF-AAS (Fig. 2.2) system 
with Zeeman background correction was used for measurement of arsenic in each 
fraction.  
A mobile phase that has been reported previously by Pedersen and Francesconi 
(2000) was used for arsenic speciation analysis. This mobile phase was slightly 
modified by using 5% methanol instead of 10%. Yu et al. (2003) reported that the 
arsenic signal increased with the increase of methanol concentration up to 5%. The 20 
mM NH4HCO3 mobile phase was prepared by dissolving 1.58 g from ammonium 
hydrogen carbonate (Fisher Chemicals, UK) in 950 ml deionised water, adjusted with 
drop-wise addition of  35% NH4OH solution to obtain a  pH 10.3. The mobile phase 
was then filtered through a 0.45 µm membrane, prior to the addition of 50 ml methanol, 
and then degassed with helium. 
 The fraction collector in Fig. 2.8 was operated by the adjustment of fraction 
collection every one minute; the flow rate of HPLC was 1.5 ml/min. Each fraction 
volume was 1.5ml.  All fractions were collected in tubes and transferred to GF-AAS for 
total arsenic concentration measurement. 
Standard (500 µg As/l) for each species was prepared separately, then a mixture 
of the five arsenic species (AB, DMA, MA, As (III) and As (V)), all these were 
prepared in the mobile phase. The speciation process was carried out using the 
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 chromatographic and operating conditions shown in Table 2.6. The data obtained 
are represented in Table 2.7 and illustrated in Fig. 2.12. 
  
Table 2.6 The chromatographic and operating conditions for HPLC-GF-AAS (off-
line). 
HPLC  
Column Hamilton PRP-X100 (250 x 4.6  mm i.d.) PEEK column; 
guard column SAX (4 x 3 mm i.d.) 
Pump HP 1050 series 
Mobile phase 20 mM NH4HCO3 + 5%MeOH; pH 10.3. 
Flow rate 1.5 ml/min. 
Injection volume 100 µl 
GF-AAS (Zeeman background correction) 
Instrument SpectraAA-220Z (Varian,UK) 
Wavelength 193.7 nm 
Lamp current 10 mA 
Slit width 0.2 nm 
Injection volume 20 µl 





















Table 2.7 Fraction time identification for arsenic species (AB, DMA, As (III), MA 
and As (V)), using HPLC-GF-AAS (off-line). 
Standard  conc.  
(µg As/l), separately 







360 DMA 3 337.2 




















Standard  conc.  




AB 2 611.1 
DMA 3 598.1 








500 for each species 



























































































































































































































































































































































































2.2.4 Method development for total arsenic and selenium in human 
urine using ICP-MS 
 A method has been developed for total arsenic analysis in human urine by using 
ELAN DRCII (PerkinElmer SCIEX, Concord, Ontario, Canada) (Fig 2.4) at The 
University of Hull; the operating conditions are shown in Table 2.8.   
Table 2.8   Operating conditions for ELAN DRCII ICP-MS. A reaction cell was 
not used; instead, a correction equation was used to remove ArCl interference. 
RF  power  1350 W 
Argon flow rate  
Plasma 15 l/min 
Auxiliary flow 1.20  l/min 
Nebulizer flow 0.97 l/min 
Sample and skimmer cones Ni 
Dwell time  50 ms 
Integration time  1250 ms 
2.2.4.1   Internal standard selection 
 
  The use of an internal standard (IS) is crucial to eliminate volume-related 
sources of error; this elimination leads to improved precision. This error can occur due 
to sample solution variability and operating conditions (Altria, 2002). The IS should 
behave almost identical to the analyte (Nixon and Moyer, 1996). Therefore, the 
selection of the appropriate IS is important to ensure reliable results. The IS should not 
interfere with the analyte or be present in the constituents of the sample matrix. 
Yittrium was chosen as IS after a replicate test of recovery (103%, n = 9) and stability 
(RSD 2.6%, n = 9). Before Y was chosen, other internal standards (e.g. Gallium, 
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 Indium) were tested, but were shown to have either high recovery or inaccurate 
results. Therefore, 10 g/l of yttrium (PlasmaCAL, Québec, Canada) was used as an 
internal standard for total arsenic analysis.  
2.2.4.2 Chloride interference 
 
Human urine contains high NaCl concentrations, hence chloride in the urine 
matrix interferes with the arsenic signal by forming 40Ar35Cl, which has the same 
arsenic nominal mass (75) (Nixon and Moyer, 1996). Interference on monoisotopic 
75As by 40Ar35Cl was corrected by monitoring the ion counts at m/z = 77, 82 and 83 and 
applying the correction equation, this based on the equation reported in section 2.1.2, 
pre-programmed in the ICP-MS software (Elan Instrument Control, version 3.0 hotfix 
3). Therefore, the  elimination of  the 40Ar35Cl’ s interference with arsenic was carried 
out by the isotopic correction using the classical 40Ar37Cl / 82Se / 83Kr correction based 
on known isotope abundances. An arsenic standard (10 µg/l) was prepared in 400 ppm 
NaCl solution, in order to check the effectiveness of the equation in removing chloride 
interference. This effectiveness was confirmed by the recovery of 104.8% (1.1%RSD;  
n = 3).  This proved the efficiency of the equation to remove the interference of the 
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 2.2.4.3   Determination of total arsenic in urine samples and 
method validation 
 
All urine samples were filtered through a 0.45 µm syringe filter and diluted 5-
fold with 2 %v/v HNO3 for total arsenic determination. The use of high purity acid can 
improve the detection limit and reduce background signal (Mester and Pawliszyn, 
2000). The calibration curve of arsenic was drawn within the range of 0 - 20 µg/l (Fig. 
2.13). This calibration curve was based on the raw data presented in Table 2.9. The 
limit of detection (LOD) and the limit of quantification  (LOQ) for total arsenic were 
calculated by measuring the blank (2 %v/v HNO3) ten times. The  LOD (3 x SD) was 
0.05 µg/l and LOQ (10 x SD) was 0.18 µg/l. The calculation of LOD and LOQ are 
shown in Table 2.10. The measurement of total arsenic in urine was validated by a 
spiking experiment, where the recovery was 103% (n = 9). The accuracy and 
reproducibility (Table 2.11) of the method were also validated by measuring 10 µg/l 
standard of arsenic after each 20 runs. The reproducibility (between-run, n =10; 
replicates (n = 3) for each measurement) was 10.5 ± 0.2 µg/l (1.4% RSD). The spiking 
experiment was carried out, in order to assess the recovery of total arsenic, by using 50 
µg/l of arsenic in urine sample, then diluted (5-fold) with 2%v/v HNO3 to achieve a 
total spiked concentration of 10 µg/l.  The results are shown in Table 2.12 with a 
recovery of 104.3% and SD = 2.2. The CRM NIES No. 18  human urine was also used 
to validate the method and the measured result was 140.7 ± 1.9 µg /l ( n = 3); the 
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 Table 2.2.9   ICP-MS raw data for total arsenic and selenium in blank, std1, std2, 
std3, std4 and std5*. 
Sample Element Mass Intensity / cps Sample Element Mass Intensity / cps 
Blank As 74.921 138 Standard 2 As 74.921 2781 
Blank Se 76.921 60 Standard 2 Se 76.921 285 
Blank Se 81.917 86 Standard 2 Se 81.917 358 
Blank Kr 82.915 91 Standard 2 Kr 82.915 75 
Blank Y 88.905 166445 Standard 2 Y 88.905 159742 
Blank As 74.921 137 Standard 2 As 74.921 2706 
Blank Se 76.921 67 Standard 2 Se 76.921 283 
Blank Se 81.917 87 Standard 2 Se 81.917 347 
Blank Kr 82.915 87 Standard 2 Kr 82.915 74 
Blank Y 88.905 166300 Standard 2 Y 88.905 164233 
Blank As 74.921 150 Standard 2 As 74.921 2747 
Blank Se 76.921 75 Standard 2 Se 76.921 281 
Blank Se 81.917 74 Standard 2 Se 81.917 364 
Blank Kr 82.915 77 Standard 2 Kr 82.915 81 
Blank Y 88.905 166761 Standard 2 Y 88.905 164595 
Sample Element Mass Intensity / cps Sample Element Mass Intensity / cps 
Standard1 As 74.921 1452 Standard 3 As 74.921 7081 
Standard1 Se 76.921 178 Standard 3 Se 76.921 679 
Standard1 Se 81.917 225 Standard 3 Se 81.917 833 
Standard1 Kr 82.915 96 Standard 3 Kr 82.915 86 
Standard1 Y 88.905 162740 Standard 3 Y 88.905 164890 
Standard1 As 74.921 1412 Standard 3 As 74.921 6985 
Standard1 Se 76.921 191 Standard 3 Se 76.921 678 
Standard1 Se 81.917 245 Standard 3 Se 81.917 791 
Standard1 Kr 82.915 69 Standard 3 Kr 82.915 74 
Standard1 Y 88.905 159961 Standard 3 Y 88.905 166952 
Standard1 As 74.921 1500 Standard 3 As 74.921 6794 
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Standard1 Se 76.921 154 Standard 3 Se 76.921 654 
Standard1 Se 81.917 221 Standard 3 Se 81.917 762 
Standard1 Kr 82.915 65 Standard 3 Kr 82.915 85 
Standard1 Y 88.905 155595 Standard 3 Y 88.905 169620 
Sample Element Mass Intensity / cps Sample Element Mass Intensity / cps 
Standard4 As 74.921 13433 Standard 5 As 74.921 26211 
Standard4 Se 76.921 1225 Standard 5 Se 76.921 2466 
Standard4 Se 81.917 1565 Standard 5 Se 81.917 2968 
Standard4 Kr 82.915 83 Standard 5 Kr 82.915 62 
Standard4 Y 88.905 157924 Standard 5 Y 88.905 164711 
Standard4 As 74.921 13099 Standard 5 As 74.921 26491 
Standard4 Se 76.921 1236 Standard 5 Se 76.921 2454 
Standard4 Se 81.917 1549 Standard 5 Se 81.917 2910 
Standard4 Kr 82.915 73 Standard 5 Kr 82.915 83 
Standard4 Y 88.905 163278 Standard 5 Y 88.905 164653 
Standard4 As 74.921 13311 Standard 5 As 74.921 26676 
Standard4 Se 76.921 1178 Standard 5 Se 76.921 2376 
Standard4 Se 81.917 1489 Standard 5 Se 81.917 2920 
Standard4 Kr 82.915 65 Standard 5 Kr 82.915 82 
Standard4 Y 88.905 165529 Standard 5 Y 88.905 164836 
 
*The blank, std1, std2, std3, std4 and std5 are 2%v/v HNO3, 1, 2, 5, 10 and 20 µg/l, respectively, for 
both elements (arsenic and selenium). All arsenic values are in bold and selenium values are in bold 
and italic. Yittrium (10 g/l) was used as an internal standard for total arsenic and selenium analysis. 
As can be seen from above it shows stable intensity (cps ) in all standards from blank to std5 
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Figure 2.13   Calibration curve for As(V) standards (0,1,2,5,10 and 20 µg/l), by using 
ICP-MS, under the operating conditions described in Table 2.8. 
Table 2.10   Determination of LOD and LOQ for ICP-MS, regarding total arsenic 
analysis 
Sample Measured Conc. (µg/l) SD (n = 3) 
Blank-1 0.036 0.038 
Blank-2 0.036 0.024 
Blank-3  0.010 0.036 
Blank-4 0.044 0.040 
Blank-5 0.007 0.017 
Blank-6 0.043 0.026 
Blank-7 0.014 0.009 
Blank-8 0.013 0.025 
Blank-9 0.039 0.041 
Blank-10 -0.004 0.071 
   
Mean 0.024  
SD 0.018  
LOD = 3 x SD  0.05  
LOQ = 10 x SD 0.18  
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 Table 2.11   Reproducibility of total arsenic measurement. 
Sample Measured Conc. (µg/l) SD (n = 3) %RSD 
Standard (10 µg/l)-1 10.721 0.219 2.041 
Standard (10 µg/l)-2 10.896 0.265 2.435 
Standard (10 µg/l)-3 10.583 0.175 1.657 
Standard (10 µg/l)-4 10.533 0.032 0.301 
Standard (10 µg/l)-5 10.536 0.170 1.615 
Standard (10 µg/l)-6 10.546 0.135 1.279 
Standard (10 µg/l)-7 10.585 0.019 0.176 
Standard (10 µg/l)-8 10.418 0.150 1.444 
Standard (10 µg/l)-9 10.120 0.158 1.557 
Standard (10 µg/l)-10 10.090 0.185 1.832 
average 10.5 0.2 1.4 
 
 










Total measured conc. 
(µg/l) 
mean ± SD (n =3) 
Recovery (%) 
US2-1 3.9 ± 0.1 50 54.3 ± 1.3 100.9 
US2-2 4.5 ± 0.2 50 56.9 ± 0.2 104.8 
US2-3 4.5 ± 0.1 50 56.8 ± 0.2 104.6 
     
Mean    104.3 
SD    2.2 
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 2.2.4.4 Determination of total selenium in urine samples and    
method validation                                                                            
 
A calibration curve of selenium was produced within the concentration range of 
0 -20 µg/l (Fig. 2.14). The calibration curve was based on raw data presented in Table 
2.13. The limit of detection (LOD) and the limit of quantification  (LOQ) for total 
selenium were calculated by measuring the blank ten times. The LOD (3 x SD) was 
0.19 µg/l and LOQ (10 x SD) was 0.63 µg/l (Table 2.13). The spiking experiment was 
carried out by using 50 µg/l of selenium in urine sample, then diluted (5-fold) with 
2%v/v HNO3 to achieve a total spiked concentration of 10 µg/l.  The accuracy and 
reproducibility of the method was also validated by measuring 10 µg/l standard of 
selenium after each 20 runs. The reproducibility (between-run, n =10; replicates (n = 3) 
for each measurement) was 10.3 ± 0.3µg/l (2.6% RSD), and the results are shown in 
Table 2.14. The measurement of total selenium in urine was validated by a spiking 
experiment and the recovery was 102% (n = 9) (Table 2.15).  The CRM NIES No. 18  
human urine was also used to validate the method and the measured result was 67.9 ± 
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Figure 2.14 Calibration curve for selenium standards (0,1,2,5,10 and 20 µg/l), by 
using ICP-MS.  The operating conditions are described in Table 2.8. 
Table 2. 13 Determination of LOD and LOQ for ICP-MS regarding total selenium 
analysis. 
Sample Measured Conc. (µg/l) SD (n = 3) 
Blank-1 0.141 0.169 
Blank-2 0.064 0.065 
Blank-3 0.074 0.034 
Blank-4 0.141 0.082 
Blank-5 0.040 0.067 
Blank-6 0.073 0.047 
Blank-7 0.068 0.094 
Blank-8 -0.004 0.069 
Blank-9 0.109 0.113 
Blank-10 -0.064 0.140 
   
Mean 0.064  
SD 0.063  
LOD = 3 x SD 0.19  
LOQ = 10 xSD 0.63  
  




Table 2.14   Reproducibility of total selenium measurement. 
Sample Measured Conc. (µg/l) SD (n = 3) %RSD 
Standard (10 µg/l)-1 10.416 0.25 2.398 
Standard (10 µg/l)-2 10.371 0.274 2.639 
Standard (10 µg/l)-3 10.720 0.112 1.042 
Standard (10 µg/l)-4 10.465 0.108 1.032 
Standard (10 µg/l)-5 10.441 0.342 3.277 
Standard (10 µg/l)-6 10.387 0.479 4.612 
Standard (10 µg/l)-7 10.543 0.392 3.715 
Standard (10 µg/l)-8 10.211 0.205 2.009 
Standard (10 µg/l)-9 9.670 0.066 0.679 
Standard (10 µg/l)-10 9.939 0.470 4.726 
Average 10.3 0.3 2.6 
 
 
Table 2.15    Spiking experiment to assess recovery of selenium. 
Sample 
name 
Measured conc. (µg/l) 





Total measured conc. (µg/l) 
mean ± SD (n =3) 
Recovery (%) 
US2-1 14.1± 0.1 50 65.0± 1.8 101.8 
US2-2 15.1± 0.2 50 67.0± 0.4 103.8 
US2-3 15.0± 0.2 50 65.8± 0.3 101.6 
     
Mean    102.4 
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 2.2.5    Method development for arsenic speciation in human urine  
using HPLC- ICP-MS 
 
A method has been developed for determination of arsenic species in  human 
urine samples using ICP-MS.  A PQ II VG Instrument (Winford, UK), shown in Fig. 
2.5, was used for this speciation analysis.  The measurements were carried out at the 
University of Manchester and the operating conditions are detailed in Table 2.16.   
 
Table 2.16   Instrumental operation conditions for HPLC-ICP-MS system: ICP-MS 
(PQ II, VG Instruments, Winford, UK). 
HPLC Instrument 
Column PEEK Hamilton PRP-X 100 anion 
exchange (250 x 4.6 mm i.d). 
Guard column Phenomenex Polymerx RP-1 (4 x 3 mm 
i.d), pH stability (1-14). 
Mobile phase 95% v/v 20 mM NH4CO3, pH 10.3 and 5% 
v/v methanol. 
Injection volume 100 µl 
ICP-MS Instrument 
Radio frequency power 1335 W 
Sample and skimmer cones Ni 
Argon flow rate  
Plasma 13 l/min 
Auxiliary flow 0.95 l/min 
Nebulizer flow 0.94 l/min 
Acquisition parameters Peak jumping 
Dwell time  100 ms 
Data acquisition time  1300 ms 
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 2.2.5.1  Chromatographic conditions  
 
Germanium (Ge) solution was added to the mobile phase (see Table 2.16) as an 
internal standard to a final concentration of 50 g/l. The HPLC system consisted of a 
790 Personal IC chromatograph (Metrohm, Switzerland), a liquid chromatography 
solvent delivery pump, fitted with a 100 l sample loop, and an anion exchange column 
Hamilton PRP-X 100 (250 × 4.6 mm i.d.) with a guard column (4 × 3 mm id), 
Polymerx RP-1 (Phenomenex, USA). An ICP-MS was used as the chromatographic 
detector. The outlet of the HPLC system was coupled directly to the inlet of the ICP 
nebulizer with PEEK i.d. 90 m tubing. Signals at m/z 75, 77 and 51 were monitored. 
The signal at m/z 51 was used to monitor the 35Cl16O+ interference. The 
chromatographic and instrumental conditions for arsenic speciation are shown in Table 
2.16.  
2.2.5.2 Speciation analysis of arsenic in urine samples and method  
validation 
HPLC-ICP-MS was used for the separation of five arsenic species: AB, DMA, 
MA, As (III) and As (V).  The calibration curves of the arsenic species were drawn 
within the range of 0 -25 µg As/l. The calibration curves were based on the raw data 
presented in Fig. 2.15, 2.16, 2.17, 2.18 and 2.19 for the blank (mobile phase(0)), 1,5,10 
and 25 µg As/l standards, respectively. The calibration curves of the five arsenic 
species are presented in Fig. 2.20.  The problem of interference from high levels of 
chloride present in the urine samples was overcome as shown in Fig.2.21.  The chloride 
was chromatographically resolved from the various arsenic species. Arsenic species 
peak integration and drift correction were calculated using an in-house Turbo Pascal 
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 programme. Detection limits for the five species (AB, DMA, As (III), MA and As 
(V)) were 0.45, 0.45, 0.95, 0.84 and 0.99 µg As/l, respectively.   
To assess the recovery of the five arsenic species, a spiking experiment was 
carried out, by using 10µg As/l for each species in a mixture. The results are shown in 
Fig. 2.22 for unspiked urine sample, and Fig. 2.23 for the same urine sample spiked 
with the mixture.  Furthermore, a control experiment was carried out by spiking a urine 
sample individually with different species to confirm the retention time of the species 
in urine samples especially for the DMA and As (III) that eluted close to each other. 
The result of unspiked urine sample is shown in Fig.2.24, the same urine sample was 
spiked with 10µg As/l for AB, DMA and As (III) separately, this shown in Fig. 2.25, 
2.26 and 2.27, respectively. An overlaid chromatogram for the above-mentioned figures 
(Fig.2.24 to 2.27) is presented in Fig. 2.28. This shows a recognised peak for each 
species. The recoveries of the arsenic species spiked in the urine sample were AB (90 
%), DMA (95 %), As (III) (86 %), MA (95 %), and As (V) (98 %); results are 
presented in Table 2.17.   
The accuracy and reproducibility of the method was also validated by 
measuring 10 µg As/l standard mixture of the five arsenic species after each six runs. 
The results are shown in Table 2.18, and the raw data are shown in Appendix 2.3. The 
CRM NIES No. 18  human urine was used to validate the method and the results were 
as follows: AB 69.7 ± 0.3 µg As/l and DMA 38.4 ± 0.4 µg As/l; the certified values 
were 69 ± 12 µg/l and 36 ± 9µg/l, respectively.  
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 Table 2. 17 The recovery percentage of the five arsenic species spiked in urine 
sample.  
Arsenic species AB DMA As (III) MA As (V) 
Measured conc. (µg As/l) ± SE 9.0 ± 1.3 9.5 ± 0.1 8.6 ± 1.1 9.5 ± 1.2 9.8 ± 6.4 
Spiked conc.(µg As/l) 10.0 10.0 10.0 10.0 10.0 
Recovery (%) 90 95 86 95 98 
 
 
Table 2.18   Reproducibility of the five arsenic species measurement in 10µg As/l 
standard mixture. 
Arsenic species AB DMA As (III) MA As (V) 
Measured conc. (µg As/l) ± SE (1) 10.0 ± 0.2 9.9 ± 0.3 10.1 ± 0.6 10.1 ± 0.3 10.3 ± 1.1 
Measured conc. (µg As/l) ± SE (2) 10.1 ± 0.3  9.9 ± 0.7  10.0 ± 1.4  10.0 ± 0.6 10.8 ± 1.2 
Measured conc. (µg As/l) ± SE (3) 9.9 ± 0.4 9.8 ± 0.8 10.2 ± 1.5 10.1 ± 0.7 9.9 ± 1.2 
      
Mean 10.0 9.9 10.1 10.1 10.3 
SD 0.1 0.1 0.1 0.1 0.5 


















































Figure 2.16   HPLC-ICP-MS chromatogram of a standard containing 1 µg As/l of each 
AB, DMA, As (III), MA and As (V).  
  


























Figure 2.17   HPLC-ICP-MS chromatogram of a standard containing 5 µg As/l of each 























Figure2.18   HPLC-ICP-MS chromatogram of a standard containing 10 µg As/l of each 
AB, DMA, As (III), MA and As (V).  
 
  

























Figure 2.19   HPLC-ICP-MS chromatogram of a standard containing 25µg As/l of each 
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Figure 2.20   Calibration curves for standards arsenic species (AB, DMA, MA, As (III) 








Figure 2.21   Chromatogram of standard solution containing five arsenic species (25 
µg As/l) overlaid with 35Cl 16O+ peak from diluted human urine; experimental 

























Figure 2.22   HPLC-ICP-MS chromatogram of a urine sample (UA1) 5-fold diluted 
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Figure 2.23  HPLC-ICP-MS chromatogram of a spiked urine sample (UA1) with 10 µg 























Figure 2.24   HPLC-ICP-MS chromatogram of a urine sample (UW18) 5-fold diluted 
with the mobile phase.  
 
  


























Figure 2.25  HPLC-ICP-MS chromatogram of a spiked urine sample (UW18) with 10 























Figure 2.26  HPLC-ICP-MS chromatogram of a spiked urine sample (UW18) with 10 
µg As/l of DMA. 
  














Figure 2.27  HPLC-ICP-MS chromatogram of a spiked urine sample (UW18) with 10 
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Figure 2.28   Overlaid chromatograms of urine sample UW18 ( ) spiked with AB 10 
µg As/l  ( )and DMA 10 µg As/l  ( )and As (III) 10 µg As/l  (---). Chromatographic 
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 2.2.6 Statistical analysis 
 
 
This section briefly describes the main statistical methods used in this thesis.  More 
details on these methods can be found in such sources as Miller and Miller (2000) and 
Kerr et al., (2002). There are two types of statistical analysis used in most research 
investigations.  
(i) Descriptive statistics: summarise the characteristics of the data set such as 
mean, median, standard deviation, variance and range.  
(ii) Inferential statistics: are used to test a hypothesis and make inferences 
about sample data, which can be generalised to a larger population (Kerr et 
al., 2002).  
 In this research, Student’ s t-test and Kolmogorov-Smirnov’ s test (KS-test) were 
used for data analysis. 
The collected data can be normally or not normally distributed. The former is 
distributed in the form of a bell-shape curve. The distribution is a mathematical concept 
and is defined by distance from the mean in standard deviation units; the same 
proportion of the area of the curve is always cut off. Therefore, the mean and the 
standard deviations provide a summary description of data that estimates the normal 
distribution (Kerr et al., 2002). 
All the following definitions are reported by Kerr et al. (2002) in their book ‘‘Doing 
statistics with SPSS’ ’ . 
Normal distribution: A theoretical distribution that is symmetrical and in which the 
distribution of data is described by z-tables. For example, approximately 68% of the 
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 population lies within ±1 standard deviations of the mean, and the equivalent 
figures for 95% and 99.7% are ±2 and ±3 respectively. 
Depending on the type of distribution, either parametric or non-parametric 
statistical tests will be used to analyse the data. Parametric tests such as t–test are based 
on the assumption that data are drawn from a normally distributed population. By 
contrast, non-parametric tests such as KS-test make no assumption about data 
distribution. The former are more likely to detect significance differences between two 
sets of data, because they make more assumptions about those data (Kerr et al, 2002; 
Miller and Miller, 2000). 
Non-parametric tests: Tests that make no assumptions about the distribution of the 
data.  
Parametric tests: Tests which use the sample data to estimate the population 
parameters. They require at least interval data, equal variance and a normal distribution.  
Some equations that show how different statistical measurements and tests can 
be derived are given in Miller and Miller (2000): 
 
Mean: A measure of central tendency calculated by adding all the scores and dividing 
by the number of scores. 
x   = 
n
x i  
 
where x the mean and n is the number of measurements. 
 
Standard deviation: The square root of the variance. It measures the dispersion of the 
scores around the mean in normal distribution. 
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where s is the standard deviation on and n is the number of measurements. 
 
RSD = 100 s/ x  
 
 
where RSD  is the relative standard deviation.  
 
 
A significance test is used to test the truth of null hypothesis (H0).  The term 
null implies that there are no differences between the values under the test, with 
exception of random variation differences. This means that if the H0 is true, then t-test 
calculates the probability (P) that the observed difference between the values is the 
result of random error. The lower the P values indicating that the observed difference 
happens by chance, the less likely H0 is true. Usually H0 is rejected if the P of the 
difference taking place by chance is less than 1 in 20, which is 0.05 or 5%. In such case 
the difference is said to be significant at 5% level, in which is P = 0.05, this gives the 
probability to reject the true (H0) (Miller and Miller, 2000). In case of comparing two 
sets of data to explore the difference, H0 will be rejected if P value is small (< 0.05) 
(Tools for science, 2006).   
The t-test is used in order to decide where the difference between two samples means, 
1x and 2x  is significant. 











s is calculated from :  
  

















The paired t-test tests whether there is a significant difference between the results 
obtained from the same subjects under different conditions  
t = dsnd /  
 
where d  and Sd are mean and standard deviation of d respectively, (d is the difference 
between paired values). 
 











where r is the correlation coefficient and r2 is the coefficient of determination. 
 
In one case, an odd ratio is used in this research to measure how frequently the 
analyte was detected, by comparing two sets of data drawn twice from the same 
subjects under different conditions. An example to show how the probability can be 
calculated was reported by UCLA (2006)  For example the probability of detection of 
the analyte is 0.X – thus  
In this thesis odd ratio was used in one case to measure how frequently detected 
is the analyte, by comparing two sets of data that drawn twice from the same subjects 
under different condition. It has been reported (UCLA, 2006) and example to show 
how the probability can be calculated.  For example, the probability of detection of the 
analyte is 0.X, thus  
P = 0.X 
The probability of absence is then 
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 Q = 1-p = 0.Y 
The odds of detection are defined as: 
Odds (detection) = p/q = 0.X/0.Y =  Z 
Thus, the odds of detection are Z to one, and the odds of absence will be q/p. 
where X,Y and Z are numbers. 
The John Turkey test was used to identify which data points are outliers. This test 
defines the data as outliers if the data points are 1.5*IQR above the third or below the 
first quartile, where IQR is the interquartile range, the range between the third and first 
quartiles and is a measure of statistical dispersion (Tools for science, 2006). 
In order to determine the statistical significance of the experimental data 
presented, the statistical methods described in this section have been applied where 
necessary to the experimental data in Chapters 3, 4 and 5.  
2.3 Summary discussion of modified/developed methods 
 
Here a brief discussion is presented to provide the rational behind the choice of 
analytical methods used in this project for the analysis of arsenic in biological samples. 
Different spectroscopic techniques were used in this project: GF-AAS, ICP-MS 
and HPLC-ICP-MS.  Suitable methodologies were modified and/or developed for 
preparation and analysis of arsenic in urine, hair and nail samples from human 
volunteers for analysis using spectroscopic techniques. ICP-MS and HPLC-ICP-MS 
were used for total arsenic and arsenic speciation analysis, respectively, especially for 
low levels of arsenic in human urine. These methods were found to be the most suitable 
techniques based on validation studies carried out. 
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 In the development stage of the project the suitability of several 
spectroscopic techniques were evaluated for the analysis of arsenic in biological 
samples. The techniques used are those that were readily accessible for the purpose of 
this research project. The preparation and analysis of urine samples were carried out 
according to previous published procedure with appropriate modifications whenever 
necessary.  Matrix effect is often a problem in the analysis of urine samples because it 
can either suppress or enhance the measured signal response of arsenic in urine. This 
problem was overcome for GF-AAS analysis by extensive dilution of the urine sample 
with the a diluent, in addition to the usage of a chemical modifier. The matrix effect 
due to chloride interference on arsenic in urine samples when using ICP-MS is 
considered as a disadvantage of this technique. This problem was overcome by using a 
correction equation, which eliminates the interference from chloride for determination 
of total arsenic in urine samples.  While for arsenic speciation analysis by HPLC-ICP-
MS in human urine, the problem of chloride interference was overcome through 
chromatographic separation. A successful elimination of the chloride was achieved 
through this method. This enabled a good separation and high recovery of arsenic 
species in the urine samples. 
The above mentioned analytical methods were validated either via spiking 
experiments or with certified reference materials. High recoveries were achieved and  
the values determined with these methods were identical with the reference values 
given for either total arsenic or arsenic species. Consequently, these methods were used 
during the course of this project.   
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Ethnicity and Arsenic Metabolism 
 
This Chapter investigates the role of ethnicity in understanding arsenic 
metabolism through a comparative study of arsenic levels in the urine, hair and 
fingernails of volunteers from three ethnic groups in Leicester, UK. 
 
3.1 Introduction  
 
Arsenic is a ubiquitous element and occurs in different chemical forms in the 
environment. In recent years, there has been much interest in this element due to the 
contamination of drinking water in some parts of the World. Millions of people in 
Bangladesh and India are exposed to high levels of arsenic from contaminated 
groundwater (Steinmaus et al., 2005; Suzuki, 2005; Tokunaga et al., 2005). 
Occupational exposure to arsenic can take place through mining, copper smelting and 
other activities (Loffredo et al., 2003). Natural exposure to arsenic can occur through 
consumption of seafood, which contains mainly organoarsenic compounds, or drinking 
water that is dominated by inorganic arsenic species (Yamaushi et al., 1992; Vahter, 
1994; Tokunaga et al., 2005; Loffredo et al., 2003). Chronic exposure to inorganic 
arsenic through drinking water has been associated with hyperkeratosis, spotted 
melanosis, skin pigmentation and lung cancer (Yoshida et al., 2004). The toxicity of 
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 arsenic  in humans is dependent on its chemical form with both As(III) and As(V) 
being the most toxic, MA and DMA are less toxic, and AB, which is mainly found in 
seafood, being considered non-toxic (Ritsema et al., 1998; Vahter et al., 2000; Shraim 
et al., 2001). Thanks to recent studies, much progress has been made in the 
understanding of the metabolic pathway of inorganic arsenic in humans (Suzuki, 2005). 
Two alternating steps are involved in inorganic arsenic metabolism: reduction of As 
(V) to As (III), followed by oxidative methylation of As (III). After human exposure, a 
substantial fraction of As (V) is reduced to As (III) in the blood, which is then taken up 
by hepatocytes and methylated to MA and DMA (Hsueh et al., 1998). These latter 
methylated metabolites are less toxic than inorganic arsenic, and because of this, the 
methylation process is considered a detoxification mechanism (Hsueh et al., 1998; 
Adair et al., 2005). However, MA (III) and DMA (III), which have been identified in 
the urine of populations exposed to inorganic arsenic in their drinking water, have been 
shown to be more genotoxic than inorganic arsenic (Hsueh et al., 1998). Therefore, 
from a toxicity perspective, arsenic speciation in urine has an important role in 
understanding human health effects and the metabolism of arsenic. The half-life of 
inorganic arsenic in the body is 2 days, so measuring arsenic in urine can reflect an 
individual's recent exposure (Watanabe et al., 2001). However, reliance on only urine 
analysis may not provide a complete picture of arsenic metabolism when comparing the 
relationship between different factors, such as ethnicity and diet. It is known that 
arsenic levels in hair (Raab and Feldmann, 2005; Yanez et al., 2005; Mandal et al., 
2003; Rahman et al., 2000), fingernail and toenail (Kile et al., 2005; Wilhem et al., 
2005; Mandal et al., 2003) samples provide an additional level of information regarding 
arsenic  exposure over a longer time scale. This is because sequestering of arsenic in 
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 these tissues occurs over a longer time frame of 2–18 months (Tobin, 2005; 
Yoshinaga et al., 1990; Nowak and Kozlowski, 1998) compared to urine samples 3–4 
days (Buchet et al., 1981). Progress in the understanding of arsenic metabolism in 
humans is hindered by the fact that little is known about arsenic metabolism in healthy 
populations. In recent years, several studies have reported on this subject with respect 
to arsenic metabolism in populations exposed to high levels of arsenic  through 
consumption of contaminated drinking water (Hopenhayn-Rich et al., 1996; Mandal et 
al., 2003; 2004; Kile et al., 2005).  
The awareness of the relationship between ethnicity, diet and arsenic 
metabolism is rather poor, particularly for populations exposed to low concentrations of 
arsenic. Ethnicity is defined as large group of people with a common background, such 
as culture, religion, language, nation, tribe or race (Merriam-Webster’ s online 
dictionary, 2006). Studies conducted on this subject suggest that dietary (Lai et al., 
2004) and ethnic differences (Loffredo et al., 2003; Hulle et al., 2004) may play a role 
in arsenic metabolism and there are also implications for the role of genetics 
(Hopenhayn-Rich et al., 1996; Vahter et al., 2000; Loffredo et al., 2003; Kile et al., 
2005) in arsenic metabolism. However, these studies have focused on populations 
exposed to high levels of arsenic and often involved analysis of just urine samples.  
Keeping these two limitations in mind, this is the first large study to investigate 
the role of ethnicity in arsenic metabolism in unexposed populations from the UK. This 
was carried out by analysis of hair, fingernails and urine samples of volunteers, from 
three different ethnic communities, residing in the same city (Leicester, United 
Kingdom), who have not been exposed to high levels of inorganic arsenic through 
drinking water or environmental and occupationional exposure. 
  





 This section covers study group, sample collection, stability of arsenic species, 
material and methods, and statistical analysis. All of these sub-sections also  apply to 
all urine samples discussed in Chapter 4 and 5, unless otherwise stated.  
3.2.1 Study group 
 
 Healthy volunteers from White, Asian and Somali Black-African communities 
were recruited from Leicester, UK. The total number of participants for the urine 
analysis was 63 adults [mean age 31.8 years (4 volunteers did not report their age); 21 
women, 42 men]. For the hair and fingernails analysis, 36 volunteers were recruited. 
These were mainly new volunteers although some of them also provided urine samples, 
which were included in the urine analysis data. The mean age of the hair and nail 
analysis volunteers was 34.6 years [(four volunteers did not report their age); 11 
women, 25 men]. In order to ensure that the volunteers were not exposed to arsenic in 
their drinking water, GF-AAS was used to determine the arsenic content of drinking 
water, from the water supply system, in Leicester. The analysis revealed that the level 
is below the detection limit of the technique (0.25 g/l).  
Each individual was asked to refrain from eating fish and seafood only for 3 
days prior to sample collection while other factors such as alcohol, smoking etc were 
recorded using a questionnaire. The volunteers were asked to complete a questionnaire 
asking for demographic information such as ethnicity, age, gender, and life-style 
characteristics such as diet, smoking and alcohol consumption. Based on the responses 
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 to the questionnaire, the participants were classified into three ethnic groups: Asian 
(Appendix 3.1), Somali Black-African (Appendix 3.2) and White (Appendix 3.3). 
Appendices 3.1, 3.2 and 3.3 provide detailed information (demographic factors and life 
style) about these three ethnic groups. The Asian group comprised individuals with 
ancestral links to India, Pakistan, and Bangladesh. The Somali Black-African 
population was made up of individuals originating from Somalia, East Africa, and the 
White group comprised indigenous white people from the UK. All of the subjects were 
resident in Leicester, UK at the time of the study. The Faculty of Health and Life 
Sciences Human Research Ethics Committee, at De Montfort University, Leicester, 
approved the study’ s design and aims.  
3.2.1.1 Time delay between urine samples collection, storage and 
analysis 
 
During the course of this project, there were time delays between sample collection 
storage and measurement. This is not unusual in the analysis of urine samples using 
analytical techniques especially those studies involving large number of samples from 
diverse groups of people. It is important to point out that conditions that have been used 
in this study such as sample collection, storage and measurements procedures are very 
similar to what has been used by others in the analysis of arsenic species in human 
urine samples. Presented below is a discussion, which shows that the arsenic species 
investigated in this project are stable for many months.  
The urine samples used in the project were transported at room temperature by the 
volunteers to the laboratory.  There is also some time delay between collection and 
storage of urine samples, which can arise from variation in the time (some hours) of 
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 collection by the volunteers.  Such transportation and time delays associated with 
analysis of urine samples is a common practice in the analysis of arsenic in human 
urine (Heitland and Koster 2006; Morton and Mason 2006).  There is literature 
evidence for stability of arsenic species at room temperature.  For example, based on 
previous studies (Feldman et al., 1999; Palacios et al. 1997) on stability of arsenic 
species and storage conditions, the following species MA, DMA and AB in urine 
sample were stable for 67 days at ambient temperature. In addition As (III), As (V), 
MA and  DMA were less stable at 25 0C for up to 2 months , while AB was stable up to 
8 months at 25 0C. Therefore, transporting urine samples at room temperature was 
considered to have no effect on the stability of these species.  
Urine samples used in this thesis were stored at -20 0C before analysis.  Storage 
of urine samples at -20 0C for many months prior to analysis is common (Aposhian et 
al., 1997). The longevity in their study was 6 months, and then the urine samples were 
thawed at room temperature overnight prior to the measurement. Few studies have been 
reported in the literature regarding stability of naturally occurring arsenic species in 
human urine some of which are discussed below. 
Naturally occurring species, such as DMA and MA, in human urine samples has 
been  reported to be stable for 8 months when stored at -20 0C (Feldmann et al., 1999). 
The samples were measured twice: 2 weeks and 8 months after the sample collection. 
The concentration of AB added to urine sample from a volunteer, has been reported 
(Feldmann et al., 1999) to remain unchanged  for up to 8 months under storage 
condition of -20 0C; with measurements being carried out three times (2, 4 and 8 
months) after sample collection. 
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 Chen et al. (2002) have reported stability of five naturally occurring arsenic 
species (AB, DMA, MA, As (III) and As (V)) in seven freshly collected human urine 
samples, and also in a certified urine sample (NIST SRM 2670). These species were 
found to be stable for up to six months when the samples were  stored at -20 0C. 
Arsenic levels in these samples were measured weekly over the period of the study. 
Other authors (Cornelis et al., 1995) have also reported that arsenic in human urine is 
stable over 6 months when stored at -20 0C.   
A stability study for naturally occurring arsenic species such AB and DMA in 
freeze-dried urine (CRM NIES No.18) over a period of 2 years has been carried out by 
Yoshinaga et al. (2000). The stability of DMA and AB was investigated for one and 2 
years respectively, by analysing freshly reconstituted samples. The concentrations of 
these species were found to be stable under storage condition for the freeze-dried CRM 
at 4 0C.  
In this study AB, DMA and MA were the main species analysed and, as discussed 
above, these arsenic species are highly stable for several months. Procedures used in 
this study are analogous to what has been used by other researchers in the field of 
arsenic analysis in human urine. 
3.2.1.2 Urine samples collection, storage and preparation 
Urine samples collection and storage were carried out as generally reported in 
the literature (Steinmaus et al., 2005; Hopenhayn-Rich et al., 1996; Vahter et al., 1995). 
First morning urine samples were collected in polyethylene bottles from the three 
healthy ethnic groups (White n = 20; Asian n = 21; and Somali Black-African n = 22), 
residing in Leicester, UK. Volunteers were asked to refrain from eating fish and 
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 seafood for 3 days prior to sample collection, and to complete a questionnaire, which 
gathered information on age, gender and ethnicity along with lifestyle. The 
questionnaire was accompanied with a letter to explain, to each of the volunteer, the 
details of the project and how to deal with the samples in terms of collection and 
storage. Morning urine samples (mid-stream) were collected directly into polyethylene 
bottles (Fisher, UK). Once in the laboratory the normality of the urine sample was 
established by using a Combur-9 urine test strip (Roche, Germany). The samples were 
then stored at − 20 °C until the analyses were carried out. Prior to total arsenic or 
arsenic speciation analysis, the samples were filtered through a 0.45 m pore syringe 
filter and diluted up to 5-fold with the mobile phase for speciation analysis, and 5-fold 
with 2%v/v HNO3 for total arsenic determination. 
All urine samples were transported at normal temperature to the laboratory 
(frozen upon receipt) or to the location of the measurement, and the time delay between 
storage (− 20 °C) and measurement was in the range of 1 – 6 months (Appendices 3.4, 
3.5 and 3.6).  
3.2.1.3 Dates of collection and  measurements of urine samples from 
the three ethnic groups 
Here, dates of collection and dates of measurements and locations for arsenic 
analysis of all urine samples from the three ethnic groups (Asian, Somali and Whites)  
are described in detail. Speciation measurements of arsenic in the urine samples from 
all ethnic groups (Asian, Somali and whites in Appendices 3.4, 3.5 and 3.6, 
respectively) were carried out at The University of Manchester (HPLC-ICP-MS, PQ II, 
VG Instruments, Winford, UK). The total arsenic in the urine samples from the three 
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 ethnic groups (Appendices  3.4, 3.5 and 3.6) were measured at The University of Hull 
(ICP-MS, ELAN DRCII, PerkinElmer SCIEX, Concord, Ontario, Canada).  
 
3.2.2 Chemicals and reagents 
 
Deionised water (>18 cm−1) was used throughout the study. Stock solutions 
of arsenic species were prepared and standardised against an As (V) standard (1000 ± 3 
mg/l, CPI, International, USA). As (III) [(As2O3), Sigma-Aldrich,Germany] was 
dissolved in 4g/l sodium hydroxide and made up to appropriate volume with 2% v/v 
HNO3 (UPA, Romil, UK).   Stock solutions of As (III), As (V),  DMA 
[(CH3)2AsO(OH), Sigma-Aldrich, Germany], MA [CH3AsO(OH)2, Greyhound, Dorset, 
England] and AB [(C5H11AsO2, Fluka, Fisher Chemicals, UK] were prepared in 
deionised water and stored in the fridge at 4 °C.   Fresh diluted solutions were prepared 
daily for analysis. The mobile phase (20 mM NH4HCO3, pH 10.3) was used for arsenic 
speciation, which was mentioned before in Section 2.2.3 (Table 2.6).  
3.2.3 Instrumentation 
 
          Methods have been developed for both total arsenic and arsenic speciation 
analysis. Details regarding this can be found in Chapter 2 (Sections 2.2.4 and 2.2.5, 
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 3.2.4 The procedure to determine the effect of seafood 
consumption on the background level of total urinary 
arsenic 
 
Different seafood consumed by one volunteer, and the effect of these seafood 
on the background of total urinary arsenic level was evaluated. The following quantities 
were ingested from the different foods: salmon (350 g), prawn (300 g), seaweed (15 g) 
and cod liver oil (10 ml). First morning void urine samples were collected from the 
volunteer on the day before ingestion time (0 day) and then every day up to seven days 
after the ingestion. The results are presented in section 3.3.1.1.  
3.2.5 Quality control and method validation 
  
CRM or known standard were also analysed during each analytical run as a 
quality control check. The method validation for total arsenic and arsenic speciation 
analysis was carried out and is same as what has been reported in Chapter 2: sections 
2.2.4 and 2.2.5, respectively. The validation of total arsenic in hair was mentioned in 
section 2.2.2.7. 
3.2.6 Determination of creatinine  
 
The creatinine measurement for this Chapter was the same to what has been 
reported in Chapter 2 (section 2.2.1.3). 
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 3.2.7 The procedure to determine the effect of storage time on 
arsenic compound stability 
An experiment was carried out to evaluate the stability of naturally occurring 
arsenic species in human urine, which was freshly collected from a volunteer. A urine 
sample was collected from the volunteer who had refrained form eating fish and 
seafood for 3 days prior to sample collection. The sample was stored at -20oC and then 
subjected to total arsenic measurement over a period of sixteen months: results are 
shown in section 3.3.1.2. An other experiment was also carried out for arsenic 
speciation analysis over a period of six months: results are shown in section 3.3.1.3. 
3.2.8 Determination of total arsenic in urine samples 
 
All urine samples were filtered through a 0.45 m pore syringe filter and diluted 
5-fold with 2%v/v HNO3 for total arsenic determination. The calibration curve of 
arsenic standard is shown in Chapter 2 (see Fig. 2.13). The determination of total 
arsenic in urine samples was carried out same as described in Chapter 2 (see section 
2.2.4). 
3.2.9   Speciation analysis of arsenic in urine samples  
 
In order to see if there were any differences in arsenic speciation in the urine 
samples from the three ethnic groups, HPLC separation of AB, MA, As (III), As (V) 
and DMA was carried out. The calibration curves are shown in Chapter 2, section 2.2.5, 
Fig 2.15. The problem of interference from high levels of chloride present in the urine 
samples was overcome as is shown in Chapter 2, section 2.2.5, Fig. 2.16. The chloride 
was chromatographically resolved from the various arsenic species.  
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 3.2.10     Collection, pre-treatment and total arsenic  determination      
of hair and fingernail samples 
 
Hair samples from different positions of the head  and fingernails, from all 
10 fingers, were collected from the three ethnic groups (White n = 11, Asian n = 10 and 
Somali Black-Africans n = 15). All samples were kept in sealed plastic bags and stored 
at room temperature. The hair and fingernails samples were washed and analysed as 
described before in Chapter 2, section 2.2.2.7.  
 3. 2.11   Statistical analysis 
 
Differences between ethnic groups in terms of arsenic species in urine and total 
arsenic levels in urine, hair and fingernail were evaluated using the t-test. The 
difference is significant when  P > 0.05 at 95% confidence interval. The association of 
age and gender were also evaluated by using the same test. 
3. 3 Results  
 
All results regarding urine samples (total arsenic and arsenic species), hair and 
fingernails (total arsenic ) are presented in the following sections: 
 3. 3. 1   Analysis of urine samples 
 
 This section includes the stability experiment on urine samples for storage and 
the effect of seafood’ s consumption on the background level of urinary arsenic.  
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 3.3.1.1   Effect of seafood consumption on the background of urinary 
arsenic level 
The main objective of this experiment was to estimate the contribution of 
seafood ingestion on the background level after one day from ingestion time. This 
experiment was also used to confirm the literature reports (Hsueh et al., 2002; Palacios 
et al., 1997) that arsenic from seafood is cleared after 3 days. The individual data is 
presented in Table 3.1 and graphically illustrated in Fig 3.1. It is apparent that three 
days is sufficient for clearance of arsenic from human body through urine, especially 
arsenic that originates from seafood and seaweed. After three days of seafood and 
seaweed ingestion, the measured level was almost the same as the background level 







0 1 2 3 4 5 6 7 8
Prawn Salmon Seaweed Cod liver oil
 
Figure 3.1   The effect of seafood ingestion on background level of urinary total 
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 Table 3.1   Total arsenic (µg/l) and creatinine (mg/l) in urine samples collected from 
one volunteer after seafood ingestion. All urine samples were measured on 17/08/2005, 



















30/05/2005 0 9.9 2398.0 4.1 0.7 
 1 143.8 2115.0 68.0 3.1 
 3 14.7 2149.0 6.9 0.3 
 5 16.1 1561.0 10.3 0.4 
 7 8.5 1810.0 4.7 0.8 




0 10.2 2613.0 3.9 0.7 
 1 13.4 2726.0 4.9 0.2 
 3 9.5 1425.0 6.6 0.2 
 5 14.4 1776.0 8.1 0.3 
 7 15.2 3110.0 4.9 0.9 
      
Seaweed, 
07/07/2005 0 11.6 611.0 18.9 
3.2 
 1 120.6 2703.0 44.6 2.2 
 3 19.6 2647.0 7.4 0.3 
 5 26.5 2873.0 9.2 0.4 
 7 30.9 1855.0 16.7 3.2 
      
Prawn, 
27/07/2005 0 65.9 1753.0 37.6 
7.6 
 1 392.8 2002.0 196.2 9.4 
 3 66.2 2816.0 23.5 1.1 
 5 46.5 2138.0 21.7 1.0 
 7 47.3 2500.0 18.9 3.7 
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3.3.1.2   Relationship between storage conditions and the stability of  
total arsenic in urine samples 
A urine sample was collected on 01/10/2004 from a volunteer with no recent 
seafood ingestion, spiked with 200 µg/l of As(V) on 04/04/2004 (100404QC). The 
sample was then stored at -20 0C. Subsequently analysis for total arsenic was carried 
out using GF-AAS. The sample was diluted 200-fold with 1%v/v HNO3 prior to 
analysis. Table 3.2 shows the dates of the analysis and measured concentrations in the 
diluted sample, and total arsenic concentrations were obtained by multiplying the 
measured concentration with the dilution factor.  A series of analysis were carried out 
over 16 months, with an average 243.7 µg/l of total arsenic and  very low standard 
deviation (6.4) and 2.6%RSD ( n = 6). This shows the stability of total arsenic in urine 
over a period of approximately one and a half years . 
Table 3.2 Measured concentration (µg/l) of arsenic in diluted (200-fold) urine sample 





Abs.  Total arsenic 
conc. (µg/l) 
SD (n = 3) 
28/10/2004 1.22 0.0114  244 0.60 
01/12/2004 1.25 0.0087  250 0.25 
04/02/2005 1.28 0.0112  246 0.17 
17/05/2005 1.16 0.0064  232 0.34 
29/07/2005 1.21 0.0097  242 0.11 
28/02/2006 1.24 0.0074  248 0.38 
      
Mean 1.23   243.7  
SD 0.04   6.4  
%RSD 3.3   2.6  
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  3.3.1.3   Relationship between storage conditions and the stability of 
arsenic species in urine samples 
The results of the experiment on the effect of urine storage condition on arsenic 
compounds stability showed that the arsenic species (AB and DMA) remained constant 
during the course of the study. The chromatograms in Fig. 3.2 and the determined 
values are as follows:  AB one month after collection (19.2 ± 1.5µg As/l) and 6 months 
after collection (19.3 ± 0.2 µg As/l); DMA one month after collection (4.0 ± 0.8µg 
As/l) and 6 months after collection (4.3± 0.2 µg As/l), at -20 0C storage condition. The 
average between of the two measurements were 19.3 ± 0.1 µg As/l and 4.2± 0.2 µg As/l 
for AB and DMA, respectively. These results are in agreement with reports of the 
literature, that these arsenic species are highly stable in human urine under similar 
storage condition. Therefore,the relevant arsenic species are stable over the period of 
the study. 
  
























































Figure 3.2   Chromatograms obtained from the HPLC-ICP-MS analyses of two arsenic 
species in urine sample (UW18) within 1 month; AB (19.2 ± 1.5µg As/l) and DMA 
(4.0 ± 0.8µg As/l) (A) and 6 months; AB (19.3 ± 0.2 µg As/l) and DMA (4.3± 0.2 µg 
As/l) (B) of collection and storage at -20 0C. 
 
 
3.3.1.4 Representative chromatograms for speciation of arsenic  
in urine samples  
Representative chromatograms for speciation of arsenic in urine samples from  
three volunteers from Asian, Somali and White ethnic groups are presented in Figures 
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 3.3, 3.4 and 3.5, respectively. Additional representative figures are presented in 
Appendix 3.7, which includes chromatograms from blank, standard solutions, certified 
urine sample (CRM NIES No.18) and real samples. The results of the CRM NIES No. 
18 were as follows: AB 63.3 ± 0.9µg As/l and DMA 38.0 ± 1.2 µg As/l; the certified 
values were 69 ± 12 µg/l and 36 ± 9µg/l, respectively. The reproducibility of the 
method was also validated by measuring 10 µg As/l standard mixture of the five arsenic 
species after each 6 runs. The reproducibility (n =3) was 9.7 ± 0.2µg As/l (2.4% RSD) 
for AB, 10.3 ± 0.6 µg As/l (6.2% RSD) for DMA, 10.0 ± 0.3 µg/l (3.3% RSD) for As 

























Figure 3.3   Example of a HPLC-ICP-MS chromatogram for speciation of arsenic in 
the urine of an Asian volunteer (UA21). Species concentrations are AB (12.5 ± 0.4 µg 
As/l) and DMA (5.4± 0.4 µg As/l) 
  

























Figure 3.4   Example of a HPLC-ICP-MS chromatogram for speciation of arsenic in 
the urine of a Somali volunteer (US5). Species concentrations are AB (8.4 ± 0.2 µg 





















Figure 3.5   Example of a HPLC-ICP-MS chromatogram for speciation of arsenic in 
the urine of a White volunteer (UW12). Species concentrations are AB (18.7 ± 0.4 µg 
As/l) and DMA (1.6± 0.6 µg As/l) 
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 3.3.1.5 Concentration of total arsenic and arsenic species before       
creatinine adjustment among the three ethnic groups 
 
This section shows total arsenic concentration (µg/l) and arsenic species (AB, 
DMA and MA) concentrations (µg As/l), before creatinine adjustment, among the three 
ethnic groups: Asian, Somali and White in Table 3.2, 3.3 and 3.4, respectively. 
Table 3.3  Asian group: Concentration of total arsenic (µg/l), arsenic species (µg As/l) 














1. UA1 26.5 <LOD <LOD 26.5 30.5 1868 
2. UA2 3.0 1.9 <LOD 4.9 17.9 3136 
3. UA3 50.5 8 <LOD 58.5 70.5 1709 
4. UA4 43.5 2.5 <LOD 46.0 55.2 1823 
5. UA5 81 11.5 <LOD 92.5 60.4 2139 
6. UA6 15.5 14.1 <LOD 29.6 47.3 2151 
7. UA7 195.0 30.5 <LOD 225.5 198.8 2355 
8. UA8 12.0 1.0 <LOD 13.0 17.4 1347 
9. UA9 <LOD 3.7 <LOD 3.7 11.8 1166 
10. UA10 7.0 1.1 <LOD 8.1 15.6 2332 
11. UA11 18.9 8.1 <LOD 27.0 40.7 1902 
12. UA12 29.5 6.4 <LOD 35.9 44.5 2264 
13. UA13 19.5 1.5 <LOD 21.0 25.2 1641 
14. UA14 12.2 1.6 <LOD 13.8 21.9 1562 
15. UA15 10.4 2.2 <LOD 12.6 18.6 2660 
16. UA16 3.0 1.4 <LOD 4.4 8.6 1075 
17. UA17 7.8 3.1 <LOD 10.9 16.5 1404 
18. UA18 95.6 7.2 1.8 104.6 63.8 1958 
19. UA19 <LOD 1.1 <LOD 1.1 6.5 283 
20. UA20 3.5 3.6 <LOD 7.1 10.1 1404 
21. UA21 12.5 5.4 <LOD 17.9 33.8 2434 
        
 Mean 30.8 5.5 0.1 36.4 38.8 1838.7 
 SD 45.5 6.8 0.4 51.6 41.5 625.2 
 Median 12.5 3.1 <LOD 17.9 25.2 1868.0 
 Min. <LOD <LOD <LOD 1.2 6.5 283.0 
 Max. 195.0 30.5 1.8 225.5 198.8 3136.0 
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 Table 3.4   Somali group: Concentration of total arsenic (µg/l), arsenic species (µg 














1. US1 1.2 1.0 <LOD 2.2 8.1 1030 
2. US2 <LOD 0.7 <LOD 0.7 4.6 758 
3. US3 <LOD 0.7 <LOD 0.7 3.1 826 
4. US4 1.7 3.2 <LOD 4.9 12.2 1664 
5. US5 8.4 5.3 <LOD 13.7 22.6 1811 
6. US6 2.4 1.0 <LOD 3.4 10.2 838 
7. US7 0.9 0.9 <LOD 1.8 7.5 1087 
8. US8 1.1 2.6 <LOD 3.7 13.2 1290 
9. US9 5.6 1.3 <LOD 6.9 10.7 724 
10. US10 <LOD <LOD <LOD <LOD 4.5 634 
11. US11 <LOD 2.9 <LOD 2.9 7.7 577 
12. US12 <LOD <LOD <LOD <LOD 3.2 634 
13. US13 <LOD <LOD <LOD <LOD 3.4 577 
14. US14 <LOD 1.4 <LOD. 1.4 3.3 838 
15. US15 <LOD 4.0 1.0 5.0 6.2 1087 
16. US16 1.4 2.0 <LOD 3.4 7.8 906 
17. US17 2.5 1.3 <LOD 3.8 8.8 1449 
18. US18 <LOD <LOD <LOD 2.3 7.8 3804 
19. US19 <LOD 0.9 <LOD 0.9 2.0 5060 
20. US20 2.1 1.8 <LOD 3.9 12.5 2422 
21. US21 <LOD <LOD <LOD <LOD 4.6 1336 
22. US22 7.5 0.7 <LOD 8.2 18.6 1743 
        
 Mean 1.6 1.4 <LOD 3.2 8.3 1413.4 
 SD 2.5 1.4 0.2 3.3 5.2 1102.5 
 Median 0.5 <LOD <LOD 2.6 7.8 1058.5 
 Min. <LOD <LOD <LOD <LOD 2.0 577 
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Table 3.5   White group: Concentration of total arsenic (µg/l), arsenic species (µg 















1. UW1 1.0 3.6 <LOD 4.6 28.6 1472 
2. UW2 1.0 2.4 <LOD 3.4 9.4 374 
3. UW3 <LOD <LOD <LOD 0.0 5.2 464 
4. UW4 75.3 <LOD <LOD 75.3 56.7 1698 
5. UW5 9.3 5.2 <LOD 14.5 30.1 2332 
6. UW6 59.7 9.9 <LOD 69.6 61.7 940 
7. UW7 <LOD 4.0 <LOD 4.0 16.2 770 
8. UW8 2.4 1.0 1.6 5.0 9.5 996 
9. UW9 <LOD 2.1 <LOD 2.1 5.7 351 
10. UW10 2.8 5.9 4.1 12.8 23.3 1324 
11. UW11 2.1 4.4 <LOD 6.5 11.9 679 
12. UW12 18.7 1.6 <LOD 20.3 27.1 543 
13. UW13 21.8 <LOD <LOD 21.8 24.2 340 
14. UW14 <LOD 4.7 <LOD 4.7 7.9 917 
15. UW15 1.5 1.9 <LOD 3.4 5.4 159 
16. UW16 2.2 2.7 <LOD 4.9 8.3 1053 
17. UW17 2.2 5.4 <LOD 7.6 10.1 951 
18. UW18 19.2 4.0 <LOD 23.2 17.9 419 
19. UW19 2.3 3.3 <LOD 5.6 9.1 1426 
20. UW20 <LOD 1.2 <LOD 1.2 4.2 475 
        
 Mean 11.1 3.2 0.3 14.5 18.6 884.2 
 SD 20.6 2.4 1.0 21 16.2 549.6 
 Median 2.2 3.0 <LOD 5.3 11.0 843.5 
 Min. <LOD <LOD <LOD <LOD 4.2 159 
 Max. 75.3 9.9 4.1 75.3 61.7 2332 
 
3.3.1.6 Concentration of total arsenic and arsenic species after 
creatinine adjustment among the three ethnic groups.  
This section shows total arsenic concentration (µg As/g creatinine) and arsenic 
species (AB, DMA and MA) concentrations (µg As/g creatinine), after creatinine 
adjustment, among the three ethnic groups: Asian, Somali and White in Table 3.6, 3.7 
and 3.8, respectively. 
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 Table 3.6   Asian group: Concentration of total arsenic and arsenic species (µg As/g 










1. UA1 14.2 0.0 0.0 14.2 16.3 
2. UA2 1.0 0.6 0.0 1.6 5.7 
3. UA3 29.5 4.7 0.0 34.2 41.3 
4. UA4 23.9 1.4 0.0 25.2 30.3 
5. UA5 37.9 5.4 0.0 43.2 28.2 
6. UA6 7.2 6.6 0.0 13.8 22.0 
7. UA7 82.8 13.0 0.0 95.8 84.4 
8. UA8 8.9 0.7 0.0 9.7 12.9 
9. UA9 0.0 3.2 0.0 3.2 10.1 
10. UA10 3.0 0.5 0.0 3.5 6.7 
11. UA11 9.9 4.3 0.0 14.2 21.4 
12. UA12 13.0 2.8 0.0 15.9 19.7 
13. UA13 11.9 0.9 0.0 12.8 15.4 
14. UA14 7.8 1.0 0.0 8.8 14.0 
15. UA15 3.9 0.8 0.0 4.7 7.0 
16. UA16 2.8 1.3 0.0 4.1 8.0 
17. UA17 5.6 2.2 0.0 7.8 11.8 
18. UA18 48.8 3.7 0.9 53.4 32.6 
19. UA19 0.4 3.9 0.0 4.2 23.0 
20. UA20 2.5 2.6 0.0 5.1 7.2 
21. UA21 5.1 2.2 0.0 7.4 13.9 
       
 Mean 15.2 2.9 0.0 18.1 20.6 
 SD 20.2 2.9 0.2 9.7 15.4 
 Median 7.8 2.2 0.0 22.5 17.5 
 Min. 0.0 0.0 0.0 1.6 5.7 
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 Table 3.7   Somali group: Concentration of total arsenic and arsenic species (µg As/g 










1. US1 1.2 1.0 0.0 2.1 7.9 
2. US2 0.0 0.9 0.0 0.9 6.1 
3. US3 0.0 0.8 0.0 0.8 3.8 
4. US4 1.0 1.9 0.0 2.9 7.3 
5. US5 4.6 2.9 0.0 7.6 12.5 
6. US6 2.9 1.2 0.0 4.1 12.2 
7. US7 0.8 0.8 0.0 1.7 6.9 
8. US8 0.9 2.0 0.0 2.9 10.2 
9. US9 7.7 1.8 0.0 9.5 14.8 
10. US10 0.0 0.0 0.0 0.0 7.1 
11. US11 0.0 5.0 0.0 5.0 13.3 
12. US12 0.0 0.0 0.0 0.0 5.0 
13. US13 0.0 0.0 0.0 0.0 5.9 
14. US14 0.0 1.7 0.0 1.7 3.9 
15. US15 0.0 3.7 0.9 4.6 5.7 
16. US16 1.5 2.2 0.0 3.8 8.6 
17. US17 1.7 0.9 0.0 2.6 6.1 
18. US18 0.0 0.0 0.0 0.6 2.1 
19. US19 0.0 0.2 0.0 0.2 0.4 
20. US20 0.9 0.7 0.0 1.6 5.2 
21. US21 0.0 0.0 0.0 0.0 3.4 
22. US22 0.0 0.4 0.0 4.7 10.7 
       
 Mean 1.3 1.3 0.0 2.6 7.2 
 SD 2.0 1.3 0.2 2.5 3.8 
 Median 0.4 0.9 0.0 1.9 6.5 
 Min. 0.0 0.0 0.0 0.0 0.4 
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 Table 3.8   White group: Concentration of total arsenic and arsenic species (µg As/g 











1. UW1 0.7 2.4 0.0 3.1 19.4 
2. UW2 2.7 6.4 0.0 9.1 25.1 
3. UW3 0.0 0.0 0.0 0.0 11.2 
4. UW4 44.3 0.0 0.0 44.3 33.4 
5. UW5 4.0 2.2 0.0 6.2 12.9 
6. UW6 63.5 10.5 0.0 74.0 65.6 
7. UW7 0.0 5.2 0.0 5.2 21.0 
8. UW8 2.4 1.0 1.6 5.0 9.5 
9. UW9 0.0 6.0 0.0 6.0 16.2 
10. UW10 2.1 4.5 3.1 9.7 17.6 
11. UW11 3.1 6.5 0.0 9.6 17.5 
12. UW12 34.4 2.9 0.0 37.4 49.9 
13. UW13 64.1 0.0 0.0 64.1 71.2 
14. UW14 0.0 5.1 0.0 5.1 8.6 
15. UW15 9.4 11.9 0.0 21.4 34.0 
16. UW16 2.1 2.6 0.0 4.7 7.9 
17. UW17 2.3 5.7 0.0 8.0 10.6 
18. UW18 45.8 9.5 0.0 55.4 42.7 
19. UW19 1.6 2.3 0.0 3.9 6.4 
20. UW20 0.0 2.5 0.0 2.5 8.8 
       
 Mean 14.1 4.4 0.2 18.7 24.5 
 SD 22.4 3.5 0.8 22.9 19.3 
 Median 2.4 3.7 0.0 7.1 17.6 
 Min. 0.0 0.0 0.0 0.0 6.4 
 Max. 64.1 11.9 3.1 74.0 71.2 
 
 
Individual data for the three ethnic groups are presented in Fig. 3.6 and 3.7. The 
data are for total urinary arsenic concentration before (µg /l) and after (µg As/g 








Figure 3.6   Total urinary arsenic concentration (µg/l) before creatinine adjustment for 




Figure 3.7   Total urinary arsenic concentration (µg As/g creatinine) after creatinine 
adjustment for the three ethnic groups (Asian, Somali and White). 
 
 As can be seen from Figures 3.6 and 3.7, the vast majority of the volunteers 
within each group had similar arsenic levels in their urine samples.  However, few 
outliers were found in the data of the three ethnic groups before and after creatinine 
  
   
146 
 adjustment in Fig. 3.6 an 3.7, respectively.  As shown in Fig. 3.6, two values were 
found to be outliers in the White group before creatinine adjustment (56.7 and 61.7 
µg/l) and one for  both the Asian (198.8 µg/l) and the Somali (22.6 µg/l) groups. After 
creatinine adjustment, the number of outliers were reduced and only one each was 
found in the Asian (84.4 µg/l) and the White (71.2 µg/l) groups.  Few samples showing 
a high level of total arsenic were observed (Fig. 3.7). The reason for these high values 
could be due to the volunteers consuming seafood within 3 days prior to sample 
collection.  However, it is important to note that the outliers have no statistically 
significant effect on the differences between Asian/White compared with the Somali 
group. Significant differences (P < 0.05) between these ethnic groups were detected 
before and after the exclusion of the outliers (see Table 3.9). 
The outliers in the sum of all species among the three groups also followed the 
same trend as was observed with the total arsenic analysis. The number of outliers were 
reduced after creatinine adjustment in all groups. A total of three outliers were seen 
before creatinine adjustment for the Asian group (92.5, 105 and 226 µg/l). In contrast, 
only one was seen for the Somali group (13.7 µg/l) and two for the White group (69.6 
and 75.3 µg/l). After creatinine adjustment, all the outliers disappeared except for the 
Asian group where two values (53.4 and 95.8 µg As/g creatinine) appear as outliers. 
 3.3.1.7   Arsenic concentrations in urine samples 
In all the three ethnic groups, (Asian, Somali and White) five arsenic species 
(AB, DMA, As (III), MA and As (V)) were analysed.  While As (III) and As (V) were 
not detected in any single volunteer, AB and DMA were mainly detected in all groups 
and MA was rarely detected. 
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  Before creatinine adjustment for the Asian group (Table 3.3), total 
concentration of arsenic varied from 6.5 to 198.8 µg/l, the mean was 38.8 ± 41.5 µg/l. 
There was one clear outlier with an extremely high value of 198.8 µg/l (Fig. 3.6). The 
detected arsenic species were AB, DMA and MA, and the mean of sum for all species 
was 36.4 ± 51.6 µg As/l. Only 3 samples did not show AB and DMA. On the other 
hand, with exception of one sample, MA was not detected in all the other samples. The 
range of creatinine concentration was 283.0 – 3136.0 mg/l. After creatinine adjustment 
(Table 3.6), the mean of total concentration of arsenic in urine was 20.6 ±15.4 µg As/g 
creatinine, with range of  5.7- 84.4 µg As/g creatinine, one value (84.4 µg As/g 
creatinine) was considered as an outlier (Fig. 3.7). The mean of sum for all arsenic 
species was 18.1 ± 9.7µg As/g creatinine with a range of 1.6–95.8 µg As/g creatinine.  
There were two values (53.4 and 95.8 µg As/g creatinine) that could be considered as 
outliers.  
For the Somali group before creatinine adjustment (Table 3.4), total 
concentration of arsenic varied from 2.0 to 22.6µg/l, the mean was 8.3 ± 5.2µg/l. Only 
one sample (22.6 µg/l ) appeared to be an outlier (Fig. 3.6).  The detected arsenic 
species were AB, DMA and MA, the mean of sum for all species was 3.2 ± 3.3 µg As/l. 
The dominant species were AB and DMA. More than 50% of the samples did not show 
AB, while DMA was detected in all but three samples. MA was detected in only one 
sample. The range of the creatinine was 577.0 –5060.0 mg/l, the highest value (5060.0 
mg/l) was seen in one sample; when the latter was excluded the range was 577.0 – 
3804.0 mg/l. After creatinine adjustment (Table 3.7), the mean of total concentration of 
arsenic in urine was 7.2 ± 3.8 µg As/g creatinine, with a range of 0.4 – 14.8 µg As/g 
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 creatinine, with no outliers. The mean of arsenic species was 2.6 ± 2.5µg As/g 
creatinine with a range of 0.0– 9.5 µg As/g creatinine. 
Urinary arsenic in the White group before creatinine adjustment is presented in 
Table 3.5. The  total concentration of arsenic varied from 4.2 – 61.7 µg/l, with a mean 
of 18.6 ± 16.2 µg/l. Two samples showed high values (56.7 and 61.7 µg/l ) and were 
considered to be outliers (Fig. 3.6).  The detected arsenic species were AB, DMA and 
MA. The mean of sum for all species was 14.5 ± 21.0 µg As/l. The dominant species 
were AB and DMA and were detected in all but six samples, while MA was detected in 
only two samples. The range of creatinine concentration was 159.0 – 2332.0 mg/l. 
After creatinine adjustment (Table 3.8) the mean of total concentration of arsenic in 
urine was 24.5 ± 19.3 µg As/g creatinine, with range of 4.2 – 61.7 µg As/g creatinine. 
One value (71.2 µg As/g creatinine) was considered to be an outlier (Fig. 3.7). The 
mean of sum for all arsenic species was 18.7 ± 22.9 µg As/g creatinine with a range of 
0.0 – 74.0 µg As/g creatinine. 
The average total urinary arsenic levels (µg As/g creatinine) in the three ethnic 
groups are shown in Table 3.6, 3.7 and 3.8 and presented in Fig. 3.8.  The average total 
arsenic was 17.2 ± 16.5 µg As/g creatinine for the three groups combined, while the 
average among the specific ethnic groups were 24.5 ±  19.3µg As/g creatinine, 20.6 
±15.4  µg As/g creatinine, 7.2 ± 3.8 µg As/g creatinine for the Asian, White and Somali 
Black-Africans, respectively. Statistical analysis using t-test at 95% confidence interval 
reveals that there is a significant difference ( P < 0.05) between Asian/White compared 
with Somali Black-Africans for the total urinary arsenic levels, both before and after 
inclusion of the outliers, as shown in Table 3.9.  
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  The fact that the sum of the different species detected was lower than the total 
arsenic is not entirely surprising, and may be explained by the presence of minor 
species at levels below the detection limit. When speciation analysis is carried out a 
significant proportion of the species will be below the level of detection of the method 
(the low total arsenic is sub-divided into various species which will be lower still) and 
therefore appear to be absent. The lower arsenic levels in these samples lead to greater 
variability and therefore larger SD values, outliers were also contributed to higher SD, 
as shown in Table 3.6, 3.7 and 3.8. 
The statistical test in this study revealed no significant effect for gender and age 





































Figure 3.8   Total arsenic concentration (µg As/g creatinine) in urine; among the three 









The results for the arsenic speciation (µg As/g creatinine) in the urine samples 
from the three ethnic groups determined using HPLC-ICP-MS analysis are shown in 
Table 3.6, 3.7 and 3.8.   Data presented in Table 3.9 shows that the application of t-test 
reveals a significant difference (P < 0.05) between Asian and White groups compared 
to the Somali Black-Africans for AB, DMA, sum of all species and total arsenic.  No 
significant difference was observed for MA (P > 0.05). Species percentages are 47 % 
AB, 50 % DMA and 2 % MA in Somali Black-Africans compared with 83 % AB,  16 
% DMA and 1 % MA in Asians and 77 % AB, 22 % DMA and 1 % MA in Whites.   
Fig. 3.9 summaries how the proportion of the arsenic species (AB, DMA, and MA) 
vary in the three groups.   
Table 3.9   A summary of statistical significance (P values) when comparing urinary 
species (AB, DMA and MMA), sum of all species and total  arsenic among the three 
ethnic groups (Asian, Somali and White), after creatinine adjustment. 




Asian  (21) vs. White (20) 0.93 0.20 0.34 0.91; 0.27* 0.50; 0.29* 
Somali (22) vs. Asian (21) 0.00 0.03 0.68 0.00; 0.00* 0.00; 0.00* 
Somali  (22) vs. White (20) 0.01 0.00 0.26 0.00; 0.00* 0.00; 0.00* 

















White Combined ethnic groups 
(Asian+Somali+White) 
Figure 3.9   Proportion of arsenic species in urine samples of three ethnic groups; 
Asian, Somali and White. 
 
 
3. 3. 2   Analysis of hair and fingernail samples 
 
Dates of collection, digestion (using the microwave Prolabo 301, Fig. 2.7) 
measurements of total arsenic in hair and nail of Asian, Somali and White by using GF-
AAS (see Chapter 2, section 2.2.2.7), and location of measurements, are presented in 
Appendices 3.8,3.9 and 3.10, respectively. 
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 Table 3.10   Asian group: total arsenic concentration (µg/kg) in hair and fingernail 
samples.  
* Numbers between brackets are additional names given to hair and fingernail samples, 













HA1(26)* 52.8 NA1(26)* 139.1 
HA2(27) 58.0 NA2(27) 118.9 
HA3(28) 103.0 NA3(28) 65.0 
HA4(29) 314.5 NA4(29) 181.1 
HA5(32) 56.7 NA5(32) 71.3 
HA6(33) 94.9 NA6(33) 207.3 
HA7(34) 134.8 NA7(34) 151.0 
HA8(35) 211.8 NA8(35) 209.3 
HA9(36) 26.3 NA9(36) 156.8 
HA10(37) 121.4 NA10(37) 239.2 
    
Mean 117.4  153.9 
SD 87.2  57.9 
Median 99.0  153.9 
Min. 26.3  65.0 
Max. 314.5  239.2 
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HS1(1) 358.5 NS1(1) 68.5 
HS2(2) 154.1 NS2(2) 881.7 
HS3(3) 31.7 NS3(3) 121.3 
HS4(4) 74.7 NS4(4) 501.4 
HS5(5) 197.4 NS5(5) 70.3 
HS6(6) 47.9 NS6(6) 897.1 
HS7(7) 238.1 NS7(7) 761.8 
HS8(8) 98.6 NS8(8) 2806.2 
HS9(9) 46.4 NS9(9) 889.4 
HS10(10) 128.8 NS10(10) 1971.2 
HS11(11) 28.6 NS11(11) 270.0 
HS12(12) 106.7 NS12(12) 109.3 
HS13(13) 87.0 NS13(13) 1288.7 
HS14(14) 108.9 NS14(14) 147.9 
HS15(15) 32.4 NS15(15) 62.0 
    
Mean 116.0  723.1 
SD 91.1  798.1 
Median 98.6  501.4 
Min. 28.6  62.0 
Max. 358.5  2806.2 
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Table 3.12    White group: total arsenic concentration (µg/kg) in hair and 



















Total arsenic concentration 
(µg/kg) 
HW1(30) 29.5 NW1(30) 61.8 
HW2(31) 144.1 NW2(31) 265.0 
HW3(38) 148.6 NW3(38) 597.2 
HW4(39) 244.3 NW4(39) 135.4 
HW5(40) 75.3 NW5(40) 208.1 
HW6(41) 345.1 NW6(41) 74.1 
HW7(42) 78.4 NW7(42) 155.9 
HW8(43) 300.0 NW8(43) 221.7 
HW9(44) 41.6 NW9(44) 98.5 
HW10(45) 66.1 NW10(45) 53.7 
HW11 (46) 80.0 NW11(46) 75.2 
    
Mean 141.2  177.0 
SD 108.4  156.5 
Median 80.0  135.4 
Min. 29.5  53.7 
Max. 345.1  597.2 
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 As shown from Fig 3.10 almost all hair and nail samples among the three ethnic 
groups are similar in each group, and clustered around their medians. Only few outliers 
were identified in hair samples and these are as follows: Asian (314 µg/kg), Somali 
(358 µg/kg) and in nail samples: Somali (2806 and 1971.2 µg/kg) and White (597 
µg/kg). These data are also presented Table 3.10, 3.11 and 3.12, for the Asian, Somali 
and the White groups, respectively. The reason for the very high values (2806 and 
1971.2 µg/kg) of the outliers for the Somail group are not clear.  Since all the samples 
had to be used for the analysis it was not possible to carry out additional measurements 
to check the reproducibility of the data.  However, excluding or including the outliers 
does not result in any significant changes in the statistical outcome (Table 3.13).    
 
Figure 3.10 Total  arsenic concentration (µg/kg) in hair and fingernail samples 
among the three ethnic groups: Asian, Somali and White. 
 
This study showed the range of total arsenic in hair and fingernails samples was 
26.3–358.5 g/kg and 53.7–2806.2 g/kg, respectively for the three groups combined. 
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 Fig. 3.11 displays the total arsenic levels of hair and fingernail samples in the three 
ethnic groups. The average total arsenic in hair and fingernails samples were 124.9 ± 
14.2 g/kg and 351.3 ± 322.2 g/kg, respectively, for the three groups combined. The 
averages for each of the ethnic groups were 153.9 ± 57.9 g/kg, 177.0 ± 156.5 g/kg 
and 723.1 ± 798.1 g/ kg for the Asians, White and Somali Black-Africans, 
respectively for fingernail samples. Statistical analysis using t-test reveals that there 
was a significant difference (P < 0.05) between Asian/White compared with Somali 
Black-Africans for the total  arsenic levels in fingernails.  
For hair samples the average for each of the  ethnic groups were 117.4 ± 87.2 
g/kg, 141.0 ± 108.4 g/kg and 116.0 ± 91.1 g/kg for the Asians, White and Somali 
Black-Africans, respectively. However, unlike the fingernail samples there were no 
significant differences (P > 0.05) among the three groups regarding arsenic levels in the 


































Figure 3.11 The mean total arsenic concentration (µg/kg) in hair and fingernail 




Table 3.13   Statistical summary of P-values for arsenic concentration (µg/kg) in hair 
(H) and  fingernails (N) samples from Asian, Somali Black Africans and White 
volunteers. Values in parentheses are number of individuals. 
 
Group (n) P -value 
Hair  
Somali (H (5) vs Asian (H  (10)) 0.97; 0.91a 
Somali (H  (5))vs White (H (11)) 0.53 
Asian (H(10))vsWhite (H (11)) 0.59 
Fingernails  
Somali (N(15) vs Asian (N (10) 0.04; 0.04a 
Somali (N (15) vs White (N (11) 0.04 
Asian (N( 10)vs White (N (11) 0.67 
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 3.4  Discussion 
 
The sample collection, storage and measurement procedures employed in this 
thesis are similar to what others have used in the scientific literature.  Furthermore, a 
survey of the literature and stability experiments carried out revealed that total arsenic 
and arsenic species in urine are stable throughout the course of this study.  Three days 
were found to be necessary for the clearance of arsenic originating from seafood from 
human urine, as indicated from the ingestion of seafood experiments.   
The vast majority of the volunteers within each ethnic group have very similar 
arsenic concentrations in their urine samples (Fig. 3.6 and 3.7).  Only few volunteers 
showed high levels of arsenic in their urine samples making them very different from 
the vast majority of the individuals.  The precise reason for this is not clear. It could be 
due to these volunteers not strictly adhering to the instructions given with the 
questionnaire, especially regarding the importance of refraining from the consumption 
of seafood. However, the overall trend of the study was unaffected, since the exclusion 
or inclusion of the data from volunteers,  appearing as outliers, does not result in any 
significant changes in the statistical outcome. 
As can be seen from Fig 3.6, before creatinine adjustment, and Fig. 3.7 after 
creatinine adjustment, the outliers either disappeared or were reduced.  The reduction of 
the outliers after creatinine adjustment indicates the importance of creatinine 
adjustment. This is considered as a means of eliminating different factors that are not 
associated with arsenic exposure, resulting in a decrease in the number of apparent 
outliers. It is noteworthy that creatinine adjustment will eliminate different factors that 
are not related to arsenic exposure such as urine volume and concentration (Hinwood et 
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 al., 2002). Suwazono et al., 2005 and Vahter et al., 2006, also confirmed the 
importance of creatinine adjustment. When analysing urine samples, the variation in the 
dilution of urine samples, due to variation of hydration status of the volunteer under 
study, which are related to fluid intake, temperature etc. These variations can be 
controlled by creatinine or specific gravity adjustment (Suwazono et al., 2005). This 
also agrees with what was reported by Vahter et al. (2006) that the concentrations of 
biomarkers in urine are highly dependent on the dilution of the sample.  
 There are few studies in the literature that explore the role of ethnicity in 
arsenic metabolism.  Those that do are limited by being restricted to a very small 
number of individuals (Lai et al., 2004, Hulle et al. 2004), or are based on 
epidemiological data on populations from different countries (Loffredo et al., 2003) 
and/or involve the study of exposed populations (Hopenhayn-Rich et al., 1996).    
Despite these drawbacks, the understanding of arsenic metabolism pathways is 
progressing thanks to studies investigating speciation of arsenicals in biological 
samples (Mandal et al., 2004; Steinmaus et al. 2005; Suzuki, 2005). 
Comparison of arsenic in urine, hair and fingernail samples  of the three 
ethnic groups 
The results of this study reveal that there are significant differences between 
Somali Black-Africans and Asian/White groups in terms of total arsenic in urine 
(Table. 3.9) and fingernails (Table 3.13) and also urinary arsenic speciation.  The 
results for the urinary arsenic analysis clearly reveal that the Somali Black-African 
group has significantly lower levels of total arsenic compared to the White and Asian 
groups (Fig. 3.8).  This difference was not restricted to total arsenic levels because 
  
   
160 
 speciation analysis revealed that differences also exist between these three groups in 
terms of the levels of different species in urine (Table 3.9).  In particular, the proportion 
of AB is lower and DMA higher in the Somali Black-African group (Fig. 3.9).  In order 
to identify the underlying reason for this difference, hair and fingernail samples from 
these three groups were also measured (Table 3.10, 3.11 and 3.12). Some  This 
revealed a statistically significant difference between the Somali Black-Africans 
compared to White and Asians for the fingernail samples with the Somali group having 
a significant higher total level of arsenic in their fingernails compared to the White and 
Asian groups (Fig. 3.11).   However, the total level of arsenic in the hair samples of the 
three groups was not significantly different (Table 3.13).    There are three possible 
reasons that may underlie the differences between the groups: (A) dietary; (B) genetic; 
and (C) a combination of diet and genetics.  The possible roles of these factors are 
discussed below in relation to what has been reported in the literature.  However, it is 
stressed that since this study did not involve a total diet study or genetic analysis, it is 
not possible to ascertain which of these two factors is responsible for the differences 
observed in this study. 
 (A) Role of Diet  
The effect of dietary differences cannot be easily answered because this study 
was not a total diet study and it was not possible to monitor and control the food intake 
of the volunteers.  However, as part of the sample collection process and the associated 
questionnaire the volunteers were asked to refrain from consuming fish and seafood for 
at least three days prior to collection of urine.  Furthermore, the questionnaire used for 
hair and fingernail sample collection showed that the most common main meal for the 
three groups consisted mainly of rice and meat.  It was found from this that 89 % of 
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 Asians and 85 % of Somali Black-Africans in the study had a diet that consisted of 
mainly rice and meat. Significantly, the Somali Black-African diet contained very little 
vegetable or fish as part of their main meal. Further discussions with the Somali 
community revealed that their diet is heavily meat based.  In contrast, the Asians and 
White groups appear to have a more balanced diet.  In this respect, the Somali diet is 
very different from the other groups and may partly explain the differences observed. 
The importance of diet in arsenic metabolism has been reported by Steinmaus et 
al. (2005) and showed that individuals with higher protein intake excreted higher levels 
of DMA in their urine compared with those who had a lower protein intake. It is 
possible that a protein rich diet provides sufficient quantities of methionine, choline, or 
cysteine, which are necessary for inorganic arsenic methylation to DMA. It has also 
been reported that rabbits with low protein dietary intake show a significant decrease in 
the urinary excretion of DMA (Vahter et al., 1987).  Furthermore, Hopenhayn-Rich et 
al. (1996) concluded that diet may partially play a role in methylation differences, from 
a study of methylation among populations exposed to arsenic in their drinking water. 
Thus, literature evidence suggests greater levels of DMA are excreted in the urine of 
humans and animals that have a higher intake of protein in their diets.   
 (i) Urine Analysis 
In light of the study by Steinmaus et al. (2005), the higher percentage of DMA 
observed in the urine of Somali Black-African group compared to the other groups 
suggests that a protein rich diet may explain their arsenic excretion profile compared to 
the White and Asian groups.  However, it is important to point out that this study 
investigated the relationship between dietary protein intake and arsenic methylation for 
subjects exposed to inorganic arsenic in their drinking water.  In this study, the three 
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 groups reside in the same city and are therefore unlikely to have different levels of 
inorganic arsenic from their drinking water.  Hence, the explanation for the high 
percentage of DMA in urine of Somali group is either ascribed to the methylation of 
trace inorganic arsenic that may be contained in their diet or resulting from breakdown 
of certain organoarsenic compounds in their body.  For example, urinary DMA was 
identified as a major metabolite in human urine after seaweed ingestion (Le et al., 1996; 
Hulle et al. 2004) as a result of the metabolism of arsenosugars. This was confirmed by 
Francesconi et al. (2002) where a volunteer ingested a pure arsenosugar and DMA was 
found to constitute 67% of the total excreted arsenic.  However, in the case of this study 
all the volunteers did not report any consumption of seaweed and all volunteers were 
asked to refrain from consumption of fish and seafood for 3 days prior to sample 
collection.   Furthermore, the Somali Black-Africans are not known to be consumers of 
seaweed or shellfish, where arsenosugars are found to occur naturally. 
The Somali Black-Africans show the lowest level of AB (48%) in their urine 
compared to Asians (83%) and White groups (77%).  The high levels of AB observed 
in all three groups is all the more surprising since this compound is known to originate 
from fish and seafood which the volunteers refrained from eating for at least three days 
prior to the collection of urine.  Other studies have also previously reported that high 
amounts of AB are excreted in urine (Ritsema et al., 1998; Lai et al. 2004).   Studies 
with 61 healthy volunteers in the Netherlands showed 69.5 % of the total arsenic as AB 
despite abstaining from seafood for 48 hours (Ritsema et al., 1998).  Slow excretion of 
AB or the ability to metabolise arsenic compounds via a different pathway was offered 
as a possible explanation for the observation (Lai et al., 2004).  This study confirms this 
finding with a seven fold higher number of volunteers compared to Lai et al. (2004) 
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 although it is still not possible to provide an unequivocal explanation for the presence 
of AB in urine samples of people refraining from fish and seafood. One explanation 
may be linked to other sources of AB in the diet, for example it has recently been 
reported that AB present in chicken (Polatajko et al., 2004) which is widely consumed 
by the three ethnic groups according to the data from the questionnaire.  This may 
partly explain the reason for the presence of urinary AB because it was detected even 
amongst volunteers who did not consume fish.  However, AB from chicken meat 
cannot be the sole source because it was also detected in some vegetarian volunteers in 
this study. Consumption of hidden fish products or other AB containing products 
cannot be ruled out as reported by Ritsema et al., 1998.   Another explanation for the 
presence of AB could be based on a recent study, which suggests that this compound 
might be synthesized by humans from trimethylarsine (TMA) (Goessler et al. 1997), 
although this has been questioned by others (Edmonds 1998).  If AB can be synthesized 
in humans, then this finding would suggest that the lower levels of AB in Somali 
Black-Africans may be due to them having a lower ability to synthesize this compound. 
Therefore, the possibility that the human body is capable of metabolizing arsenic 
compounds to AB must be further investigated. 
 (ii) Fingernail analysis 
Keratin-rich tissues such as hair and nail can accumulate arsenic  and this can be 
used as an indicator of arsenic exposure.  Both hair and fingernails are rich in -keratin 
which is a fibrous protein containing a high proportion of cysteine residues.  The main 
difference is that the keratins in fingernail contain a higher proportion of this amino 
acid (up to 22%) compared to hair (10–14%) (Mandal et al., 2003).  This study and 
those of others have shown the level of arsenic in fingernail samples are about 3 times 
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 higher compared to levels in hair.  This difference could be attributed to the higher 
content of cysteine residues in fingernails compared to hair or the slower rate at which 
nails (0.1 mm/day ) grow compared to hair (0.35 mm/day) (Tobin et al., 2005). 
The most interesting aspect of the hair and fingernails analysis is the very high 
level of arsenic observed in fingernails of the Somali Black-African group.  They had 
4-5 times higher level of arsenic in their fingernail compared to the Asian and White 
groups.   Clearly, Somali fingernails accumulate far higher levels of arsenic compared 
to the other ethnic groups and this is possibly due to the chemical composition of their 
fingernails.  It is possible their fingernails contain a higher quantity of cysteine rich 
keratin or some other compound with a high arsenic binding capacity compared to the 
other groups.   From the knowledge of the Leicester-based Somali community and 
information obtained using the questionnaire it is clear that their diet is more meat 
based and therefore protein rich, compared to the other groups.  Previously it has been 
reported that there is a positive correlation between arsenic levels in hair and 
consumption of meat (Saad and Hassanien, 2001).  A diet dominated by meat may 
result in a higher level of cysteine rich keratin in the fingernails of the Somali Black-
Africans, thereby favouring greater accumulation of arsenic.   However, one cannot 
rule out the possibility that they possess a higher level of arsenic species, either from 
metabolism or from their diet, that preferentially deposit in fingernails.  As already 
discussed the Somalis display a higher proportion of total urinary arsenic  as DMA 
compared to the two other ethnic groups. Therefore, it is possible that arsenic in the 
form of DMA may also be deposited in the fingernails of the Somali ethnic group. This 
is plausible since it has been previously reported that DMA(III) has greater affinity for 
fingernail compared to hair (Mandal et al., 2003).  
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  (B) Role of Genetics  
The other explanation for the difference in urinary arsenic levels, especially in 
arsenic speciation, between the two groups could be based on genetic differences 
associated with arsenic metabolism. Currently three different genes have been 
suggested to be involved in arsenic biotransformation (Kile et al. 2005 and references 
therein) , these are As(III) methyltransferase (CYT19), purine nucleoside phosphorylase 
(PNP), glutathione-S-transferase omega (GSTO).  Several studies have suggested that 
there may be a link between genetic polymorphism and arsenic metabolism and these 
are discussed below.  
 (i) Urine Analysis 
The difference in urinary arsenic levels, especially in arsenic speciation, 
between the two ethnic groups could be based on genetic differences. A significant 
difference (P < 0.05) was found in the level of one of the methylated species, namely 
DMA, between the Somali Black-Africans and the White/Asian groups, so it is 
plausible that a genetic difference underlies this variation in a methylated species. 
Although there are no data on unexposed population to high arsenic in their drinking 
water, linking variation in arsenic metabolism with genetic differences, there are 
several studies with exposed populations which points towards a genetic basis for the 
difference. For example, it has been reported that there is strong genetic association 
between polymorphisms of CYT19 and MA: DMA ratio in Mexican children from an 
arsenic exposed region (Meza et al., 2005). Chung et al. (2002) also reported that 
methylation differences had a genetic basis, as they found a stronger correlation 
between arsenic methylation-related phenotypes among siblings than among genetically 
unrelated individuals. The significantly higher percentage of DMA detected in the 
  
   
166 
 Somali Black Africans in this study requires further investigation to determine if this 
is due to a genetic basis. 
 (ii) Fingernail Analysis 
As with urinary DMA, the significantly higher level of arsenic observed in the 
fingernail samples of Somali Black-Africans could also be attributed to genetic factors 
since a recent study (Kile et al., 2005) reported that the arsenic content in toenails of 
subjects exposed to inorganic arsenic  in their drinking water is related to the GSTT1 
gene.  Individuals with GSTTl-null genotypes displayed higher levels of total arsenic 
than those possessing the GSTT1 wild-type gene. 
 (C) Combined dietary and genetic effects 
 Another possible explanation for the unusual pattern of arsenic metabolism in 
Somali Black-Africans could be a combination of diet and genetics.   It is possible that 
a specific dietary habit established over a long period of time, may enhance the activity 
of particular enzyme(s), which are then inherited by the following generations resulting 
in metabolic variations between different populations.  The Somali Black-Africans are 
known to have a very protein rich diet, heavily biased towards consumption of animal 
meat.  Following such a diet over many generations may result in over expression of 
certain genes, linked to metabolism that may explain the unusual arsenic methylation 
profile observed for this community compared to Asian and White groups.  In this 
context, it is noteworthy that the Somali-Black Africans are recent immigrants to the 
United Kingdom and therefore less adjusted to a western diet compared to the Whites 
and Asians.  A possible link between dietary habits and arsenic excretion profile, before 
and after seaweed ingestion, is also apparent from a study reported by Hulle et al. 
(2004) involving four Chinese and one  European.  Although the number of individuals 
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 studied by these workers are too few to draw a reliable conclusion, the significantly 
different excretion profile for the Chinese volunteers compared to the European 
volunteer may be due to the fact that marine algae has been a major constituent in the 
diet of Chinese, Japanese and Korean people, which is not the case for the Europeans. 
However, because this study was not a total diet study and the detailed dietary habits of 
the three groups were not controlled, it is not possible to unequivocally establish if the 
difference observed between the groups is due to dietary or genetic factors or if it is a 
combination of both.   
 
3. 5  Conclusion 
 
All the data from the different studies described above were analysed for each 
individual within different groups.  Only a few individuals showed major deviation 
from the rest of the population within each ethnic group. However, inclusion or 
exclusion of these values does not alter the statistical significance of the outcome.  The 
results presented here provides evidence that there is a significant difference in arsenic 
levels in fingernails and in urine samples of the Somali ethnic group compared to the 
Asian and White ethnic groups residing in the same city, but not exposed to high 
concentrations of arsenic.  Which of the three factors (dietary, genetic, or a combination 
of both.) discussed above is responsible for these differences cannot be unequivocally 
ascertained.  Further studies focusing on the role of ethnicity associated with arsenic 
metabolism among a larger number of healthy individuals with controlled diet from 
different ethnic communities are needed to resolve this issue.     
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Millions of people are at risk of various diseases such as cancer and heart 
disease resulting from chronic arsenic exposure. A historic poisoning has been reported 
among tens of millions of the population in West Bengal, India and Bangladesh due to 
high concentration of arsenic in their drinking water (Smith et al., 2000; Chakraborti et 
al., 2001; Rahman et al., 2001; Mandal and Suzuki, 2002; Charlet and Polya, 2006).  
The arsenic concentration in groundwater in these regions has been reported to be in the 
range of 10 –3200 µg/l (Tokunaga et al., 2002; Lindberg et al., 2006; Smedley and 
Kinniburgh, 2002), exceeding the recommended guideline (10 µg/l) set by the World 
Health Organization (WHO, 2004). It has been previously reported that arsenic 
metabolism and toxicity may vary depending on nutritional status of an individual 
(Mitra et al., 2004).  This was investigated among the largest population in the world 
exposed to arsenic in their drinking water, West Bengal, India and Bangladesh (Mitra et 
al., 2004). They concluded that low intake of animal protein, folate, calcium and fibre 
can increase the possibility of arsenic-caused skin lesions, although they could not 
provide clear evidence of a protective effect of overall protein consumption and 
vegetables against the development of skin lesions (Mitra et al., 2004; McCarty et al., 






Ramadan fasting during the daylight hours for one month every year. How this may 
modulate their pattern of arsenic metabolism has not been previously investigated, but 
is an issue that requires further investigation.  
The general definition of Ramadan fasting is refraining from food and beverages 
intake for  approximately 12 hours a day during the day light hours for a month, which 
start from dawn to sunset every day.  Some changes that are associated with Ramadan 
fasting includes slowing down of the rate of metabolism, a small reduction in body 
mass, dehydration and an increase in uric acid in serum (Roky et al., 2004; Toda and 
Morimoto, 2004).  Toda and Morimoto (2004) reported that Ramadan fasting has both 
positive and adverse effects on healthy individuals, although they suggest that adverse 
effects are unlikely to continue, or lead to further complications, after Ramadan fasting.  
They concluded their study by stating that healthy individuals can perform Ramadan 
fasting without any concern about their health. The subject of fasting and its 
relationship to health is a rapidly growing field of research. Studies by Mattson (2005) 
and co-workers have investigated the role of energy intake and meal frequency on 
health, reporting some positive aspects of intermittent fasting, and caloric restriction, 
including the suppression of the development of various diseases, and an increase in 
life span in laboratory animals.  
Some biological indicators, such as folic acid and homocysteine, are associated 
with arsenic metabolism (Chung et al., 2002; Gamble et al., 2005) and these biological 
parameters undergo significant changes during the fasting. For example, it has been 
reported that the folate level increases during fasting (Cahill et al., 1998), whereas 






et al. (2005) reported that arsenic methylation was dependent on folic acid, which is 
important since inorganic arsenic is methylated to MA and DMA sequentially. 
Moreover, it was reported that an inadequate folate intake in mice resulted in a 
decreased biotransformation of urinary arsenic (Spiegel stein et al., 2003).  Aksungar et 
al. (2005) reported that intermittent fasting has beneficial effects on cardiovascular 
disease, because serum high-density lipoprotein (HDL) levels increased and 
homocysteine levels decreased during Ramadan fasting. This latter effect could 
influence arsenic metabolism, because De Kimpe et al. (1999) reported that 
homocysteine inhibits arsenic methylation. Thus, if Ramadan fasting results in a 
decrease in the level of homocysteine and an increase in folate, one would expect to see 
an enhancement of arsenic methylation. The proportion of methylated arsenic species is 
important since it has been reported that a relatively lower proportion of DMA in 
human urine is associated with an increased risk of cancers such as bladder and skin 
cancer among individuals chronically exposed to arsenic (Gamble et al., 2005, and 
references cited therein).  In addition, a high percentage of MA in urine and elevated 
plasma homocysteine may increase the risk for developing atherosclerosis (Wu et al., 
2006). 
  Toxicity of arsenic in humans is dependent on its chemical form, with As (III) 
and As (V) being the most toxic forms, MA and DMA are less toxic, and AB which is 
mainly found in seafood is considered to be non-toxic (Shraim et al., 2001; Vahter et 
al., 2000; Ritsema et al., 1998). The half-life of inorganic arsenic in the body is two 
days. Therefore, measuring arsenic in urine can reflect an individual's recent arsenic 






inorganic arsenic metabolism: reduction of arsenate to arsenite and oxidative 
methylation of arsenite. These consecutive reduction and oxidative methylation 
reactions result in DMA as a major arsenic urinary metabolite (Suzuki, 2005).  After 
arsenic exposure, As (V) is reduced to As (III), which is then methylated to MA and 
DMA (Adair et al., 2005). These methylated metabolites are less toxic than inorganic 
arsenic, and because of this, the methylation process is considered as a detoxification 
mechanism (Hsueh et al., 1998). However, MA (III) and DMA (III) produced through 
the methylation process are considered more toxic than inorganic arsenic (Hsueh et al., 
1998). Generally, MA and DMA are the only metabolites arising from the methylation 
process and appear in urine, although a recent publication reported MA (III) and DMA 
(III) in urine of chronically exposed populations to inorganic arsenic (Valenzuela et al., 
2005). Fasting is one of the factors that may have an influence on arsenic species 
distribution, since it has been associated with changes in some important biological 
parameters that have an effect on arsenic metabolism. 
The aim of this study was to investigate whether Ramadan fasting - abstaining 
from food and fluid for a period of about 12 hours - results in a modification of arsenic 
metabolism, as investigated through speciation analysis of urine samples.  This study is 
potentially important since many people in arsenic-affected regions of India and 
Bangladesh practice Ramadan fasting during the day light hours for one month every 
year.  The study involved recruitment of 29 Ramadan fasting volunteers living in 
Leicester, UK.   Urine samples were monitored for their arsenic levels at the beginning 






4.2  Experimental   
    
 This section includes the following sub-sections: chemical reagents, 
instrumentation, samples collection, quality control, creatinine determination and 
statistical analysis.  
  4.2.1    Chemicals and reagents 
 
 
The chemicals reagents used for experiments related to this Chapter was same 
to that reported in Chapter 3 (section 3.2.2.) 
4.2.2 Instrumentation 
  
The instrumentation and analysis used for experiments related to this Chapter is 
described in Chapter 2 (sections 2.2.4 and 2.2.5) 
4.2.3  Samples collection and preparation 
 
Urine sample collection and storage were carried out similar as reported in 
Chapter 3 (section 3.2.1.2). Samples were collected from 29 Ramadan fasting (RF) 
volunteers. Each volunteer gave two samples. One sample was collected at the 
beginning of the fasting period (RF1), first morning void urine, and the second sample 
was collected at the end of the fasting period (RF2), first sunset void urine. Dates of 
urine samples collection were spread in the middle (24/10/2004 – 09/11/204) of the 
Ramadan, for a single volunteer and the RF group, one week after the beginning 
(15/10/2004 )  of the month and one week before the end (14/11/2004) of the fasting 






consecutive days.   The RF group were from Leicester, UK [mean age 31.9 years (one 
individual did not report his age); 3 women and 26 men]. The ethnicity background of 
the volunteers was mixed and composed of nine Asian or Asian British, 10 Black or 
Black British, seven Middle Eastern and three North African. All volunteers were asked 
to refrain from eating fish and seafood for three days prior to sample collection, and to 
complete a questionnaire, which gathered information on age, gender and ethnicity 
along with lifestyle (all this information is detailed in Appendix 4.1). All procedures 
regarding ethics approval, samples collection, normality test, storage, and sample pre-
treatment were same as reported in Chapter 2 (section 2.2.1.2) and Chapter 3 (section 
3.2.1).  
 Appendices  4.2 and 4.3 show the dates of collection and dates of measurements 
and locations for total arsenic and arsenic speciation for a single fasting volunteer and 
Ramadan fasting volunteers (n = 29), respectively. 
 Data for the non-fasting group (NF) was taken from Chapter 3.  
4.2.4 Quality control and method validation 
 
The quality control and method validation procedures related to this Chapter is 
same to what has been reported in Chapter 2 (sections 2.2.4 and 2.2.5).  
4.2.5 Determination of creatinine 
 







4.2.6 Statistical analysis 
 
 
Differences (95% confidence level) between the two groups (RF1 and RF2) in 
terms of arsenic species and total arsenic levels in urine samples were evaluated by 
using Paired Student’ s t-test, since all the participants were sampled twice. The 
difference between RF1 and RF2 for MA in terms of level and percentage was also 
tested by using the same test (Paired Student’ s t-test), by assigning half of the lowest 
detected concentration or calculated percentage of MA to not-detected MA, because 
MA was not detected in many samples. The  Student’ s t-test was used to evaluate the 
influence (95% confidence level) of age and gender. The Kolmogorov-Smirnov test 
(KS-test) was used for not normally distributed data. Moreover, for analysis of MA 
frequency of detection, estimates and 95% confidence intervals for the odds ratio (OR) 
were calculated. The frequency distribution (P-value) for data sets were calculated 
using the Fisher Exact test. 
 
4.3  Results  
 
All the urine samples investigated were found to be normal according to the 
results of test strip analysis.  The pH of all the 58 urine samples studied was found to be 
in the range of 5 to 8. This is within the normal range (4.5 – 8.0) expected for human 
urine (Chen et al., 2002). 
Table 4.1 shows arsenic concentration before creatinine adjustment, while Table 4.2 






samples of a single fasting volunteer collected over five consecutive days was in the 
range of 7.6 – 25.0 µg/l with a mean of 13.1 ± 7.1 µg/l before creatinine adjustment 
(Table 4.1) and the range was 5.8 – 18.0 µg/g creatinine with a mean of 10.0 ± 5.1 µg/g 
creatinine, after  creatinine adjustment (Table 4.2). For RF2 urine samples, the range 
was 15.9 – 36.8 µg/l with a mean of 20.9 ± 9.0 µg/l before creatinine adjustment (Table 
4.1) and the range was 4.6 – 14.5 µg/g creatinine after creatinine adjustment with a 
mean of 9.2 ± 4.5 µg/g creatinine (Table  4.2).  
The percentages of arsenic species for a single volunteer were calculated after 
creatinine adjustment (Table 4.2). For RF1 the percentages were 68% AB and  29% 
DMA, compared with 60% AB and 34% DMA for RF2. There was a decrease in the 
percentage of AB and an increase in the percentage of DMA observed in RF2 urine 
samples. A trend of increasing percentage of methylated arsenic toxic species (DMA) 
compared to AB for RF2 samples has detected. However, there was no difference 
























Table 4.1   Concentrations of total arsenic (µg/l), arsenic species (µg As/l) and 















1. UNC1F1 0.6 1.0 1.6 8.6 1404 
2. UNC1F2 0.9 0.8 1.7 7.6 423 
3. UNC1F3 10.1 1.7 11.8 25.0 2106 
4. UNC1F4 3.8 0.8 4.6 13.9 1721 
5. UNC1F5 <LOD <LOD <LOD 10.2 1766 
       
 Mean 3.1 0.9 4.9 13.1 1484 
 SD 4.2 0.6 4.8 7.1 643.0 
 Median 0.9 0.8 3.2 10.2 1721 
 Min. 0 0 1.6 7.6 423 
 Max. 10.1 1.7 11.8 25 2106 
       
 RF2      
1. UC1F1 <LOD 3.0 3.0 15.9 3487 
2. UC1F2 4.6 2.1 6.7 36.8 2773 
3. UC1F3 1.0 2.3 3.3 18.2 3068 
4. UC1F4 4.1 1.9 6.0 17.1 2196 
5. UC1F5 2.5 2.0 4.5 16.3 1121 
       
 Mean 2.4 2.3 4.7 20.9 2529 
 SD 2.0 0.4 1.6 9.0 917.0 
 Median 2.5 2.1 4.5 17.1 2773 
 Min. <LOD 1.9 3.0 15.9 1121 





























Table 4.2   Concentrations of total arsenic and arsenic species (µg As/g creatinine) in 







AB DMA Sum of all 
species 
Total arsenic 
1. UNC1F1 0.4 0.7 1.1 6.1 
2. UNC1F2 2.1 1.9 4.0 18.0 
3. UNC1F3 4.8 0.8 5.6 11.9 
4. UNC1F4 2.2 0.5 2.7 8.1 
5. UNC1F5 0.0 0.0 0.0 5.8 
      
 Mean 1.9 0.8 2.7 10.0 
 SD 1.9 0.7 2.2 5.1 
 Median 2.1 0.7 2.7 8.1 
 Min. <LOD <LOD <LOD 5.8 
 Max. 4.8 1.9 5.6 18.0 
      
 RF2     
1. UC1F1 0.0 0.9 0.9 4.6 
2. UC1F2 1.7 0.8 2.4 13.3 
3. UC1F3 0.3 0.7 1.1 5.9 
4. UC1F4 1.9 0.9 2.7 7.8 
5. UC1F5 2.2 1.8 4.0 14.5 
      
 Mean 1.2 1.0 2.2 9.2 
 SD 1.0 0.4 1.3 4.5 
 Median 1.7 0.9 2.4 7.8 
 Min. <LOD 0.7 0.9 4.6 














Fig. 4.1 and 4.2 show HPLC-ICP-MS chromatograms of arsenic speciation in 
two urine samples for RF1 and RF2 time point, respectively for a single fasting 
volunteer. A chloride peak was observed in both Figures with an increase in Fig. 4.2, 
which suggests more chloride is observed in fasting urine samples that increases at the 





Figure 4.1   HPLC-ICP-MS chromatogram for speciation of arsenic in the urine of a 








Figure 4.2   HPLC-ICP-MS chromatogram for speciation of arsenic in the urine of a 




The levels of arsenic in urine samples of the time points RF1 and RF2 samples for 
29 volunteers of Ramadan fasting group are shown in Table 4.3 and 4.4, respectively, 
before creatinine adjustment. In addition, the levels of arsenic after creatinine 
adjustment for the sample of the two time points, RF1 and RF2 for the 29 volunteers, 
are shown in Table 4.5 and 4.6, respectively. Total arsenic in RF1 was in the range of 
5.3 – 83.6 µg/l with a mean of 24.9 ± 19.9 µg/l before creatinine adjustment, and 2.4 – 
46.4 µg/g creatinine with a mean of 13.3 ± 12.4 µg/g creatinine after creatinine 
adjustment. While total arsenic in RF2 was in the range of 7.0 –136.8µg/l with a mean 
of 30.2 ± 27.6 µg/l before creatinine adjustment, and1.8 –52.3 µg/g creatinine with a 






Table 4.3   Concentrations of total arsenic (µg/l), arsenic species (µg As/l) and 














1. UNF1 5.4 7.5 1.2 14.1 5.3 804 
2. UNF2 4.8 3.2 1.5 9.5 20.2 3090 
3. UNF3 13.5 3.9 1.6 19 33.8 2196 
4. UNF4 4.0 4.2 1.3 9.5 12.2 1472 
5. UNF5 8.0 3.3 1.2 12.5 16.4 2660 
6. UNF6 39.0 19.4 2.2 60.6 83.6 3396 
7. UNF7 8.0 0.8 0 8.8 14.2 1211 
8. UNF8 7.8 6.4 0 14.2 12.2 1234 
9. UNF9 8.8 6.5 2.3 17.6 30.9 3328 
10. UNF10 6.1 1.1 0 7.2 25.2 1189 
11. UNF12 11.9 4.1 3.1 19.1 25.7 985 
12. UNF13 12.2 3.4 0 15.6 16.3 1223 
13. UNF14 2.6 6.3 2.2 11.1 12.7 1041 
14. UNF15 8.4 3.3 0 11.7 16.1 532 
15. UNF16 69.5 15.9 0.8 86.2 78.9 1845 
16. UNF17 47.5 8.8 0 56.3 51.0 1245 
17. UNF19 0 3.3 1.2 4.5 7.8 1381 
18. UNF21 4.7 1.5 0 6.2 9.2 589 
19. UNF22 5.2 2.6 0 7.8 10.1 951 
20. UNF24 7.3 8 0.8 16.1 15.5 894 
21. UNF25 8.1 1.6 0 9.7 15.5 2287 
22. UNF26 8.0 2.9 0 10.9 13.1 238 
23. UNF27 4.2 1.7 0 5.9 10.5 724 
24. UNF28 0.9 1.9 0 2.8 9.1 498 
25. UNF29 12.9 6.6 0 19.5 37.1 2004 
26. UNF30 3.9 3.6 0 7.5 13.0 679 
27. UNF32 13.3 3.7 2 19 46.0 2015 
28. UNF33 5.6 3.0 0 8.6 42.3 2117 
29. UNF34 9.4 <LOD 0 9.4 38.3 1789 
        
 Mean 11.8 4.8 0.5 13.4 24.9 1504 
 SD 14.9 4.2 0.7 12.3 19.9 860 
 Median 8 3.4 0.0 9.4 16.1 1234 
 Min. 0.0 0.0 0.0 3.1 5.3 238 






Table 4.4   Concentrations of total arsenic (µg/l), arsenic species (µg As/l) and 














1. UF1 8.4 17.8 2 28.2 64.4 4403 
2. UF2 10.0 2.0 0.8 12.8 20.1 3022 
3. UF3 9.5 5.1 1.2 15.8 27.8 4030 
4. UF4 6.6 5.0 1.8 13.4 25.1 2106 
5. UF5 0.8 1.0 0 1.8 7.6 985 
6. UF6 87.5 17.5 2.2 107.2 136.8 2049 
7. UF7 18.2 2.3 0 20.5 33.8 1709 
8. UF8 23.4 15.1 3.1 41.6 35.3 3509 
9. UF9 8.8 6.5 1.8 17.1 26.0 1936 
10. UF10 0.6 2 0 2.6 9.1 1460 
11. UF12 12.4 3.9 1.1 17.4 27.1 860 
12. UF13 9.4 5.0 1.1 15.5 18.3 1211 
13. UF14 7.4 8.6 1.5 17.5 22.3 951 
14. UF15 20.0 7.1 0.9 28 33.1 1743 
15. UF16 14.4 4.9 0 19.3 21.2 2083 
16. UF17 13.7 6.4 1 21.1 22.1 1721 
17. UF19 1.4 11.6 3.6 16.6 23.2 1245 
18. UF21 1.1 3.4 0 4.5 11.5 1675 
19. UF22 1.4 3.1 0 4.5 7.2 272 
20. UF24 17.5 20.5 4.1 42.1 48.0 1562 
21. UF25 8.6 0.8 0 9.4 12.8 702 
22. UF26 11.0 4.6 1.1 16.7 22.5 1789 
23. UF27 22.0 8.0 0.8 30.8 7.0 3384 
24. UF28 3.1 3.2 0 6.3 16.5 1823 
25. UF29 33.6 15.4 0 49 96.1 2932 
26. UF30 3.9 4.1 0 8 19.3 1664 
27. UF32 7.1 6.0 2.3 15.4 42.2 2151 
28. UF33 3.4 3.9 1.3 8.6 25.3 951 
29. UF34 2.2 <LOD 0 2.2 14.0 623 
        
 Mean 12.7 6.7 1.1 20.5 30.2 1881.1 
 SD 16.4 5.5 1.2 20.6 27.6 1017 
 Median 8.8 5 1 16.6 22.5 1721 
 Min. 0.6 0 0 1.8 7.0 272 






Table 4.5   Concentrations of total arsenic and arsenic species (µg As/g creatinine) in 










1. UNF1 6.7 9.3 1.5 17.5 6.6 
2. UNF2 1.6 1.0 0.5 3.1 6.5 
3. UNF3 6.1 1.8 0.7 8.7 15.4 
4. UNF4 2.7 2.9 0.9 6.5 8.3 
5. UNF5 3.0 1.2 0.5 4.7 6.2 
6. UNF6 11.5 5.7 0.6 17.8 24.6 
7. UNF7 6.6 0.7 0.0 7.3 11.7 
8. UNF8 6.3 5.2 0.0 11.5 9.9 
9. UNF9 2.6 2.0 0.7 5.3 9.3 
10. UNF10 5.1 0.9 0.0 6.1 21.2 
11. UNF12 12.1 4.2 3.1 19.4 26.1 
12. UNF13 10.0 2.8 0.0 12.8 13.3 
13. UNF14 2.5 6.1 2.1 10.7 12.2 
14. UNF15 15.8 6.2 0.0 22.0 30.3 
15. UNF16 37.7 8.6 0.4 46.7 42.8 
16. UNF17 38.2 7.1 0.0 45.2 41.0 
17. UNF19 0.0 2.4 0.9 3.3 5.6 
18. UNF21 8.0 2.5 0.0 10.5 15.6 
19. UNF22 5.5 2.7 0.0 8.2 10.6 
20. UNF24 8.2 8.9 0.9 18.0 17.3 
21. UNF25 3.5 0.7 0.0 4.2 6.8 
22. UNF26 33.6 12.2 0.0 45.8 55.0 
23. UNF27 5.8 2.3 0.0 8.1 14.5 
24. UNF28 1.8 3.8 0.0 5.6 18.3 
25. UNF29 6.4 3.3 0.0 9.7 18.5 
26. UNF30 5.7 5.3 0.0 11.0 19.1 
27. UNF32 6.6 1.8 1.0 9.4 22.8 
28. UNF33 2.6 1.4 0.0 4.1 20.0 
29. UNF34 5.3 0.0 0.0 5.3 21.4 
       
 Mean 9.0 3.9 0.5 13.4 18.3 
 SD 10.1 3.1 0.7 12.3 15.6 
 Median 6.1 2.8 0.0 9.4 11.8 
 Min. 0.0 0.0 0.0 3.1 5.6 






Table 4.6   Concentrations of total arsenic and arsenic species (µg As/g creatinine) in 











1. UF1 1.9 4.0 0.5 6.4 14.6 
2. UF2 3.3 0.7 0.3 4.2 6.7 
3. UF3 2.4 1.3 0.3 3.9 6.9 
4. UF4 3.1 2.4 0.9 6.4 11.9 
5. UF5 0.8 1.0 0.0 1.8 7.7 
6. UF6 42.7 8.5 1.1 52.3 66.8 
7. UF7 10.6 1.3 0.0 12.0 19.8 
8. UF8 6.7 4.3 0.9 11.9 10.1 
9. UF9 4.5 3.4 0.9 8.8 13.4 
10. UF10 0.4 1.4 0.0 1.8 6.2 
11. UF12 14.4 4.5 1.3 20.2 31.5 
12. UF13 7.8 4.1 0.9 12.8 15.1 
13. UF14 7.8 9.0 1.6 18.4 23.4 
14. UF15 11.5 4.1 0.5 16.1 19.0 
15. UF16 6.9 2.4 0.0 9.3 10.2 
16. UF17 8.0 3.7 0.6 12.3 12.8 
17. UF19 1.1 9.3 2.9 13.3 18.6 
18. UF21 0.7 2.0 0.0 2.7 6.9 
19. UF22 5.1 11.4 0.0 16.5 26.5 
20. UF24 11.2 13.1 2.6 27.0 30.7 
21. UF25 12.3 1.1 0.0 13.4 18.2 
22. UF26 6.1 2.6 0.6 9.3 12.6 
23. UF27 6.5 2.4 0.2 9.1 2.1 
24. UF28 1.7 1.8 0.0 3.5 9.1 
25. UF29 11.5 5.3 0.0 16.7 32.8 
26. UF30 2.3 2.5 0.0 4.8 11.6 
27. UF32 3.3 2.8 1.1 7.2 19.6 
28. UF33 3.6 4.1 1.4 9.0 26.6 
29. UF34 3.5 0.0 0.0 3.5 22.5 
       
 Mean 7.0 3.9 0.6 11.5 17.7 
 SD 7.9 3.3 0.8 9.9 12.5 
 Median 5.1 2.8 0.5 9.3 14.6 
 Min. 0.4 0.0 0 1.8 2.1 







Fig. 4.3 and 4.4 show representative HPLC-ICP-MS chromatograms of arsenic 
speciation in two urine samples for RF1 and RF2 time point, respectively, for one 
volunteer from the fasting group. Appendix 4.4 includes more chromatograms for 
blank, standard solutions, certified urine sample (CRM NIES No.18) and real samples. 
The results of the CRM NIES No. 18 were as follows: AB 69.5 ± 4.8µg As/l and DMA 
33.5 ± 1.3 µg As/l; the certified values were 69 ± 12 µg/l and 36 ± 9µg/l, respectively. 
The reproducibility of the method was also validated by measuring 10 µg As/l standard 
mixture of the five arsenic species after each six runs. The reproducibility (n =3) was 
10.2 ± 0.2µg As/l (1.5% RSD) for AB, 10.1 ± 0.3 µg As/l (2.6% RSD) for DMA, 10.2 
± 0.3 µg/l (1.7% RSD) for As (III), 10.2 ± 0.1µg As/l (1.2% RSD) for MA and 10.0 ± 










Figure 4.3   HPLC-ICP-MS chromatogram for speciation of arsenic in the urine sample 
of a fasting volunteer RF1 (UNF24). 
 
 
Figure 4.4   HPLC-ICP-MS chromatogram for speciation of arsenic in the urine sample 









Total arsenic levels of all the volunteers - before and after creatinine adjustment 
- for the fasting group are presented in Fig. 4.5. This reveals only few outliers. There 
were two (83.6, 78.9 µg/l) and three (55.0, 42.8, 41.0 µg As/g creatinine) for RF1 
before and after creatinine adjustment, respectively. For RF2 there were three (136.8, 
96.1, 64.4 µg/l) and one (66.8 As/g creatinine) outliers before and after creatinine 
adjustment, respectively. These values for both RF1 and RF2 appeared as outliers due 
to their very high arsenic level compared to the vast majority of the other volunteers. 
However, the exclusion or inclusion of these outliers does not influence the statistical 
significance (P = 0.67 and 0.86 respectively) of the analysis when comparing RF1 with 
RF2.    
The most plausible explanation for the outliers is that these volunteers did not 
adhere to the strict request to avoid consumption of seafood within 3 days prior to 
sample collection. Despite these outliers, there were no statistical significant 
differences (P > 0.05) between RF1 and RF2 for total arsenic levels. The combined 
levels of total arsenic (18.0 ± 12.1 µg/g creatinine) for RF group was also compared 
with the mean arsenic level (17.2 ± 16.5µg/g creatinine)  for the non-fasting group (NF, 
ethnic group: Asian, Somali and White that was studied in Chapter 3). There is no 
statistically significant difference (P > 0.05) between these two groups, which  suggests 
that Ramadan fasting has no effect on total urinary arsenic levels.  
The influence of gender and age on total arsenic in urine samples (RF1 and RF2) 










Figure 4. 5   Urinary arsenic concentration (µg /l) before and after (µg As/g creatinine) 
creatinine adjustment for  RF1 and RF2 samples. 
 
The measured species percentages in the two different sample types for the 29 
volunteers were 67% AB and 29% DMA and 4% MA in RF1, compared to 61% AB, 
34% DMA and 5% MA in RF2 samples. These percentages of arsenic species in fasting 
group for the two time points RF1 and RF2, combined fasting group (RF) and non-
fasting group (NF) are presented in Fig. 4.6.  The combined percentages of these 
species among the fasting group were 64% AB, 31% DMA and 5% MA, compared to 
the combined percentages of these species among the non-fasting group being 70% AB, 






DMA and MA – are present in higher percentage amongst the fasting group compared 
to the non-fasting group. 
Methylarsonate was detected in 53% (31 out of 58) of the fasting samples compared 
to only 6% (4 out of 63) of the non-fasting samples. Differences in MA between fasting 
and non-fasting groups was assessed by comparison of the frequency of detection.  The 
odds ratio (OR) was 12.0 (95%CI 3.8 to 37.4), with P < 0.001. This reveals that MA in 
the  fasting group is almost 12 times as likely to be detected as among non-fasting 
group. In the fasting group (RF1 and RF2) MA was detected in 62% (18 out of 29) of 
RF2 samples compared to only 45% (13 out of 29) of RF1 samples. Differences in MA 
between RF2 and RF1 groups was assessed by comparison of frequency of detection. 
The odds ratio (OR) was 2.0 (95%CI 0.7 to 5.7), with a P > 0.001. This reveals that 
MA at the end of the fast (RF2) is almost  twice as likely to be detected as at the 


























Figure 4.6   Percentages of arsenic species in urine of fasting group for two time points 
RF1, RF2, combined fasting group (RF) and  non-fasting (NF).  The data for the NF 
group is taken from Chapter 3. 
 
Table 4.7 shows P-values presented for a single fasting volunteer as well as for 
the fasting group and the non-fasting group. Significant differences (P < 0.05) were 
observed in both the levels and percentages of MA between the fasting and the non-
fasting group, while no significant differences (P > 0.05) were found by comparing the 
total arsenic levels or the arsenic species between the fasting and the non-fasting group. 
Moreover, no significant differences were seen between RF1 and RF2 samples from the 









Table 4.7   P-values are represented to show the significant test for creatinine, arsenic 
species and total arsenic after creatinine adjustment. 
 P-value 
Sample group and 
number (n) 





Single fasting volunteer 





N/A 0.70 0.81 
Fasting group 








Fasting group (RF) and non-fasting group (NF)b 










  a  These P-values are associated with species (AB, DMA and MA) percentages. 
b 
  non-fasting group correspond to data for the three ethnic groups (Asian, Somali and 
White) taken from Chapter 3. 
4.4  Discussion 
 
 The present investigation is the first of its kind to evaluate the effect of 
Ramadan fasting on urinary arsenic levels of unexposed volunteers practising Ramadan 
fasting. A Ramadan fasting (RF) group was recruited from the same city (Leicester, 
UK), who were not exposed to arsenic-contaminated water. The volunteers were asked 






The vast majority of the volunteers have a very similar arsenic concentrations in 
their urine samples (Fig. 4.5). Only few volunteers showed high levels of arsenic in 
their urine samples. The precise reason for this is not clear. It could be due to the 
volunteers not strictly adhering to the instructions given with the questionnaire, 
especially regarding the need to avoid consumption of seafood for 3 days prior to 
sample collection. As can be seen from Fig. 4.5, creatinine adjustment results in a 
reduction in the number of outliers.  The reduction in number of outliers after creatinine 
adjustment indicates the importance of creatinine adjustment.  Creatinine adjustment 
eliminates the role of different factors that are not related to arsenic exposure, such as 
urine volume and concentration, which is widely used (Hinwood et al., 2002; 
Suwazono et al., 2005) and Vahter et al., 2006).  
Analysing of the data for 29 volunteers revealed only few outliers. The 
exclusion or inclusion of these values in the analysis did not influence the significance 
of the findings. The results of this study were compared with the results of non-fasting 
group (ethnic group: Asian, Somali and White) from Chapter 3. No significant 
difference (P> 0.05) in both total arsenic and arsenic species for the two different 
groups was found. This indicates that Ramadan fasting has no effect on total and the 
sum of urinary arsenic species. Moreover, by comparing the two different samples 
types (RF1 and RF2) of fasting group, there was no significant difference (P> 0.05) in 
both the total and arsenic species was found. This further suggests that during the 
course of a Ramadan fasting there is no significant effect on urinary arsenic with regard 
to the total levels excreted at the beginning and the end of a 12h fast. Similarly, there 






volunteer, at these two time points.  However, the pattern of urinary arsenic species 
showed difference between fasting and non-fasting groups, and among the fasting 
group at the beginning and at the end of the fasting period. 
Methylarsonate was detected more frequently in the fasting group compared to 
the non-fasting group, which was 12-fold higher in the fasting than in non-fasting 
group. In the fasting group, the frequency of detection of MA was 2-fold higher in RF2 
than in RF1.  This finding may be taken to suggest that the human body, during 
Ramadan fasting, creates an environment that favours the elimination of the more toxic 
organoarsenic species (MA). Volunteers who practice Ramadan fasting  excrete more 
of a toxic form of organoarsenic from the body than those who eat at regular intervals. 
This suggests that the way arsenic is excreted from the body changes during periods of 
fasting 
One could argue that daytime activity rather than fasting per se may be the 
reason for this. Daytime activity is a possible confounding factor that could not be 
eliminated.  However, a recent study comparing spot urine with 24 hour urine revealed 
that no significant differences was observed in urinary arsenic species between these 
two different points of time collection (Hinwood et al., 2002), which suggests that 
daytime activity does not influence urinary arsenic species distribution.  
The reason for the increase in MA percentages and a decrease in AB 
percentages in urine samples collected at sunset (RF2), after approximately 12 hours 
fasting, is unlikely to be due to diet since no food was consumed between the two time 
points of the samples collection.  The finding also highlights the need for caution in use 






percentage due to fasting condition. Furthermore, this finding indicates that the time 
point of urine sample collection and the nutritional status (fasting/starvation) of the 
individual should be known.  
Generally, urinary arsenic analysis involves collection of first morning void 
urine. Previously it has been reported that total arsenic level and species does not 
significantly vary between spot urine samples and that collected over a 24 hours period 
(Hinwood et al., 2002). However, that study did not investigate the situation where the 
body is subjected to a condition where it is deprived from the consumption of food and 
fluid for over 12 hours during the daytime.   
One possible explanation for the increase in the percentage of MA in Ramadan 
fasting urine samples (RF2; collected at sunset before the breaking of the fast) could be 
related to the biomethylation process, attributed to the altered metabolic state of the 
body caused by the fasting. It has been previously reported that Ramadan fasting results 
in a reduction of homocysteine levels (Aksungar et al., 2005). Homocysteine is 
considered as a factor that influences arsenic methylation. Therefore, it can be 
suggested that a lowering of the homocysteine level will result in an increase in the 
percentage of DMA and a significant increase in MA. An elevated level of 
homocysteine was reported to negatively influence the biosynthesis of S-
adenosylmethionine and glutathione (Alan et al., 1997). These latter compounds were 
well known as being essential for arsenic biotransformation in humans.  Arsenic  
methylation takes place in the liver where the arsenic receives a methyl group from S-
adenosylmethionine in its trivalent oxidation state, in which reduced glutathione is 






reduction of homocysteine levels would increase the availability of methionine for the 
biomethylation of arsenic.  This is because homocysteine is normally metabolised 
through two biochemical pathways: re-methylation and trans-sulfuration. 
Homocysteine is converted to methionine via the first pathway and to cysteine and 
taurine through the latter pathway (Miller, 2003).   
The methylation process of arsenic is a biochemical pathway that is also 
dependent on folate (Gamble et al., 2005), which has been reported to increase under 
fasting condition (Cahill et al., 1998). This could also offer an explanation for the 
observed distribution of arsenic species during the two time points of Ramadan fasting 
investigated in this study. DMA is positively associated with plasma folate (Gamble et 
al., 2005). The increased level of folate in animals was also reported to increase 
biomethylation processes (Spiegelstein et al., 2003). Thus, one can postulate that during 
the course of fasting, the level of folate increases, which results in an increase in the 
percentage of DMA and a significant increase of detected MA among RF2 urine 
samples.   
It is noteworthy that there was a high percentage of AB in almost all the urine 
samples of the two types with average percentages of 64% AB in RF1 and 60% AB in 
RF2, although all the volunteers were asked to refrain from eating fish and seafood for 
three days prior to sample collection. There was no significant (P > 0.05) difference 
between RF1 and RF2 regarding the level of AB.  It is worth mentioning that previous 
studies have also reported high levels of AB in urine (Ritsma et al., 1998; Lai et al., 
2004).  For example, Ritsma et al. (1998) found 69.5% AB in the urine of healthy 






this  may be linked to other sources of AB in the diet. For example, it has recently been 
reported that AB is  present in chicken (Polatajko et al., 2004) which is widely 
consumed  among the volunteers used in this study based on the data from a 
questionnaire (Chapter 3). Furthermore, Consumption of fish ingredients in some 




The data from this study were analysed for each individual within different 
groups.  Only few individuals showed major deviation from the rest of the population 
within each group. However, inclusion or exclusion of these values does not alter the 
statistical significance of the outcome. The more frequent detection of MA seen in the 
fasting group, compared with the non-fasting group (data taken from Chapter 3), and at 
the end of the fast compared to the beginning of the fast, provides support for an effect 
of fasting on urinary arsenic species distribution. In addition, the increase in the 
percentage of DMA and MA detected at the end of an approximately 12h long fast, 
compared to the beginning of the fast, suggests that the human body, during the fasting 
period favours the removal of the most toxic methylated species detected in this study.  
However, fasting has no significant effect on the total level of urinary arsenic seen at 
the start and after the 12 hours long fast. Further study on a larger group of volunteers 
and different types of fasting is required to confirm the finding of this research 
especially in epidemiological areas, where the people are exposed to high arsenic 
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Urinary Arsenic and Selenium Ratio 
 
 
This Chapter describes the determination of the baseline value for urinary arsenic (As): 
selenium (Se) ratio for an unexposed population in Leicester, United Kingdom. 
 
5.1 Introduction  
 
The chemical properties and metabolic fate are similar for arsenic and selenium, 
because both elements are metalloids. The metabolism and toxicity of these two 
elements have been reported to be modulated by each other (Styblo and Thomas, 2001; 
Hsieh and Ganther, 1975). Glutathione (GSH) and S-adenosylmethionine (SAM) are 
necessary for their reductive metabolism and methylation, respectively (Styblo and 
Thomas, 2001).  The metabolism and toxicity of inorganic and organic selenium 
compounds have been shown to be modified by inorganic arsenic (Hsieh and Ganther, 
1975). Selenite (Se (IV)) has been demonstrated to modify the toxicity and metabolism 
of As (III) (Styblo and Thomas, 2001). Seleno-bis(S-glutathionyl) arsinium ion 
[(GS)2AsSe]- was identified as  a new arsenic-selenium compound in the bile of rabbits 
injected with aqueous Se (IV) and As (III) solutions (Gailer et al., 2000). This 
compound contains equimolar arsenic and selenium and provides understanding of the 
metabolism of Se (IV) and As (III) by animals (Gailer et al., 2000). Although selenium 






body. Thus, selenium is considered as an essential micronutrient (NRC, 1989), whereas 
arsenic is classified as a carcinogen and toxic to humans (IARC, 1987; ATSDR, 2000).  
The arsenic and selenium metabolites that are excreted in human urine are 
discussed in the following paragraphs. In arsenic-exposed populations, arsenic excreted 
in human urine generally comprises 10 – 30% inorganic arsenic, 10 – 20% MA and 60 
– 80% DMA (Hsueh et al., 1997; Hopenhayn-Rich et al., 1996). Urine of unexposed 
population contains an average percentage of 70% AB, 29% DMA and 1% MA 
(Chapter 3). The normal level of arsenic in urine has been reported to be in the range of 
5 – 40 µg/1.5L/day (Rahman et al., 2005; Farmer and Johnson 1990). In addition, the 
total concentration of arsenic in urine among unexposed populations in Europe is in the 
range of 10 -20 µg/l (Ritsema et al, 1998; Stoeppler and Vahter, 1994; Cornelis et al., 
1995).   
Most of the selenium consumed by humans is excreted in urine. Thus, the 
amount of selenium detected in urine is a reflection of the dietary intake. After stepwise 
methylation, selenium is excreted in urine as monomethylated selenium (MSe) and 
trimethylelenium (TMSe), while dimethylselenide (DMSe) is exhaled in the breath 
(McConnell and Portman, 1952). In normal human urine Se (IV) and two selenosugars 
(methyl 2-acetamido-2-deoxy-1-seleno-d-galactopyranoside and methyl 2-amino-2-
deoxy-1-seleno-d-galactopyranoside) are considered as typical urinary species 
(Francesconi et al., 2004). Selenosugar (Se-methyl-N-acetylselenohexosamine) was 
identified as a major metabolite in human urine (Gammelgaard et al., 2003), after 
volunteers were exposed to a diet supplemented with selenium. Exposure to 2 µg Se/g 






increase arsenosugar level to some extent, while TMSe starts to increase in rats. 
Therefore, TMSe can be used as a biomarker of excessive selenium dose (Suzuki, 
2005b). However, several selenium species remained unidentified. Background levels 
of selenium in human urine has been reported to be in the range of 10 – 100 µg/l (Wang 
et al., 2001; Tiez, 1983; Alaejos and  Romero, 1993).   Various foods are considered as 
dietary sources of selenium, such as Brazil nuts, grain, wheat, cucumber, mushroom, 
crab, liver and shellfish (Ogra et al., 2004;  Rayman, 2002). Deficiency in selenium 
intake results in different diseases such as Keshan’ s disease, numbness in the legs and 
arms, brittle hair and deformed nails (ATSDR, 2001), while excessive selenium in the 
diet causes toxic effects such as neruromuscular symptoms and skin lesions (ATSDR, 
1996). 
Selenium has been reported to have a positive role against arsenic toxicity, 
because the two elements act as metabolic antipodes (Schrauzer, 1992).  Urinary 
selenium was reported to be associated with an increased proportion of DMA and a 
decreased inorganic arsenic content in human urine (Christian et al., 2006). It has been 
reported that selenium and arsenic counteract the toxicity of each other by a mechanism 
involving reaction of the two elements to form a conjugate in the liver, which is then 
excreted in the bile (Levander, 1977). Kenyon et al. (1997) carried out a study on 
mouse to investigate whether differing dietary selenium status could alter urinary 
arsenic after exposure to As (V). They concluded that an excess of selenium in the diet 
was associated with excretion of high proportion of urinary inorganic arsenic and low 






In contrast, a selenium deficient diet was found to eliminate As (V), As (III) and DMA 
in urine more slowly than a selenium sufficient diet.  
In another study with humans, selenium was shown to be an effective treatment 
against arsenism, a disease that result from long-term exposure to high arsenic in the 
environment (Wuyi et al., 2001). After administration of 100 - 200 µg Se/day to 
patients and control groups for 14 months, the patients showed decreased levels of 
arsenic in blood, hair and urine compared to those of the control group (Wuyi et al., 
2001). This would suggest that for health risk assessment among populations exposed 
to arsenic, selenium measurement is also important to estimate the extent of arsenic 
toxicity.  
Whilst some studies have been reported on the relationship between arsenic and 
selenium, they have been limited to studies of arsenic exposed populations (Hsueh et 
al., 2003; Christain et al., 2006). The study with exposed populations demonstrated a 
positive correlation between arsenic and selenium in urine and hair (Hsueh et al., 2003; 
Spallholz et al., 2005) although one study (Miyazaki et al., 2003) suggested that there 
was negative correlation between both elements.  
Results presented in this Chapter is based on study of unexposed  volunteers 
from different ethnic groups, fasting volunteers and a single volunteer whose urinary 
arsenic and selenium levels were monitored over a period of one year.   The objective 
of the study was to establish a baseline level of urinary As:Se ratio, in addition to 








5.2 Experimental   
    
This section covers the following sub-sections: chemical reagents, 
instrumentation, samples collection, quality control, creatinine determination and 
statistical analysis.  
 
5.2.1 Chemicals and reagents 
 
The chemicals reagents used for experiments related to this Chapter are same as 
what has been reported in Chapter 3, section 3.2.2, section, with the exception of the 
following: a selenium stock solution standard was purchased from Sigma-Aldrich 
(Germany). Selenium atomic absorption standard solution contains 978 µg/ml of Se in 
1.4 wt. % HNO3. 
5.2.2 Instrumentation 
 
Determination of total arsenic and selenium in urine was performed by monitoring 
signal at m/z = 75 and 82. Interference on 75As by 40Ar35Cl was corrected by monitoring 
the ion counts at m/z = 77, 82 and 83 and applying the correction equation pre-
programmed in the ICP-MS software (Elan Instrument Control, version 3.0 hotfix 3). 
Possible interference from 40Ar35Cl was overcome by chromatographic resolution of 
chloride from all five arsenic species (AB, DMA, MA, As (III) and As (V)). Analysis 
of both totals (arsenic and selenium) and arsenic species were carried out as what has 






5.2.3 Samples collection and preparation 
Urine sample collection and storage were carried out as reported in Chapter 3, 
section 3.2.1.2 and Chapter 4, section 4.2.3. In addition twelve urine samples were 
collected from one volunteer over the course of a year without (volunteer part A, n = 6) 
and with (volunteer part B, n = 6) seafood consumption. In total 133 urine samples 
were collected from an ethnic group (n = 63, Chapter 3), a fasting group (n = 58, 
Chapter 4) and one volunteer over one year (n = 12).  
 
5.2.4 Quality Control  
 
A certified reference material (CRM) was used to validate arsenic speciation 
analysis.  The CRM used was human urine No.18 from the National Institute of 
Environmental Studies (NIES) Japan. The CRM NIES No.18 was reconstituted as 
described by the manufacturer.  Total arsenic and selenium analysis were validated by a 
spiking experiment, which was also used for arsenic speciation. The spiking experiment 
for both total arsenic and selenium, and arsenic species in urine, was carried out and the 
results indicated that any interference present in the urine samples had no effect on the 
accuracy of the total arsenic or selenium measurements, or the arsenic speciation 
analysis. The spiking experiment was carried out by using 50 µg/l of each element in 
urine sample, then diluted (5-fold) with 2% v/v HNO3 to achieve 10 µg/l total spiked 







5.2.5 Determination of creatinine  
 
Creatinine was analysed as described in Chapter 2, section 2.2.1.3.  
5.2.6 Statistical analysis 
 
Statistical test in this Chapter was as reported in Chapter 3, section 3.2.11, and 
Chapter 4, section 4.2.6. Correlations coefficients and P-values were calculated by 
using statistic software (Wessa, 2007). 
5.3. Results 
The pH of all urine samples studied was within the range of 5 to 8. This is 
within the normal range (4.5 – 8.0) expected for the human urine previously reported 
by Chen et al. (2002). The results of total arsenic and arsenic species, especially for 
ethnic and fasting group, are reported here for comparative analysis with selenium 
results in order to determine the As: Se ratio and the relationship between arsenic and 
selenium in human urine. 
5.3.1 Dates of total arsenic and selenium measurements  
 
Dates of collection and dates of measurements and locations for total arsenic 
and selenium are same as presented  in Chapter 3 (ethnic groups, Appendices 3.4, 3.5 
and 3.6) and Chapter 4 (fasting group, Appendix 4.3). Total selenium was measured on 
the same dates and in the  laboratory as indicated in these Appendices. Total arsenic 






section 2.2.4.3 and 2.2.4.4 respectively. Dates of collection and analysis of urine 




5.3.2 Concentration of total arsenic and selenium in urine samples of  
all volunteers 
 
The concentrations of total arsenic and selenium in the urine samples of all 
volunteers are given below. The concentrations of both elements were expressed with 
and without creatinine adjustment among the different groups.  
The levels of arsenic, selenium and As:Se ratios for the one-year study of a single 
volunteer, the ethnic groups (Asian, Somali and White) and  the fasting group (paired 
samples: RF1 and RF2) are shown in Table 5.1 and 5.2 for the single  volunteer,  Table 
5.3, 5.4 and 5.5 for Asian, Somali and Whites, respectively. Table 5.6 and 5.7 presents 
the data for the fasting group, for RF1 and RF2, respectively. All these Tables show 
















































1. Au04U 2 65.6 21.3 2590  25.3 8.2 3.1 
2. Sep04U 7 31.8 25.1 2420  13.1 10.4 1.3 
3. Oct04U 7 27.8 20.5 2036  13.7 10.1 1.4 
4. Nov04U 2 22.5 7.5 961  23.4 7.8 3.0 
5. Dec04U 2 47.0 17.1 2556  18.4 6.7 2.7 
6. Jan05U 1 119.8 16.1 1267  94.6 12.7 7.4 
7. Feb05U 1 115.7 11.4 2409  48.0 4.7 10.1 
8. Mar05U 1 66.3 23.7 2613  25.4 9.1 2.8 
9. Apr05U 14 15.9 22.0 2726  5.8 8.1 0.7 
10. May05U 14 12.9 19.6 1759  7.3 11.1 0.7 
11. Jun05U 7 12.8 18.6 2785  4.6 6.7 0.7 
12. Jul05U 21 38.8 29.9 3370  11.5 8.9 1.3 
          
 Mean  48.1 19.4 2291  24.3 8.7 2.9 
 SD  37.3 6.0 678  25.1 2.2 2.9 
 Median  35.3 20.1 2488  16.0 8.5 2.1 
 Min.  12.8 7.5 961  4.6 4.7 0.7 









Data from Table 5.1 are divided into two parts depending on whether seafood 
was ingested shortly before urine sample collection or not. Volunteer part A (no recent 
seafood > 7 days ago), Volunteer part B (recent seafood < 3 days ago). These are 
detailed in Table 5.2. 
 
Table 5.2   For the one year study single volunteer split into two sample groups; 




Samples (n) Mean SD Median Min. Max. 
 Volunteer part A* (6) 11.6 3.5 13.2 4.6 13.7 





    
 Volunteer part A (6) 9.2 1.7 9.5 6.7 11.2 
 Volunteer part B (6) 8.2 2.7 8.0 4.7 12.7 
As: Se       
 Volunteer part A (6) 1.2 0.3 1.3 0.7 1.6 
 Volunteer part B (6) 4.9 3.2 3.0 2.7 10.1 
 











Table 5.3   Asian group: concentrations of total arsenic and selenium in urine samples 

























1. UA1 30.5 29.5 1868  16.3 15.8 1.0 
2. UA2 17.9 38.9 3136  5.7 12.4 0.5 
3. UA3 70.5 60.2 1709  41.3 35.2 1.2 
4. UA4 55.2 36.3 1823  30.3 19.9 1.5 
5. UA5 60.4 81.9 2139  28.2 38.3 0.7 
6. UA6 47.3 83.1 2151  22.0 38.6 0.6 
7. UA7 198.8 108.5 2355  84.4 46.1 1.8 
8. UA8 17.4 27.7 1347  12.9 20.5 0.6 
9. UA9 11.8 24.2 1166  10.1 20.7 0.5 
10. UA10 15.6 68.8 2332  6.7 29.5 0.2 
11. UA11 40.7 38.6 1902  21.4 20.3 1.1 
12. UA12 44.5 39.6 2264  19.7 17.5 1.1 
13. UA13 25.2 25.6 1641  15.4 15.6 1.0 
14. UA14 21.9 45.3 1562  14.0 29.0 0.5 
15. UA15 18.6 38.6 2660  7.0 14.5 0.5 
16. UA16 8.6 25.5 1075  8.0 23.7 0.3 
17. UA17 16.5 42.8 1404  11.8 30.5 0.4 
18. UA18 63.8 55.1 1958  32.6 28.2 1.2 
19. UA19 6.5 7.8 283  23.0 27.5 0.8 
20. UA20 10.1 27.6 1404  7.2 19.6 0.4 
21. UA21 33.8 57.2 2434  13.9 23.5 0.6 
         
 Mean 39.0 45.8 1838.7  20.6 25.1 0.8 
 SD 41.0 24.0 625.2  15.4 9.0 0.4 
 Median 25.2 38.9 1868.0  17.5 23.5 0.6 
 Min. 6.5 7.8 283.0  5.7 12.4 0.2 










Table 5.4   Somali group: concentrations of total arsenic and selenium in urine 

























1. US1 8.1 23.6 1030  7.9 23.0 0.3 
2. US2 4.6 15.3 758  6.1 20.2 0.3 
3. US3 3.1 14.0 826  3.8 16.9 0.2 
4. US4 12.2 39.4 1664  7.3 23.7 0.3 
5. US5 22.6 32.9 1811  12.5 18.2 0.7 
6. US6 10.2 17.4 838  12.2 20.8 0.6 
7. US7 7.5 19.2 1087  6.9 17.6 0.4 
8. US8 13.2 37.1 1290  10.2 28.8 0.4 
9. US9 10.7 18.6 724  14.8 25.6 0.6 
10. US10 4.5 9.2 634  7.1 14.6 0.5 
11. US11 7.7 13.4 577  13.3 23.2 0.6 
12. US12 3.2 13.5 634  5.0 21.3 0.2 
13. US13 3.4 12.0 577  5.9 20.7 0.3 
14. US14 3.3 6.0 838  3.9 7.2 0.5 
15. US15 6.2 10.4 1087  5.7 9.6 0.6 
16. US16 7.8 110.2 906  8.6 121.6 0.1 
17. US17 8.8 16.6 1449  6.1 11.4 0.5 
18. US18 7.8 30.6 3804  2.1 8.1 0.3 
19. US19 2.0 3.4 5060  0.4 0.7 0.6 
20. US20 12.5 34.9 2422  5.2 14.4 0.4 
21. US21 4.6 29.9 1336  3.4 22.3 0.2 
22. US22 18.6 33.1 1743  10.7 19.0 0.6 
         
 Mean 8.3 24.6 1413.4  7.2 22.2 0.4 
 SD 5.2 21.9 1102.5  3.8 23.2 0.2 
 Median 7.8 18.0 1058.5  6.5 19.6 0.4 
 Min. 2.0 3.4 577  0.4 0.7 0.1 














Table 5.5   White group: concentrations of total arsenic and selenium in urine samples 
























1. UW1 28.6 63.3 1472  19.4 43.0 0.5 
2. UW2 9.4 20.0 374  25.1 53.4 0.5 
3. UW3 5.2 19.9 464  11.2 42.9 0.3 
4. UW4 56.7 44.7 1698  33.4 26.3 1.3 
5. UW5 30.1 42.3 2332  12.9 18.1 0.7 
6. UW6 61.7 42.6 940  65.6 45.3 1.4 
7. UW7 16.2 25.9 770  21.0 33.6 0.6 
8. UW8 9.5 30.1 996  9.5 30.2 0.3 
9. UW9 5.7 11.2 351  16.2 31.9 0.5 
10. UW10 23.3 62.9 1324  17.6 47.5 0.4 
11. UW11 11.9 37.5 679  17.5 55.3 0.3 
12. UW12 27.1 18.5 543  49.9 34.1 1.5 
13. UW13 24.2 16.3 340  71.2 48.0 1.5 
14. UW14 7.9 29.0 917  8.6 31.6 0.3 
15. UW15 5.4 10.1 159  34.0 63.7 0.5 
16. UW16 8.3 21.7 1053  7.9 20.6 0.4 
17. UW17 10.1 24.0 951  10.6 25.2 0.4 
18. UW18 17.9 17.0 419  42.7 40.6 1.1 
19. UW19 9.1 22.0 1426  6.4 15.5 0.4 
20. UW20 4.2 12.1 475  8.8 25.5 0.3 
         
 Mean 18.6 28.5 884.2  24.5 36.6 0.7 
 SD 16.2 15.7 549.6  19.3 13.2 0.4 
 Median 11.0 23.0 843.5  17.6 33.9 0.5 
 Min. 4.2 10.1 159  6.4 15.5 0.3 










Table 5.6   Fasting group (RF1*): concentrations of total arsenic and selenium in 
























1. UNF1 5.3 6.3 804  6.5 7.8 0.8 
2. UNF2 20.2 58.9 3090  6.6 19.1 0.3 
3. UNF3 33.8 38.8 2196  15.4 17.7 0.9 
4. UNF4 12.2 29.2 1472  8.3 19.8 0.4 
5. UNF5 16.4 48.9 2660  6.1 18.4 0.3 
6. UNF6 83.6 66.2 3396  24.6 19.5 1.3 
7. UNF7 14.2 15.9 1211  11.7 13.2 0.9 
8. UNF8 12.2 29.5 1234  9.9 23.9 0.4 
9. UNF9 30.9 48.4 3328  9.3 14.5 0.6 
10. UNF10 25.2 27.3 1189  21.2 23.0 0.9 
11. UNF12 25.7 34.6 985  26.1 35.2 0.7 
12. UNF13 16.3 24.7 1223  13.4 20.2 0.7 
13. UNF14 12.7 24.1 1041  12.2 23.1 0.5 
14. UNF15 16.1 25.6 532  30.2 48.1 0.6 
15. UNF16 78.9 54.7 1845  42.8 29.6 1.4 
16. UNF17 51.0 45.5 1245  41 36.5 1.1 
17. UNF19 7.8 30.1 1381  5.7 21.8 0.3 
18. UNF21 9.2 17.6 589  15.7 29.9 0.5 
19. UNF22 10.1 21.9 951  10.6 23.1 0.5 
20. UNF24 15.5 16.4 894  17.3 18.3 0.9 
21. UNF25 15.5 65.2 2287  6.8 28.5 0.2 
22. UNF26 13.1 14.7 238  54.9 61.8 0.9 
23. UNF27 10.5 16.0 724  14.5 22.1 0.7 
24. UNF28 9.1 19.8 498  18.3 39.8 0.5 
25. UNF29 37.1 35.9 2004  18.5 17.9 1.0 
26. UNF30 13.0 32.1 679  19.2 47.3 0.4 
27. UNF32 46.0 40.5 2015  22.8 20.1 1.1 
28. UNF33 42.3 66.7 2117  20 31.5 0.6 
29. UNF34 38.3 47.8 1789  21.4 26.7 0.8 
         
 Mean 24.9 34.6 1504  18.3 26.2 0.7 
 SD 19.9 16.9 859.7  11.8 11.7 0.3 
 Median 16.1 30.1 1234  15.7 23.0 0.7 
 Min. 5.3 6.3 238  5.7 7.8 0.2 
 Max. 83.6 66.7 3396  54.9 61.8 1.4 
*RF1 and RF2 are paired urine samples, collected from the same person at the 






Table 5.7   Fasting group (RF2*): concentrations of total arsenic and selenium in 
























1. UF1 64.4 64.7 4403.0  14.6 14.7 1.0 
2. UF2 20.1 53.2 3022.0  6.7 17.6 0.4 
3. UF3 27.8 58.9 4030.0  6.9 14.6 0.5 
4. UF4 25.1 46.2 2106.0  11.9 21.9 0.5 
5. UF5 7.6 28.2 985.0  7.7 28.6 0.3 
6. UF6 136.8 40.3 2049.0  66.8 19.7 3.4 
7. UF7 33.8 34.2 1709.0  19.8 20.0 1.0 
8. UF8 35.3 90.5 3509.0  10.0 25.8 0.4 
9. UF9 26.0 39.5 1936.0  13.4 20.4 0.7 
10. UF10 9.1 40.1 1460.0  6.3 27.4 0.2 
11. UF12 27.1 37.2 860.0  31.5 43.2 0.7 
12. UF13 18.3 41.4 1211.0  15.2 34.2 0.4 
13. UF14 22.3 41.9 951.0  23.4 44.1 0.5 
14. UF15 33.1 55.1 1743.0  19.0 31.6 0.6 
15. UF16 21.2 45.9 2083.0  10.2 22.0 0.5 
16. UF17 22.1 77.1 1721.0  12.8 44.8 0.3 
17. UF19 23.2 39.7 1245.0  18.6 31.9 0.6 
18. UF21 11.5 41.4 1675.0  6.9 24.7 0.3 
19. UF22 7.2 22.7 272.0  26.6 83.4 0.3 
20. UF24 48.0 58.5 1562.0  30.7 37.4 0.8 
21. UF25 12.8 34.5 702.0  18.2 49.1 0.4 
22. UF26 22.5 41.3 1789.0  12.6 23.1 0.5 
23. UF27 7.0 10.4 3384.0  2.1 3.1 0.7 
24. UF28 16.5 48.0 1823.0  9.1 26.3 0.3 
25. UF29 96.1 53.6 2932.0  32.8 18.3 1.8 
26. UF30 19.3 42.7 1664.0  11.6 25.7 0.5 
27. UF32 42.2 53.4 2151.0  19.6 24.8 0.8 
28. UF33 25.3 49.7 951.0  26.6 52.3 0.5 
29. UF34 14.0 27.3 623.0  22.5 43.8 0.5 
         
 Mean 30.2 45.4 1881.1  17.7 30.2 0.7 
 SD 27.6 15.8 1016.6  12.5 15.4 0.6 
 Median 22.5 41.9 1721  14.6 25.8 0.5 
 Min. 7.0 10.4 272  2.1 3.1 0.2 
 Max. 136.8 90.5 4403  66.8 83.4 3.4 
 
*RF1 and RF2 are paired urine samples, collected from the same person at the 






Outliers for total arsenic have been already discussed in Chapter 3 and 4. It was 
found that creatinine adjustment resulted in a reduction of outliers. As shown in Fig. 
5.1 two groups (White and RF1) appear to have no outliers for  selenium before 
creatinine adjustment. However, there are outliers seen for the other groups before 
creatinine adjustment and these include the following:  Asian (108 µg/l), Somali (110 
µg/l), RF2 (10.4, 90.5, and 77.1 µg/l). After creatinine adjustment, Asian and White 
groups  have no outliers (Fig. 5.2). The outliers seen after creatinine adjustment are as 
follows: Somali (122 µg Se/g creatinine), RF1 (61.8 µg Se/g creatinine) and RF2 
(83.4µg Se/g creatinine). The As:Se ratios among all these groups did not show any 
outliers before and after creatinine adjustment (Fig. 5.3), except for the fasting group 
(RF2), which had two outliers (1.8 and 3.4). 
 
 
Figure 5.1  Urinary selenium concentration (µg/l) before creatinine adjustment among 









Figure 5.2   Urinary selenium concentration (µg Se/g creatinine) after creatinine 
adjustment among the three ethnic groups (Asian, Somali and White) and the fasting 
group (RF1 and RF2). 
 
 
Figure 5.3   As: Se ratio among the three ethnic groups (Asian, Somali and White) and 







Table 5.8 shows P-values to test the influence of seafood consumption (the 
single volunteer), ethnicity, and fasting on total arsenic, selenium and As:Se ratio. 
Seafood consumption and ethnicity showed a significant influence (P < 0.05) on the 
As: Se ratio. The results of one volunteer that was monitored for one year for total 
urinary arsenic and selenium levels, showed the influence of seafood consumption on 
arsenic level, which has a significant effect on As:Se ratio. This is because selenium 
levels remained relatively constant and the arsenic level changed due to seafood 
consumption. The Somali group showed a significant difference (P < 0.05) compared 
with the Asian and White groups, regarding total arsenic level, which was discussed in 
Chapter 3. The White ethnic group showed a significant difference (P < 0.05) in the 
selenium level compared with the Asian and Somali groups. Fasting  showed no   
significant  effect   on total arsenic, total selenium  and As:Se ratio for the volunteers 
whose urine was collected before and after an approximately 12h long fast (Table 5.8). 
Table 5.8   P-values show the significant test for total arsenic, total selenium and As: 
Se ratio, in urine samples among different groups. 
 P-value 
One volunteer Total arsenic Total selenium As:Se ratio 
Part A(6) vs. Part B (6) 0.04 0.45 0.02 
Ethnic groups    
Asian (21) vs. Somali (22) 0.00 0.60 0.00 
Asian (21) vs. White (20) 0.50 0.00 0.35 
Somali (22) vs. White (20) 0.00 0.02 0.02 
Fasting group    







Urine samples were collected from one volunteer over one year, without 
(volunteer part A, no seafood consumption for more than one week) and with seafood 
consumption (volunteer part B, seafood consumption within three days). The ratio of 
As:Se  for the volunteer remains constant (part A 1.2 ± 0.3) when refraining from 
seafood consumption. However, this ratio alters after seafood consumption (part B 4.9 
± 3.2). As shown in Fig.5.4 the clearance of arsenic originating from seafood is 
achieved 3 days after the ingestion of seafood.  It is clear from this graph that seafood 
ingestion has an effect on both total arsenic levels and the As:Se ratio, but the  selenium 
levels were unaffected.  
The As:Se ratios in urine samples for different groups are shown in Fig. 5.5. 
These are compared with calculated values from the literature studies for unexposed 
populations from different countries: UK (White et al., 1998), Germany (Heitland and 
Koster, 2006) and Brazil (Correia et al., 2005).  
As:Se ratios were similar for  the Asian (0.8 ± 0.4), White (0.7 ± 0.4) and 
fasting groups (0.7 ± 0.5). The Somali group was significantly different(0.4 ± 0.2). The 
As:Se ratio in fasting volunteers (0.7 ± 0.5) is similar to the Asian (0.8 ± 0.4) and the 
White (0.7 ± 0.4) groups, with the exception of Somali group (0.4 ± 0.2.). This suggests 
that the diurnal fasting does not result in an overall alteration in As:Se ratio, which is 
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Figure 5.4   Total arsenic (A) ,  total selenium (B) and As:Se ratio (C) in urine samples 
of the single volunteer collected over one year and shows the effect of seafood 





















































 Figure 5.5   As:Se ratios (mean ± SD) in urine samples of unexposed populations in 
UK: Asian, Somali and White; fasting groups (RF1 and RF2);  volunteer part A 
(without seafood).  
 
The Somali group displays the lowest As:Se ratio, indicating that the level of 
excreted selenium is higher than that of arsenic , which is true for all the ethnic groups. 
However, the exceptional situation for the Somali group is that the level of selenium is 
3.1-fold higher than that of arsenic, compared to 1.3 and 1.5-fold higher for the Asian 
and White groups, respectively.  The As:Se ratios were also calculated from the 
literature (Table 5.9) based on studies in different countries: UK (White et al., 1998), 
Germany (Heitland and Koster, 2006) and Brazil (Correia et al., 2005).  Table 5.9 
shows the arsenic, selenium, and As:Se values determined in this study together with 






studies.  It is evident from this Table that, with the  exception of the Somali group, the 
average As:Se ratio is between 0.7-1.2 for all the studies reported so far, to the best of 
my knowledge,  regarding arsenic  and selenium levels in human urine. 
 
Table 5.9   As:Se ratios in urine samples of exposed and unexposed volunteers to high 













Unexposed§      
UK(White) 20 24.5 ± 19.0 36.6  ± 13.2 0.7 ± 0.4 This work 
UK (Asian) 21 20.6  ± 17.5 25.1 ± 9.0 0.8 ± 0.4 This work 
UK 
(Somali) 




6 9.3 ± 3.9 9.2 ± 2.0 1.2 ± 0.3 This work 
UK 200 12.3 µg/l 16.2 (9.2)µg/l 0.8 (1.3),1.1± 0.4 
White et 
al., 1998 















Brazil# 4 28.5 ± 7.0 µg/l 39 ± 7.4 µg/l 0.8 ± 0.3 
Correia et 
al., 2005 




6 37.2 ± 30.6 9.2 ± 3.6 4.0 ± 2.7 This work 




Taiwan 252 96.9 ± 7.3µg/l 22.4 ± 0.9 µg/l 4.3 
Hsueh et 
al., 2003 






§ exposed and unexposed  to high arsenic level in drinking water or seafood. 
# No recent seafood consumption (personal communication). » exposed to arsenic 
through seafood ingestion ( 2 days ago).  exposed to arsenic in drinking water. † 
Geometric mean, seafood ingestion was not reported, total arsenic range (1 - 375µg/l); a 
children, b Adults.* The mean and SD were calculated after the data were pooled. 
 
 
Correlations between total arsenic and total selenium in urine samples of 
different ethnic groups (Asian, Somali and White) and  fasting group are shown in Fig. 
5.6. Urinary total arsenic concentration was positively linearly correlated with the 
urinary total selenium concentration. The correlation coefficients for Asian, Somali, 






(Fig. 5.6). This correlation was established  after creatinine adjustment for both arsenic 
and selenium. However, before creatinine adjustment, the correlation was also seen and 
there was positive correlation among all the different groups. The correlation 
coefficients for Asian, Somali, White, fasting group (RF1 and RF2) are in the range of 
0.4 – 0.8 with P-values < 0.05. This shows that the correlation remains unaffected 
before and after creatinine adjustment. The correlation coefficients and P-values  are as 
follows: Asian (r = 0.8, P = 0.00 ), Somali (r =  0.6, P = 0.00 ), White (r = 0.6, P = 
0.00), RF1 (r = 0.7, P = 0.00 )  and RF2 (r = 0.7 , P = 0.00 ). The correlation 
coefficient (r) is used to measure the linear relationship between the two data sets. A 
value of r close to 0 indicates little correlation between two data sets, while r values 
close to +1 or -1 shows a high level of correlation. In addition, a small P-value (< 0.05) 






Figure 5.6   Correlations of total arsenic and total selenium in urine samples of 
different groups: ethnic group (Asian (A), Somali (B) and White (C)), fasting group: 
RF1 (D) and RF2 (E).* r values for the Somali and the RF2 groups  are shown after the 










0 20 40 60 80 100



























0 5 10 15 20




























0 20 40 60 80



























0 20 40 60

























0 20 40 60 80






















5.3.3 Arsenic  speciation analysis in urine samples 
 
The actual concentrations of arsenic species detected in all different groups were 
expressed in µg As/g creatinine. The values of arsenic species (AB, DMA) were taken 
from Chapter 3 and Chapter 4, for ethnic groups and fasting group, respectively. 
Arsenic species concentrations also showed a positive correlation with selenium 
levels in urine samples of the different groups. For AB only two groups (Asian and 
RF1) showed a positive correlation before (Asian, r = 0.7, P = 0.00; RF1, r = 0.4, P = 
0.02) and after (Asian, r = 0.6, P = 0.00; RF1, r = 0.5, P = 0.00) creatinine adjustment. 
This positive correlation was also seen for DMA in all groups before and after 
creatinine adjustment, with the exception of the Somali group. Before creatinine 
adjustment, the correlation coefficients and P-values are as follows:  Asian (r = 0.8, P = 
0.00), White (r = 0.5, P = 0.04), RF1 (r = 0.3, P = 0.08) and RF2 (r = 0.5, P = 0.01). 
After creatinine adjustment, the correlation coefficients and P-values are as follows:  
Asian (r = 0.8, P = 0.00), White (r = 0.5, P = 0.02), RF1 (r = 0.4, P = 0.01) and RF2 (r 
= 0.4, P = 0.02). RF1 showed a positive correlation for DMA only after creatinine 
adjustment. Because MA was not detected in many samples and inorganic arsenic 
species were not detected in all samples of the different groups, a correlation was not 
feasible.  
 
5.4  Discussion 
 
As was discussed in Chapters 3 and 4, the majority of the volunteers have 






This is also applicable to urinary selenium levels of all volunteers in the different 
groups that are presented in this Chapter (Fig 5.2 and 5.3). The selenium levels that 
were identified as outliers were all within the normal range [10 – 100 µg/l,  Wang et al., 
(2001); Tiez, (1983)], but only two values (108.5 and 110.2 µg/l, see Table 5.3 and 5.4 
) were  high.  However, even these two values are also close to the highest value in the 
normal range.   Importantly, the overall trend of the study is not affected by the few 
outliers seen, since the exclusion or inclusion of these outliers does not result in any 
significant changes in the statistical outcome.  The individual data of all volunteers in 
all the different groups for As:Se ratios (Fig 5.4) were found to be  clustered around 
their medians. Only one group (RF2) showed two values as outliers. This suggests the 
similarity of these ratios among each group, despite the ethnic differences and different 
condition regarding fasting and non-fasting. 
After creatinine adjustment (Fig. 5.3), the outliers either disappeared or were 
reduced among all the groups. This is in agreement with what reported by Vahter et al., 
(2006a), that the concentrations of biomarkers in urine are highly dependent on the 
dilution of the sample. Therefore, the need to adjust this using specific gravity or 
creatinine is important. The same trend was also established previously for total arsenic 
in Chapters 3 and 4 for ethnic groups and the fasting group, respectively.  
The interesting finding of this study is that a relatively constant As:Se ratio 
(Table 5.2) was obtained for the single volunteer for a period of one year, and this only 
alters after recent seafood consumption. Further observation that a similar As:Se ratio is 
observed for not only the different groups studied here (Table 5.3, 5.4, 5.5, 5.6 and 5.7), 






5.5) in other studies ( UK study with 200 volunteers, German study with 159 volunteers 
and a Brazilian study with 4 volunteers).  Indeed, the As:Se ratio is also relatively 
constant within a single day as was evident from the analysis of urine samples collected 
at the beginning of a fast and after an approximately 12 hour fast for 29 volunteers. 
Although the specific concentration of arsenic and selenium varies significantly 
between the different groups studied here and  previous studies with normal population, 
the ratio of As:Se determined was found to be very similar with the exception of the 
Somali group. The average ratio of As: Se (0.7) in Asian and White populations from 
Leicester (UK) observed in this study and calculated from a previous study of 200 
people from the UK (White et al., 1998)  suggests that the ratio of these two elements is 
also similar in the general UK population.  In the case of exposed and unexposed 
population to high arsenic level, the concentration of selenium does not vary greatly 
between the various groups studied here and by others. However, large variations in 
arsenic levels can be observed because of exposure to arsenic through consumption of 
fish or arsenic-contaminated drinking water. Thus, these two factors are the most 
important factors for   variations in the As:Se ratio. 
It is tempting to suggest that the As:Se ratio determined in the current study can 
be considered the baseline level for the As:Se ratio in unexposed populations and can 
be used as a reliable biomarker of arsenic and selenium level in humans rather than 
relying solely on arsenic or selenium levels separately.  However, the baseline value 
should be used with caution, because the ratio for one of the groups (Somali) is 
significantly different from the other groups studied here. Nevertheless, it appears the 






when used in conjunction with the actual concentration of the two elements coupled 
with background knowledge of the individual’ s recent food intake.  
Dietary intake of arsenic and selenium may play a role in the observed ratio.  In 
the UK, the average total daily dietary intake is 67 µg As/day (MAFF, 2006) and the 
recommended daily dietary intake of selenium is 60-70 µg Se/day (Rayman, 2002).  
The dietary intake ratio of As:Se in the UK population is therefore likely to be 
approximately 1.0.  It may be possible that similar intake of these two elements results 
in a similar pattern of urinary excretion resulting in a ratio of approximately 1.0 for 
urinary As:Se.  The observation that the ratio is also close to one for volunteers from 
Brazil, suggests that despite geographical and dietary differences the ratio is also 
similar although the actual levels of arsenic and selenium reported in the study from  
Brazil is very different from this study. The As:Se of approximately 1.0 was also 
calculated for a German study with 159 volunteers (Heitland and Koster, 2006).   
Although diet may play a role, as to if there is a biological reason for the relatively 
constant As:Se ratio observed in this study is not clear. If a biological process exists in 
maintaining a ratio of approximately 1.0 between arsenic and selenium, then it suggests 
that arsenic intake may also be important for human health.  This would be in 
agreement with a previous suggestion which indicated that intake of trace amounts of 
arsenic may be necessary for metabolism (ATSDR 2000).  
The other interesting finding in this study is the positive correlation between 
total arsenic and selenium in urine samples of all the groups investigated  in this thesis. 
These correlations between total arsenic and selenium in urine samples were 






correlation between total arsenic and selenium has been established among unexposed 
population.  
Two previous studies (Hsueh et al., 2003, Christain et al., 2006) reported a 
positive correlation between arsenic and selenium in urine samples of exposed 
populations. However, this correlation was questioned by Vahter et al., (2006a), 
because the urine samples were not adjusted with creatinine in theses two studies.  
When analysing urine samples, the variation in the dilution of urine samples can be 
controlled by creatinine or specific gravity adjustment (Suwazono et al., 2005).  
Therefore, Vahter et al., (2006a) suggested that the correlation observed by Hsueh et 
al., (2003) and  Christain et al., (2006) before creatinine adjustment, could arise merely 
from the dilution effect. The samples used in the two studies were neither adjusted with 
creatinine nor with specific gravity. Vahter et al., (2006b) found a significant 
correlation between urinary arsenic and selenium before adjustment, in their analysis of 
urine samples from Bangladeshi population exposed to high levels of arsenic through 
their drinking water. However, this correlation disappeared after specific gravity 
adjustment. 
 Miyazaki et al., (2003) established a negative correlation between arsenic and 
selenium in urine samples of exposed populations. However, this negative correlation  
was questioned by Christian et al., (2006) who suggested that this could be because 
Miyazaki et al., (2003) did not adequately control a range of factors with the exception 
of gender.  However, unlike Hseuh et al., 2003 and Christian et al., (2006) the study by 
Miyazaki et al., (2003) adjusted the concentrations of arsenic and selenium in their 






and selenium.  In light of the recent study by Vahter et al., (2006a) the negative 
correlation observed by Miyazaki et al., (2003) is more likely to be reliable. 
However, there is a disagreement between Vahter et. al., (2006b) where no 
correlation was found after specific gravity adjustment, and Miyazaki et al., (2003) 
where creatinine adjustment revealed a negative correlation. The reason for this 
disagreement is not clear and one cannot rule out the possibility that creatinine and 
specific gravity could have different effect on the correlation. 
There is controversy in the literature regarding as to if there is a positive 
correlation between urinary arsenic and selenium for exposed population. Findings 
reported here do show a positive correlation between total arsenic and selenium and 






The As:Se ratio data in this Chapter were analysed for each individual within 
different groups.  As:Se ratios for only a few individuals significantly deviated from the 
rest of the population within each group. However, inclusion or exclusion of these 
values does not influence the outcome. For the first time a baseline value for urinary 
As:Se ratio was established for an unexposed population.  The intra-individual variation 
of As:Se ratio remains relatively constant over time, as determined by monitoring a 
volunteer over a period of one year, and is only affected by recent seafood 






levels reported in a previous study of 200 people in the UK, and it agrees with values 
calculated for 159 volunteer from Germany and a small group of volunteers from 
Brazil. Besides seafood consumption, this study revealed that ethnicity may also result 
in a significant deviation in this ratio.  Seafood consumption and exposure to arsenic 
through drinking water results in an increase in the ratio to between 2.0 to 9.6.  The 
Somali ethnic group showed a low As:Se ratio (0.4) which can be explained as being 
due to the lower level of arsenic in their urine. The established baseline value of As:Se 
ratio in this study among unexposed volunteers from Leicester city may also apply to 
the general population in UK, assuming that arsenic level is similar in their diet and 
drinking water.  However, a larger study needs to be carried out to confirm that this 
value can be applied to unexposed populations across UK, Europe and the rest of the 
world. 
This study demonstrated a positive correlation between urinary arsenic and 
selenium levels amongst unexposed UK population. The fact there is a positive 
correlation between arsenic and selenium and also that the ratio of these elements 
remains very similar, with the exception of seafood consumption,  between different 
groups strongly supports the previous studies, which have reported that these two 
elements interact in the human body such as the involvement of selenium in the 
methylation of arsenic.   When the correlation between arsenic and selenium is not 
positive and the As:Se ratio alters significantly, despite taking into consideration 
seafood consumption and other sources of dietary arsenic, it may be a warning sign 






 This study can not provide an explanation as to if there is a biological 
mechanism that results in the attainment of the As:Se of approximately 1.0 in 
populations unexposed to arsenic, nor can it determine whether selenium supplement in 
food or water can be used to restore this ratio in populations exposed to arsenic.  
However, this finding should be considered as a first step in evaluating the relationship 
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6 Overall conclusion 
 
Suitable methods were developed and/or modified to apply the ICP-MS 
technique for determination of arsenic levels and speciation of human urine and relate 
this to different factors such as ethnicity and fasting. The method developed has been 
successfully applied to establish a baseline arsenic level in human urine samples from 
volunteers in the United Kingdom who are only exposed to background levels of 
arsenic. Moreover, a baseline value for As:Se ratio was also determined for the first 
time.  The ICP-MS methods used in this thesis allows establishing a basal data for 
epidemiological studies.  
In addition to ICP-MS, GF-AAS was also used for the analysis of arsenic in 
human urine, hair and fingernails.  Based on the studies reported in this thesis, ICP-
MS has proved to be the more powerful technique compared to GF-AAS, regarding 
total and speciation analysis for arsenic in human urine, especially at low levels. 
Arsenic levels in urine, hair and fingernails samples presented in this thesis 
were analysed for each individual within different groups.  Only a few individuals 
showed major deviation from the rest of the population within each group.  However, 
inclusion or exclusion of these values does not alter the statistical significance of the 
outcome and the conclusions of the study. 
For the first time, a study has been performed with 63 volunteers to explore if 
there are ethnic differences in arsenic metabolism reflected by differences in levels of 
arsenic in nail, hair and urine samples. The results obtained did not reveal any 
statistically significant ethnic differences in the level of arsenic in hair samples.  






urine samples of one particular ethnic group (Somali-Black-African) compared to two 
other groups (Whites and Asian) residing in the same city (Leicester, UK).  
Furthermore, ethnic difference in urinary arsenic species was found.  The study 
revealed that the Somali ethnic group has a statistically significant difference in the 
percentage of DMA and AB percentages compared to Whites and Asians.  This 
provides evidence that ethnic difference exist in urinary arsenic excretion patterns. 
This may be due to differences in genetics, diet or a combination of both dietary and 
genetic factors. 
No major difference in the total level of urinary arsenic in urine samples 
collected at the beginning and end of 12 hours long fast in a study carried out with 29 
volunteers. However, the frequency of detection of MA at the end of fasting period, 
suggest that the human body, during the daytime fasting period, favours the removal of 
the most toxic methylated arsenic species detected in this study.  It is therefore 
concluded, that fasting does have an effect on the pattern of urinary arsenic excretion 
that requires further investigation especially in arsenic exposed regions of the world 
such as Bangladesh and India.  
Relationship between two closely related metalloids, arsenic and selenium, has 
not been previously investigated with unexposed population, although studies with 
animals and exposed populations suggest interaction between them. Results presented 
in this thesis shows that urinary arsenic and selenium are positively correlated amongst 
a group of unexposed volunteers from Leicester, UK. The urinary As:Se ratio is not 
influenced by fasting, although ethnicity has a significant effect as one of the groups 






explains the lower As:Se ratio for the latter group.  Other than the Somali group, the 
vast majority of the population in the UK and in other countries display a constant 
As:Se ratio that is close to one.  This together with the relative constancy in this value 
observed over a one year period with one volunteer raises the possibility that the As:Se 
ratio could be considered as a potential biomarker in human urine.  The ratio may 
provide a more complete picture of the urine analysis and the relationship between 
arsenic and selenium, then just measuring the individual concentrations of these 
elements.  This study cannot explain the underlying reason behind the attainment of the 
highly constant As:Se ratios (approx. 1.0) in unexposed population, nor can it 
determine whether selenium supplement in food or water could be used restore this 
ratio in exposed populations. Nevertheless, the finding of this study should be 
considered as a first step in evaluating the relationship between arsenic and selenium in 
humans in order to understand the mechanism behind the established ratio and the 
relationship between these two elements.           
 
7 Future work 
Analysis carried out in this study, principally focused on the analysis of arsenic in 
urine samples. More analysis need to be carried out with other biological samples 
including blood.  Such samples can be employed for further confirmation of the 
findings of this thesis. Future studies, such as the ones listed below, needs to be carried 






(i)  Studies with a larger population size, carefully controlled diet, and genetic 
analysis need to be carried out in order to identify the precise reason for the observed 
differences between various ethnic groups in terms of levels and arsenic species 
detected in urine samples. These studies would aim to ascertain as to which of the 
following factors is responsible for the difference: dietary, genetic or a combination of 
both.  
(ii)  More studies need to be conducted to understand the effect of fasting on 
urinary arsenic excretion pattern in humans. For example, a study can be carried out 
with volunteers one month before fasting, during the month long fasting, and one 
month after fasting to fully understand the effect of Ramadan fasting on arsenic 
metabolism in exposed and unexposed population. Such a study could reveal if exposed 
people can perform fasting without suffering adverse health effects from arsenic 
exposure. 
(iii)  As:Se ratio may be a potential biomarker in human urine analysis to 
complement the measurement of arsenic and selenium alone.  This may provide a better 
understanding of the correlation between these two elements. In the future, studies with 
a larger groups of volunteers, with carefully controlled factors such as ethnicity and 
diet, needs to be carried out to see if the baseline ratio of As:Se reported in this study is 
maintained.  Importantly, research needs to be carried out to see if a biological process 
is responsible for the As:Se ratio obtained and the  positive correlation between arsenic 
and selenium.  Further work with measurements of other biological tissues such as 
blood, hair and nail will also help in the understanding of the relationship between 
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       E.I.Brima BSc MSc AMRSC 
Leicester School of Pharmacy 
Faculty of Health and Life Sciences The 
Gateway, Leicester, LE1 9BH 
Date: 
 
Re: Study of naturally occurring arsenic containing chemicals in urine. 
Dear Sir/Madam, 
 
This study is intended to assess the amount of arsenic found in the human urine 
of people from as broad a cross-section of society as possible.  Non-toxic forms of 
arsenic are present naturally in an individual’ s urine.  A primary objective of this study 
is to elucidate the source, i.e. diet or natural origin, of arsenic found in human urine, 
and determine whether diet or ethnic background is a determining factor in the types of 
arsenic observed.  
The information we need from you via the questionnaire attached to this letter and the 
analysis result will be treated as confidential. 
  Please use the following procedure for collection of the urine sample: 
 
   1. Collect the first morning urine (mid-stream). 
2. About half a bottle urine will be sufficient for the tests.  
  3. Collect the sample into the polyethylene bottle supplied. 
  4. Keep the sample cool prior to returning it to Eid Brima and return as soon as after 
collection as possible. 
 











                                                                                                                  
Building: Hawthorn 
Room:  4.1/1.10 
Ext:  8286/8834 
Mob:  07919140216 
Email:  ebrima@dmu.ac.uk 
Leicester School of Pharmacy 
Faculty of Health and Life Sciences       
The Gateway, Leicester, 
LE1 9BH 
 
Investigation of arsenic in human urine 
 




Please tick (   ) as appropriate. 
* Please refrain from eating fish and seafood for 3 days prior to sample collection. 
Gender Male  Female  Age 
 
Are you currently 
menstruating? 
 
Yes  No   
Are you pregnant? 
 
Yes  No   




Yes  No   
Do you participate in 
sporting activities? 





Are you a vegan? Yes  No        
Are you a vegetarian? Yes  No  If yes, do you eat fish? 
                Yes    No   
Are you a none meat 
eater? 
Yes  No        




 Once a 
week  
         
 
Once a month Never            
Have you eaten fish 
recently?  
              Yes    No     
If yes, 







2 days ago     
3 days ago     
1 week ago    
 
 




 Once a 
week  
         
 
Once a month Never            
Have you eaten seafood 
recently?  
              Yes    No     
If yes, 
1 day ago         
2 days ago        
3 days ago        
1 week ago       
 
 




 Once a 
week  
         
 
Once a month Never            
Have you eaten Mushrooms 
recently?  
              Yes    No     
If yes, 
1 day ago         
2 days ago        
3 days ago        
1 week ago       
 
 
Are you a smoker? Yes  No  If yes, how many cigarettes 
per day? 
 





Do you drink alcohol? 
* 1 unit = ½ pint beer, 1.5 unit 
= 1 single spirit, 1 unit = 1 
glass wine, 1 unit = 1 glass 
sherry  
 















Do you drink tea? Yes  No  If yes, how many cups per 
day? 
 
How many cups per week? 
 
 
Do you drink Coffee? 
Yes 
 No  If yes, how many cups per 
day? 
 
How many cups per week? 
 
 
Do you drink soft drinks? Yes  No  If yes, how many litres per 
week? 
 











 Asian or Asian  British – 












 Other Black Background 










 Other mixed background  
                 




 Other White 
background 
 Other ethnic background  
                 
 
Please Specify,… … … … . 
 










Raw data shows the Repreducibility of GF-AAS by meausuring 
arsenic standard for ten times 
Tube    Sample ID              Conc ppb   %RSD    Mean Abs   BG Abs  Readings 
S:MIX  CAL ZERO                   0.00     12.8        0.0093   0.0749    0.0101   0.0084 
S:MIX  STANDARD 1               9.99      6.1        0.0677   0.0092    0.0706   0.0648 
S:MIX  STANDARD 2              29.99     3.0        0.1979   0.0081    0.1937   0.2021 
S:MIX  STANDARD 3               59.97     0.5        0.4038  -0.0076    0.4023   0.4053 
1:1    042104CTRLAsV              29.34     0.8        0.1946  -0.0077    0.1934   0.1957 
1:2    042105CTRLAsV               32.67     1.1        0.2166  -0.0023    0.2148   0.2183 
1:3    042106CTRLAsV               32.06     1.1        0.2125  -0.0091    0.2142   0.2109 
1:4    042107CTRLAsV               32.34     1.6        0.2144  -0.0111    0.2168   0.2120 
1:5    042108CTRLAsV                30.99     2.4        0.2055  -0.0168    0.2089   0.2021 
1:6    042109CTRLAsV                32.18     0.1        0.2133  -0.0191    0.2136   0.2131 
1:7    042110CTRLAsV               31.26     2.0        0.2072  -0.0145    0.2101   0.2044 
1:8    042111CTRLAsV               31.99     3.0        0.2121  -0.0168    0.2165   0.2077 
1:9    042112CTRLAsV               28.60     8.6        0.1897  -0.0158    0.1782   0.2012 
1:10   042113CTRLAsV               30.29     0.8        0.2009  -0.0151    0.2020   0.1997 
 
Typical raw data from blank, standards , control and CRM NIES 
No.18 by using GF-AAS 
 
Tube    Sample ID                  Conc ppb   %RSD      Mean Abs   BG Abs  Readings 
S:MIX  CAL ZERO                            0.00    1.1         0.0093   0.0488    0.0094   0.0093 
S:MIX  STANDARD 2                       1.00    25.1       0.0087   0.0078    0.0102   0.0071 
S:MIX  STANDARD 3                       1.50     10.6       0.0144   0.0102    0.0133   0.0155 
S:MIX  STANDARD 4                       3.01     3.3       0.0346  -0.0131    0.0338   0.0354 
1:8    091604CTRLAsV                       2.16     0.0        0.0230   0.0076    0.0230   0.0230 
1:14   091604CTRLAsV                      2.18    11.9      0.0232   0.0030    0.0212   0.0251 
1:23   091604CRM200-1%HNO3      0.85   33.4      0.0086   0.0158    0.0066  0.0107 
1:24   091604CRM200-1%HNO3        0.64     7.4       0.0065   0.0120    0.0068   0.0061 
1:25   091604CRM200-1%HNO3       0.72    7.3       0.0073   0.0137    0.0069  0.0077 






























































Figure A2.3.2   HPLC-ICP-MS chromatogram of a standard containing 1 µg As/l of 
























Figure A2.3.3   HPLC-ICP-MS chromatogram of a standard containing 5 µg As/l of 
























Figure A2.3.4   HPLC-ICP-MS chromatogram of a standard containing 10 µg As/l of 





























Figure A2.3.5   HPLC-ICP-MS chromatogram of a standard containing 25 µg As/l of 
























Figure A2.3.6   HPLC-ICP-MS chromatogram of a certified urine sample (CRM NIES 






























Figure A2.3.4   HPLC-ICP-MS chromatogram of a standard containing 10 µg As/l  






















Figure A2.3.4   HPLC-ICP-MS chromatogram of a standard containing 10 µg As/l  














Detailed information (variables) for urine samples (n = 21) collected 














































1. UA1 21 Gender 0 0 1 14 2 5.0 
2. UA2 21 Male 0 0 8 0 4 7.0 
3. UA3 20 Male 0 0 0 0 0 5.0 
4. UA4 20 Male 0 0 0 0 0 7.0 
5. UA5 20 Male 0 0 0 0 0 6.0 
6. UA6 21 Male 0 0 0 0 0 6.0 
7. UA7 18 Male 0 1 0 0 21 5.0 
8. UA8 30 Male 0 0 0 25 3 5.0 
9. UA9 33 Male 0 0 0 25 28 6.5 
10 UA10 28 Male 0 0 1 1 0 5.5 
11. UA11 28 Male 0 0 1.5 7 0 5.0 
12. UA12 21 Male 0 0 0 21 0 7.0 
13. UA13 26 Male 10 0 0 21 28 8.0 
14. UA14 26 Male 0 0 1.5 21 0 7.0 
15. UA15 22 Male 0 0 0 14 0 6.0 
16. UA16 - Male 0 0 0.4 5 0 6.0 
17. UA17 20 Male 0 0 0 20 3 6.5 
18. UA18 33 Male 0 0 0.5 25 0 6.0 
19. UA19 23 Male 0 0 0 12 1 6.5 
20. UA20 26 Female 0 0 2 14 0 6.5 








Detailed information (variables) for urine samples (n =22) collected 











































1. US1 35 Male 0 0 3 21 0 5.0 
2. US2 35 Female 0 0 2 3 0 7.0 
3. US3 35 Male 0 0 3 4 0 5.0 
4. US4 24 Male 0 0 0 0 0 7.0 
5. US5 - Male 0 0 0 21 0 6.0 
6. US6 34 Male 0 0 0 10 6 6.0 
7. US7 - Male 0 0 0 72 0 5.0 
8. US8 36 Male 0 0 4 14 7 5.0 
9. US9 25 Female 0 0 1 6 1 6.5 
10 US10 23 Female 0 0 0 4 0 5.5 
11. US11 27 Male 0 0 0 14 0 5.0 
12. US12 36 Male 0 0 4 14 20 7.0 
13. US13 20 Female 0 0 0 12 3 8.0 
14. US14 36 Female 0 0 0 21 0 7.0 
15. US15 43 Male 0 0 0.5 21 2 6.0 
16. US16 23 Female 0 0 1 14 7 6.0 
17. US17 18 Female 0 0 1 5 3 6.5 
18. US18 49 Male 0 0 0 21 0 6.0 
19. US19 31 Male 0 0 1 21 10 6.5 
20. US20 17 Female 0 0 1 4 3 6.5 
21. US21 19 Female 0 0 4 28 0 5.0 








Detailed information (variables) for urine samples (n = 20) collected 













































1. UW1 34 Female 10 5 0.5 3 21 5.0 
2. UW2 50 Female 0 1 1 7 28 5.0 
3. UW3 28 Male 0 20 0 10 10 5.0 
4. UW4 30 Male 0 0 0 7 7 5.0 
5. UW5 56 Male 0 5 1 5 30 5.0 
6. UW6 48 Male 0 5 0 7 14 5.0 
7. UW7 40 Female 0 5 0 0 5 6.0 
8. UW8 43 Female 0 10 4 0 50 7.0 
9. UW9 51 Male 0 20 0 0 14 5.0 
10. UW10 37 Female 0 0 0 3 14 5.0 
11. UW11 69 Male 0 20 1 0 35 6.0 
12. UW12 27 Female 20 20 3 7 7 7.0 
13. UW13 27 Female 0 5 0.5 4 8 5.0 
14. UW14 57 Male 0 20 3.5 0 40 5.0 
15. UW15 41 Female 0 10 0.3 21 0 5.0 
16. UW16 22 Female 0 5 1 21 0 5.0 
17. UW17 36 Male 0 5 0.5 25 12 5.0 
18. UW18 57 Male 10 1 2 18 0 5.0 
19. UW19 31 Male 0 20 2 0 15 5.0 








Dates of collection and  measurements, and locations of urine samples 








Sample name Date of 
collection 
Date of measurement 
(speciation)-  at  Manchester 
University 
Date of measurement 
(total)-  at Hull University 
UA1 01/10/2004 25/02/2005 16/08/2005 
UA2 01/10/2004 25/02/2005 16/08/2005 
UA3 20/10/2004 25/02/2005 16/08/2005 
UA4 20/10/2004 25/02/2005 16/08/2005 
UA5 20/10/2004 25/02/2005 17/08/2005 
UA6 20/10/2004 25/02/2005 16/08/2005 
UA7 25/10/2004 25/02/2005 16/08/2005 
UA8 01/11/2004 25/02/2005 16/08/2005 
UA9 01/11/2004 25/02/2005 16/08/2005 
UA10 03/11/2004 25/02/2005 16/08/2005 
UA11 04/11/2004 25/02/2005 16/08/2005 
UA12 05/11/2004 25/02/2005 16/08/2005 
UA13 09/11/2004 25/02/2005 16/08/2005 
UA14 23/11/2004 04/04/2005 16/08/2005 
UA15 24/11/2004 04/04/2005 16/08/2005 
UA16 30/11/2004 04/04/2005 16/08/2005 
UA17 30/11/2004 04/04/2005 16/08/2005 
UA18 30/11/2004 04/04/2005 17/08/2005 
UA19 01/12/2005 04/04/2005 16/08/2005 
UA20 09/12/2004 04/04/2005 16/08/2005 









Dates of collection and  measurements, and locations of urine samples 












Sample name Date of collection Date of measurement 
(speciation)-  at  
Manchester University 
Date of measurement 
(total)-  at  Hull 
University 
US1 19/10/2004 04/04/2005 16/08/2005 
US2 19/10/2004 05/04/2005 16/08/2005 
US3 19/10/2004 05/04/2005 16/08/2005 
US4 19/10/2004 05/04/2005 16/08/2005 
US5 19/10/2004 05/04/2005 16/08/2005 
US6 19/10/2004 05/04/2005 16/08/2005 
US7 20/10/2004 05/04/2005 16/08/2005 
US8 21/10/2004 05/04/2005 16/08/2005 
US9 22/10/2004 05/04/2005 16/08/2005 
US10 22/10/2004 05/04/2005 16/08/2005 
US11 22/10/2004 05/04/2005 16/08/2005 
US12 26/10/2004 05/04/2005 16/08/2005 
US13 26/10/2004 05/04/2005 16/08/2005 
US14 27/10/2004 06/04/2005 16/08/2005 
US15 27/10/2004 06/04/2005 16/08/2005 
US16 28/10/2004 06/04/2005 16/08/2005 
US17 02/11/2004 06/04/2005 16/08/2005 
US18 02/11/2004 06/04/2005 16/08/2005 
US19 02/11/2004 06/04/2005 16/08/2005 
US20 02/11/2004 06/04/2005 16/08/2005 
US21 02/11/2004 06/04/2005 16/08/2005 










Dates of collection and  measurements, and locations of urine samples 











Sample name Date of collection  Date of measurement 
(speciation)- at 
Manchester University 
Date of measurement 
(total)-  at  Hull 
University 
UW1 11/10/2004 23/02/2005 16/08/2005 
UW2 14/10/2004 23/02/2005 16/08/2005 
UW3 14/10/2004 24/02/2005 16/08/2005 
UW4 15/10/2004 24/02/2005 17/08/2005 
UW5 15/10/2004 24/02/2005 16/08/2005 
UW6 18/10/2004 24/02/2005 16/08/2005 
UW7 18/10/2004 24/02/2005 16/08/2005 
UW8 19/10/2004 24/02/2005 16/08/2005 
UW9 22/10/2004 24/02/2005 16/08/2005 
UW10 25/10/2004 24/02/2005 16/08/2005 
UW11 22/11/2004 24/02/2005 16/08/2005 
UW12 25/11/2004 24/02/2005 16/08/2005 
UW13 06/12/2004 24/02/2005 16/08/2005 
UW14 10/12/2004 11/02/2005 16/08/2005 
UW15 13/11/2004 11/02/2005 16/08/2005 
UW16 14/11/2004 11/02/2005 16/08/2005 
UW17 09/01/2004 11/02/2005 16/08/2005 
UW18 12/01/2004 23/02/2005 16/08/2005 
UW19 13/01/2005 11/02/2005 16/08/2005 







Representive figures from blank, standards, CRM NIES No.18, and 


















































 Figure A3.7.2   HPLC-ICP-MS chromatogram of a standard containing 1 µg As/l of 

































Figure A3.7.3   HPLC-ICP-MS chromatogram of a standard containing 5 µg As/l of 























Figure A3.7.4   HPLC-ICP-MS chromatogram of a standard containing 10 µg As/l of 


























As III MA As V
 
Figure  A3.7.5   HPLC-ICP-MS chromatogram of a standard containing 25µg As/l of 























Figure A3.7.6   HPLC-ICP-MS chromatogram of a certified urine sample (CRM NIES 



























Figure A3.7.7  HPLC-ICP-MS chromatogram of a standard containing 10 µg As/l 






















Figure A3.7.8  HPLC-ICP-MS chromatogram of a standard containing 10 µg As/l 
































Figure A3.7.9   HPLC-ICP-MS chromatogram of a urine sample (UA5) 5-fold diluted 






















Figure A3.7.10   HPLC-ICP-MS chromatogram of a urine sample (UA3) 5-fold diluted 






























Figure A3.7.11   HPLC-ICP-MS chromatogram of a urine sample (US9) 5-fold diluted 



















Figure A3.7.12   HPLC-ICP-MS chromatogram of a urine sample (US11) 5-fold 






























Figure A3.7.13   HPLC-ICP-MS chromatogram of a urine sample (UW13) 5-fold 
























Figure A3.7.14   HPLC-ICP-MS chromatogram of a urine sample (UW4) 5-fold 









Dates of collection and  measurements, and locations of hair and 
fingernail samples analysis from the Asian volunteers.  
 
* Numbers between brackets are additional names given to hair and fingernail samples, 
and apply to the following Appendices 3.9 to 3.10. The additional names are read as 

















Date of measurement 
(total arsenic)-  at  
De Montfort 
University 
HA1(26)* NA1(26)* 06/06/2005 03/09/2005 24/10/2005 11/11/2005 (HA1) 
HA2(27) NA2(27) 06/06/2005 03/09/2005 24/10/2005 
HA3(28) NA3(28) 20/05/2005 03/09/2005 24/10/2005 11/11/2005 (HA3) 
HA4(29) NA4(29) 20/05/2005 03/09/2005 24/10/2005 11/11/2005 (NA4) 
HA5(32) NA5(32) 05/08/2005 03/09/2005 24/10/2005 
HA6(33) NA6(33) 09/08/2005 03/09/2005 24/10/2005 11/11/2005 (NA6) 
HA7(34) NA7(34) 09/08/2005 03/09/2005 24/10/2005 
HA8(35) NA8(35) 10/08/2005 03/09/2005 24/10/2005 11/11/2005 (HA8) 
HA9(36) NA9(36) 10/08/2005 03/09/2005 24/10/2005 11/11/2005 (NA9) 








Dates of collection and  measurements, and locations of hair and 

















(total arsenic)-  at  
De Montfort 
University 
HS1(1) NS1(1) 13/05/2005 03/08/2005 24/10/2005 
HS2(2) NS2(2) 14/05/2005 03/08/2005 24/10/2005 11/11/2005 (HS2) 
HS3(3) NS3(3) 14/05/2005 03/08/2005 11/11/2005  
HS4(4) NS4(4) 15/05/2005 03/08/2005 24/10/2005 11/11/2005 (HS4) 
HS5(5) NS5(5) 15/05/2005 05/08/2005 24/10/2005 
HS6(6) NS6(6) 16/05/2005 05/08/2005 24/10/2005 
HS7(7) NS7(7) 20/05/2005 05/08/2005 24/10/2005 
HS8(8) NS8(8) 20/05/2005 05/08/2005 24/10/2005 11/11/2005 (NS8) 
HS9(9) NS9(9) 20/05/2005 05/08/2005 24/10/2005 11/11/2005 (HS9) 
HS10(10) NS10(10) 24/05/2005 05/08/2005 24/10/2005 
HS11(11) NS11(11) 24/05/2005 05/08/2005 24/10/2005 
HS12(12) NS12(12) 24/05/2005 07/08/2005 11/11/2005  
HS13(13) NS13(13) 24/05/2005 07/08/2005 24/10/2005 
HS14(14) NS14(14) 24/05/2005 07/08/2005 24/10/2005 11/11/2005 (HS14) 








Dates of collection and  measurements, and locations of hair and 





















Date of measurement 
(total arsenic)-  at  De 
Montfort University 
HW1(30) NW1(30) 03/06/2005 05/09/2005 11/11/2005 
HW2(31) NW2(31) 06/08/2005 05/09/2005 24/10/2005 
HW3(38) NW3(38) 09/08/2005 07/09/2005 11/11/2005 
HW4(39) NW4(39) 09/08/2005 07/09/2005 11/11/2005 
HW5(40) NW5(40) 09/08/2005 07/09/2005 11/11/2005 
HW6(41) NW6(41) 09/08/2005 07/09/2005 11/11/2005 
HW7(42) NW7(42) 09/08/2005 07/09/2005 11/11/2005 
HW8(43) NW8(43) 10/08/2005 07/09/2005 11/11/2005 
HW9(44) NW9(44) 01/09/2005 07/09/2005 11/11/2005 
HW10(45) NW10(45) 02/09/2005 09/09/2005 11/11/2005 







Detailed information (variables) for urine samples (n = 58) collected from the fasting volunteers (n = 29) at two time 




























1. UNF1 UF1 B 39 Male 0 0 1 10 0 5 5 
2. UNF2 UF2 A 19 Male 0 0 0.5 9 0 5 5 
3. UNF3 UF3 B 37 Male 0 0 1 14 0 5 5 
4. UNF4 UF4 ME - Male 0 0 0 28 3 6 5 
5. UNF5 UF5 B 32 Male 0 0 1 14 0 7 6 
6. UNF6 UF6 B 34 Male 0 0 0 4 0 7.5 7 
7. UNF7 UF7 B 32 Male 0 0 2 15 0 6 7.5 
8. UNF8 UF8 B 27 Male 0 0 1 7 0 7 5 
9. UNF9 UF9 ME 39 Male 0 0 6 15 1 6 7 
10. UNF10 UF10 A 42 Male 0 0 2 14 1 7.5 7 
11. UNF12 UF12 ME 26 Male 0 0 1 10 0 6.0 7.5 
12 UNF13 UF13 A 33 Male 0 0 2 25 3 6 6 
13 UNF14 UF14 A 28 Male 0 0 0 25 28 6 7.5 
14 UNF15 UF15 ME 26 Male 0 0 3 15 0 6.5 6 
15 UNF16 UF16 NA 42 Male 0 0 0 10 0 6.5 7 





































































































































































































































































































































































































































































































































































































































Dates of collection and  measurements, and locations of urine samples 
analysis from the single fasting volunteer. 
 
 
* Each pair samples were collectedon the same day , at the beginning of fasting period 
RF1 (UNF) and at the end of fasting period RF2 (UF).   






























(total arsenic)-  at 
Hull University 
1. UNC1F1 UC1F1 05/11/2004 30/06/2005 16/08/2005 
2. UNC1F2 UC1F2 06/11/2004 30/06/2005 16/08/2005 
3. UNC1F3 UC1F3 07/11/2004 30/06/2005 16/08/2005 
4. UNC1F4 UC1F4 08/11/2004 30/06/2005 16/08/2005 








Dates of collection and  measurements, and locations of urine samples 













(total)-  at  Hull 
University 
UNF1 UF1 24/10/2004 25/05/2005 16/08/2005 
UNF2 UF2 27/10/2004 25/05/2005 16/08/2005 
UNF3 UF3 27/10/2004 25/05/2005 16/08/2005 
UNF4 UF4 27/10/2004 26/05/2005 16/08/2005 
UNF5 UF5 27/10/2004 26/05/2005 16/08/2005 
UNF6 UF6 28/10/2004 26/05/2005 16/08/2005 
UNF7 UF7 28/10/2004 26/05/2005 16/08/2005 
UNF8 UF8 29/10/2004 13/06/2005 16/08/2005 
UNF9 UF9 29/10/2004 26/05/2005 16/08/2005 
UNF10 UF10 29/10/2004 27/05/2005 16/08/2005 
UNF12 UF12 01/11/2005 27/05/2005 16/08/2005 
UNF13 UF13 01/11/2005 13/06/2005 16/08/2005 
UNF14 UF14 01/11/2005 14/06/2005 16/08/2005 
UNF15 UF15 01/11/2005 14/06/2005 16/08/2005 
UNF16 UF16 01/11/2005 14/06/2005 16/08/2005 
UNF17 UF17 01/11/2005 14/06/2005 16/08/2005 
UNF19 UF19 03/11/2005 14/06/2005 16/08/2005 
UNF21 UF21 03/11/2005 15/06/2005 16/08/2005 
UNF22 UF22 03/11/2005 15/06/2005 16/08/2005 
UNF24 UF24 03/11/2005 15/06/2005 16/08/2005 
UNF25 UF25 03/11/2005 15/06/2005 16/08/2005 
UNF26 UF26 03/11/2005 28/06/2005 16/08/2005 
UNF27 UF27 04/11/2005 28/06/2005 16/08/2005 
UNF28 UF28 04/11/2005 29/06/2005 16/08/2005 
UNF29 UF29 04/11/2005 29/06/2005 16/08/2005 
UNF30 UF30 05/11/2005 29/06/2005 16/08/2005 
UNF32 UF32 05/11/2005 29/06/2005 16/08/2005 
UNF33 UF33 04/11/2005 29/06/2005 16/08/2005 







Representive chromatograms from blank, standards, CRM NIES No. 18 



















































Figure A4.4.2   HPLC-ICP-MS chromatogram of a standard containing 1 µg As/l of 



























Figure A4.4.3   HPLC-ICP-MS chromatogram of a standard containing 5 µg As/l of 





















Figure A4.4.4   HPLC-ICP-MS chromatogram of a standard containing 10 µg As/l of 
























As III MA As V
 
Figure A4.4.5   HPLC-ICP-MS chromatogram of a standard containing 25 µg As/l of 























Figure A4.4.6  HPLC-ICP-MS chromatogram of a certified urine sample (CRM NIES 

























Figure A4.4.7   HPLC-ICP-MS chromatogram of a standard containing 10 µg As/l 





















Figure A4.4.8   HPLC-ICP-MS chromatogram of a standard containing 10 µg As/l 




























Figure A4.4.9  HPLC-ICP-MS chromatogram of a certified urine sample (UNF3), 
























Figure A4.4.10  HPLC-ICP-MS chromatogram of a certified urine sample (UF3), 












Dates of collection and  measurements, and locations of urine samples 
















Date of measurement 
(total arsenic and 
selenium)-  at Hull 
University 
Au04U 23/08/2004 2 17/08/2005 
Sep04U 23/09/2004 7 17/08/2005 
Oct04U 28/10/2004 7 17/08/2005 
Nov04U 22/11/2004 2 17/08/2005 
Dec04U 20/12/2004 2 17/08/2005 
Jan05U 20/01/2005 1 17/08/2005 
Feb05U 22/02/2005 1 17/08/2005 
Mar05U 24/03/2005 1 17/08/2005 
Apr05U 22/04/2005 14 17/08/2005 
May05U 20/05/2005 14 17/08/2005 
Jun05U 27/06/2005 7 17/08/2005 
Jul05U 27/07/2005 21 17/08/2005 
